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Abstract 
Polycystic ovary syndrome (PCOS) has been recognized as one of the most common 
endocrine disorders affecting reproductively aged women. PCOS is a complex disorder of 
developmental origin comprising of genetic and environmental factors, including 
abnormal exposure to androgens during a critical period of prenatal development. As 
such, women with PCOS and ewes prenatally exposed to testosterone (T) show similar 
reproductive and metabolic defects, including anovulatory dysfunctions stemming from 
abnormal gonadotropin releasing hormone GnRH/luteinizing hormone LH secretion, 
insulin resistance, and hyperinsulinemia. Our lab has previously shown that prenatal T-
treated sheep show alterations in arcuate (ARC) KNDy (co-expressing kisspeptin, 
neurokinin B/dynorphin) and agouti-related peptide (AgRP) neurons in the arcuate 
nucleus (ARC), two populations that play an important role in the control of reproduction 
and metabolism, respectively. For this dissertation, I examine the effects of prenatal T 
treatment on androgen receptor (AR) and insulin receptor (IR) expression with the 
reproductive and metabolic neurons of the hypothalamus, the ARC KNDy, AgRP and 
proopiomelanocortin (POMC) neurons, the preoptic area (POA) kisspeptin neurons, and 
the GnRH neurons. Analysis of immunohistochemical staining revealed that prenatal T 
treatment increases AR-immunoreactivity (ir) in several brain areas of the sheep brain as 
well as colocalization of AR with ARC KNDy and AgRP and POA kisspeptin neurons. 
Conversely, prenatal T treatment decreases IR colocalization with ARC KNDy and AgRP 
neurons, but not POMC neurons, while POA kisspeptin and GnRH neurons do not 
colocalize IR. Prenatal, but not postnatal interventions blocking androgen action 
(Flutamide, F) or increasing sensitivity to insulin (Rosiglitazone, R) can prevent the 
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prenatal T induced alterations in these populations.  Lastly, I show that leptin, an 
important metabolic signal that can influence GnRH secretion and reproductive function, 
indirectly activates ARC KNDy neurons through a pathway that may include the leptin-
sensitive AgRP and POMC neurons. Overall, these results indicate that prenatal exposure 
to T masculinizes the female brain and alters insulin signalling in the reproductive and 
metabolic neurons of the ARC and highlights the importance of prenatal interventions in 
blocking these effects. These changes may contribute the reproductive and metabolic 
dysfunctions associated with the PCOS phenotype.  
 
 
 
 
Keywords: 
Prenatal testosterone; PCOS; Kisspeptin; KNDy; AgRP; POMC; androgen receptor; 
insulin receptor; leptin; PCOS; metabolism; reproduction; insulin sensitizer, androgen 
blocker
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Chapter 1: Literature Review 
 
1.1 Regulation of gonadotropin secretion in the normal menstrual cycle 
 
In mammals, ovulatory function relies on a series of complex and integrated interactions 
between the hypothalamus, pituitary gland and ovaries (Fig. 1). The hypothalamic-
pituitary unit is the principal driver of reproductive function. It controls gonadal function 
by the dual action of the pituitary gonadotropins luteinizing hormone (LH) and follicle-
stimulating hormone (FSH). The synthesis and release of these gonadotropins are 
regulated by gonadotropin releasing hormone (GnRH), released in a pulsatile manner 
from GnRH neurons in the hypothalamus. The frequency of GnRH pulses largely 
determines which gonadotropin hormone is synthesized and secreted by the same 
gonadotrope cell. Rapid GnRH pulses favor LH, whereas slower GnRH pulses favor FSH 
secretion (1-2). In females, two modes of GnRH secretion occur at different times during 
the ovarian cycle. Through most of the cycle, GnRH is secreted in a pulsatile manner (3-
4). During this time, estradiol (E2) and progesterone (P) act in a negative feedback 
manner to regulate GnRH pulsatile secretion, with E2 inhibiting pulse amplitude and P 
inhibiting pulse frequency (5). GnRH pulsatility progressively increases during the 
follicular phase, partly due to a gradual loss of the restrictive influence of progesterone 
(6), reaching a peak of one pulse per hour during the late follicular phase (7). At this 
stage of the cycle, the preovulatory GnRH/LH surge is induced by the positive feedback 
actions of high concentrations of E2 produced by the dominant ovarian follicle(s). The 
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GnRH/LH surge is marked by an upsurge in pituitary LH release in response to the rapid 
GnRH pulses, which in turn stimulates ovulation (8-9). Following ovulation, the corpus 
luteum secretes E2 and P, which act in a negative feedback manner to slow GnRH pulses 
to one pulse every 3–4 h (7). This pulse frequency favors synthesis and release of FSH 
and initiation of the next wave of follicular development. Considering the complex set of 
interactions that are essential for ovulatory function, alterations at any level of the 
hypothalamic–pituitary–ovarian axis can result in ovulatory dysfunction. 
 
 
Figure 1. Schematic diagram illustrating the female hypothalamo-pituitary-gonadal (HPG) axis. 
Abbreviations: GnRH: gonadotropin releasing hormone, LH: luteinizing hormone, FSH: follicle 
stimulating hormone. 
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1.2 Prenatal programming of reproduction and the origins of polycystic 
ovarian syndrome (PCOS) 
Several decades ago, David Barker proposed that exposure of the developing fetus to 
certain environmental factors could permanently program physiology function during 
adulthood (10). Among these factors are the gonadal steroid hormones. It is now widely 
accepted that exposure of the developing female to high levels of androgens during the 
critical period of prenatal development, permanently changes the organization of the 
neuroendocrine axis, setting the framework for dysfunctions in adulthood  (11).  The 
gonadal steroid hormones, testosterone (T) and estrogen (E2) are important for organizing 
the brain during early development as well as regulating growth, maintenance and 
function of various reproductive tissues. In the brain and other tissues, testosterone can be 
aromatized to estradiol by the enzyme aromatase and act on estrogen receptors (ER) (12-
13). Alternatively, 5α-reductase can reduce testosterone to more a potent androgen 
dihydrotestosterone (DHT) which also binds androgen receptors (AR) (14-15) (Fig. 2). In 
humans, a neonatal surge in T starts at about 2 weeks of age and peaks over the next 12–
17 weeks (16); however, T levels remain approximately ten times lower in female fetuses 
compared to males (17). It has been proposed that the increase in T is critical for sexual 
differentiation of the brain, specifically masculinization and defeminization in the male 
(18-19). As such, exposure of the female fetus to excess T during critical periods of 
prenatal development results in phenotypic, behavioural and reproductive abnormalities 
in humans (20-21). This has also been documented in other mammalian species including 
monkeys (22-23), sheep (24-27), rats (28), mice (29), and guinea pigs (30).  This type of 
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abnormal steroid exposure can occur when female fetuses (or their mothers) produce 
excessive levels of androgens (ie. congenital adrenal hyperplasia (CAH) (31) or are 
exposed  to androgens via an exogenous source, such as endocrine disruptive agents (32-
33) or certain medical interventions (34). 
 
Figure 2. Genomic and non-genomic actions of testosterone (T). Unbound bioactive T interacts 
with the cytoplasm androgen receptor (AR). AR is also activated by dihydrotestosterone in a 
similar way. Ligand binding induces conformational changes of the receptor. T-AR complex 
forms dimers and acts as a functional transcription factor. Activated AR recognizes the androgen 
response element in the nucleus due its specific structure. Coactivators (CA) and RNA 
polymerase II are recruited for transcription initiation. Gene expression produces a pool of 
specific proteins that can affect cell characteristics, metabolism and activity. The non-genomic 
response is mediated via receptor-tyrosine-kinases (RTK) or G-protein coupled receptors. 
Subsequently, downstream signaling cascades are activated, that can result in genomic effect. 
Adapted from Durdiakova et al. (2011)(35). 
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Prenatal exposure to androgens has been shown to have an organizational effect on the 
brain circuitry involved in reproductive and metabolic regulation (36), leading to 
ovulatory dysfunction, infertility, increased risk of obesity, insulin resistance, and 
hyperlipidemia (37). These reproductive and metabolic dysfunctions are often associated 
with one of the most common female endocrine disorder, polycystic ovarian syndrome or 
in short, PCOS (Fig. 3). This multifaceted disorder affects more than 10 percent of 
reproductively aged women (38) and both genetic and environmental factors, such as 
exposure to excess T during a critical stage of prenatal development, are thought to play 
an important role in the manifestation of PCOS (26, 39-40). Exposure to androgens 
during the prenatal period may arise from either maternal or fetal hyperandrogenism. For 
example, circulating levels of testosterone are higher than normal during pregnancy in 
women with PCOS (41), proving a mechanism by which maternal androgen excess may 
disrupt normal development of the fetus. In addition, fetal hyperandrogenism can result 
from a hyperandrogenic fetal ovary (42), hyperandrogenic fetal adrenal cortex (31), or 
both. Furthermore, maternal hyperinsulinemia during pregnancy, a common occurrence 
in women with PCOS (41), induces excessive placental human chorionic gonadotropin 
(HCG) secretion leading to fetal ovarian hyperandrogenism (42). Therefore, both 
maternal and fetal hyperandrogenism can provide a mechanism by which the fetus is 
exposed to excess androgens during a critical period of development and may by 
permanently programmed to develop PCOS. 
As the most frequent cause of anovulatory infertility (43), PCOS is characterized by a 
constellation of reproductive and metabolic deficits, including hyperandrogenemia, 
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polycystic ovaries, disrupted menstrual cycles and fertility complications, hypersecretion 
of gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH), insulin 
resistance, and hyperinsulinemia (44-48). According to the 2003 Rotterdam consensus 
criteria, the presence of any two of three of oligo-ovulation or anovulation, 
hyperandrogenism (clinical or biochemical or both), and polycystic ovaries, fulfills a 
diagnosis of PCOS (49). In women with PCOS, the primary site associated with excess 
production of androgens are the ovaries (50-51). Although the etiology of excess ovarian 
androgen production is unknown, elevated levels of LH are believed to play a role in 
increasing production of androgens in the theca cells of the ovaries (50). These elevated 
LH levels may be due to LH hypersecretion by the pituitary gland or may be a result of 
increased amplitude and frequency of LH pulse. Nonetheless, this type of LH profile is 
believed to be a secondary reaction to an increase in GnRH from the hypothalamus (45).  
Indeed, women with PCOS have persistently rapid LH (GnRH) pulse frequency, reaching 
a frequency of one pulse per hour, without the normal cycle variation seen in ovulatory 
women (52).  This rapid GnRH pulsatility results in preferential secretion of LH over 
FSH, and may help explain the elevated LH levels and increased LH to FSH ratios 
characteristic of PCOS (53).  
Insulin resistance with compensatory increases in circulating insulin levels are also 
common features in PCOS, occurring in 30 % of lean and 75 % of obese women with 
PCOS (54). As such, insulin may exert its effects at the level of the hypothalamus, 
pituitary or ovaries, contributing to the elevated levels of LH. In vitro studies have shown 
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that insulin stimulates androgen synthesis in the thecal cells of the ovary by increasing 
LH-induced androgen production (55).  
 
 
Figure 3. Prenatal Testosterone (T) excess and the development of polycystic ovarian syndrome 
(PCOS) phenotype in adulthood. 
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1.3 Insulin sensitizers and anti-androgens in the management of PCOS 
symptoms 
 
Increased insulin resistance, hyperandrogenism and obesity have a significant impact on 
women’s menstrual cyclicity and reproductive health. It is logical to assume that 
therapies promoting a decrease in circulating insulin or androgen levels will improve 
some undesirable symptoms of PCOS. Insulin sensitizers such as Rosiglitazone are 
widely used in the treatment of hyperinsulinemia in women with PCOS (56). 
Rosiglitazone works by binding to the peroxisome proliferator-activated receptors-γ 
(PPAR- γ) expressed in fat cells and subsequently increasing the cell’s responsiveness to 
insulin (57). In a study by Yilmaz et al. (2005), Rosiglitazone treatment for 4 months 
reduced hyperinsulinemia and restored regular menstrual cyclicity in 60 percent of lean 
and 50 percent of obese PCOS patients (58). It is important to take into account weight 
loss as a significant contributor to the improvement of the metabolic and reproductive 
dysfunctions associated with PCOS (59-60). In a study by Pasquali et al. (1989), an 
average weight loss of 10-30 lbs. was shown to improve hyperinsulinemia and 
hyperandrogenism and to recover normal menstrual cyclicity in 30 percent of the patients 
studied (61). Considering that 50 percent of PCOS women are obese (59) and up to 70 
percent are insulin resistant (62), weight loss should be an important part of any treatment 
regime in women with this syndrome.  
Anti-androgens such as Flutamide have been used in women with PCOS mainly for the 
treatment of hirsuitism (63-66). Flutamide works by competitively inhibiting the binding 
of testosterone and its metabolite, dihydrotestosterone (DHT), to the androgen receptor 
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(67).  In women with PCOS, Flutamide treatment significantly alleviates a majority of the 
clinical and biochemical androgenic manifestations; however it has a minimal effect on 
insulin sensitivity (68-70). As such,  a combination of Flutamide with an insulin 
sensitizer may be more effective in improving a wider range of PCOS symptoms (71). 
 
1.4 Developing animal models of PCOS 
 
The development of reliable animal models of PCOS has proven very useful in 
understanding the pathogenesis of this syndrome, and particularly its reproductive and 
metabolic consequences. Since the 1960s, a variety of animal models, including rodents, 
sheep, and non-human primates, have been utilized to study the origins and pathology of 
PCOS (22, 72-74). Studies in both humans (31) and animals (24, 40, 75-76) have shown 
that prenatal exposure to excess T affects the development of the hypothalamus-pituitary-
gonadal (HPG) axis and contributes to reproductive and metabolic dysfunction in adults. 
The majority of the human data documenting the permanent organization effects of 
prenatal T exposure are derived from women with congenital adrenal hyperplasia (CAH) 
due to 21-hydroxylase deficiency. Females with classic 21-hydroxylase deficiency are 
exposed to excess androgen prenatally due to excessive adrenal androgen synthesis (77). 
These women also display PCOS-like phenotype, including hyperandrogenism, menstrual 
irregularities, and elevated LH levels (77). When LH secretion levels are compared in 
women with classic CAH and late-onset 21-hydroxylase deficiency, only women with the 
classic form, who have been exposed to androgens prenatally, show elevated levels of LH 
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and increased LH response to GnRH agonist (31). This suggests that exposure to 
androgens, whether derived from fetal adrenal or ovarian sources, or both, during a 
critical period of prenatal development, might provide a crucial hormonal insult that is 
necessary for the development of complex disorders such as CAH and PCOS in 
adulthood. Animal studies have provided further support for the effects of early exposure 
to androgens on neuroendocrine function. For example, female rhesus monkeys (78-79), 
sheep (26, 80-81) and rats (82-83) exposed to T during the prenatal period, develop 
abnormal gonadotropin secretion and elevated levels of LH, polycystic ovaries, and 
progressive disruptions in ovulatory cycles during adulthood.  
 
1.5 Prenatal testosterone treated sheep model 
In order to investigate the effects of prenatal T exposure on the brain, peripheral tissues 
and social behaviors, our research group has developed a prenatal T-treated sheep model 
of PCOS, which has been widely studied and documented (37) (Fig. 4). Therefore, along 
with my specific research aim to examine the effects of prenatal T on hypothalamic 
neurons, research contributions from our collaborators complement our findings and 
provide a “whole systems” approach of this disease model. Sheep are excellent models 
for studying developmental programming of adult disorders and have long been used to 
study fetal development (84). With a gestation length of 147 days, and time of puberty in 
females at 28 weeks, the sheep is ideally suited for integrative studies that investigate 
progression of reproductive ⁄ metabolic disruption from the initial prenatal insult to 
manifestation of adult consequences. The sheep’s neuroendocrine aspects of reproductive 
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cyclicity are also comparable to those in the human (85-86). In addition, sheep are 
reliable subjects for assaying hormone levels as large quantities of blood can be sampled 
with ease and minimal stress to the animal. 
 
 
Figure 4. Schematic diagram illustrating the prenatal testosterone (T) sheep model. The pregnant 
mother is injected with T twice weekly from gestational days 30-90. Two years after birth, the 
adult prenatal T treated female offspring is ovariectomized (OVX), receives an estradiol implant 
(designed to mimic follicular phase levels of E2), sacrificed, and the brain is collected for 
research. 
 
 
1.6 Focusing on the hypothalamus 
 
The main site of action for androgen induced reproductive dysfunctions appears to be at 
the level of the hypothalamus. Similar to the male, the hypothalamic–pituitary component 
of the reproductive axis in prenatal T treated females is unable to generate a GnRH-
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induced LH surge in response to increasing levels of estradiol (E2) (87-89). However, 
normal ovarian function appears secondary to and dependent on normal hypothalamic 
function. For example, removing the ovaries from non-cycling, perinatally androgenized 
female rats and transplanting them into normal females, reestablishes ovulatory function 
(90). Conversely, removing ovaries from normal females and transplanting them into 
perinatally androgenized females terminates ovulatory function (90-91). The role of the 
pituitary also appears to be dependent on normal hypothalamic function. For example, in 
the perinatally androgenized female rat, providing electrical stimulation to the 
hypothalamus is sufficient to induce ovulation (92). Although prenatal T treatment results 
in alterations at the level of the brain and periphery, these studies identify the 
hypothalamus as the major site for early life testosterone excess programming of 
anovulation. 
 
1.7 Regulation of metabolic homeostasis by the AgRP and POMC 
neurons of the hypothalamus 
In today’s society, the prevalence of obesity is increasing worldwide, reflecting 
environmental factors such as over consumption and decreased physical activity. 
Maintaining energy balance requires establishment of equilibrium between energy intake 
and energy expenditure. The arcuate nucleus of the hypothalamus (ARC) is a central 
point of integration for various hormonal signals which regulate energy homeostasis. 
Within the ARC, the melanocortin system, comprising of proopiomelanocortin 
(POMC)/cocaine- and amphetamine-regulated transcript (CART) co-expressing neurons 
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(93) and agouti-related protein (AgRP)/neuropeptide Y (NPY) co-expressing neurons 
(94-96), is crucial for normal energy homeostasis. In the anorexigenic POMC neurons, 
the neuropeptide precursor POMC is cleaved to α-melanocyte stimulating hormone (α-
MSH) (97), activates melanocortin 3 and 4 receptors (MC3R and MC4R) expressed on 
secondary neuron populations, located in the paraventricular nucleus (PVN) of the 
hypothalamus, among other nuclei (98). Thus, membrane depolarization of POMC 
neurons leads to α-MSH release, MC3/4R activation and ultimately decreases food intake 
and increases energy expenditure (98). The orexigenic AgRP acts by blocking α-MSH 
mediated activation of the MC3/4R, thus inhibiting α-MSH action and increasing appetite 
and energy expenditure (99). There is extensive evidence supporting the critical role of 
AgRP and POMC in the regulation of metabolic homeostasis (Fig. 5). For example, null 
POMC mice (-/-) exhibit hyperphagia, are obese and have a lower basal metabolic rate 
(100) and humans with POMC mutations are obese and hyperphagic (101). In rodents 
and sheep, central administration of AgRP increases food intake (102-103), while chronic 
exposure to exogenous AgRP causes continued hyperphagia resulting in obesity in 
rodents (104). Moreover, sheep fed an ad libitum diet have decreased AgRP neuronal 
numbers (103, 105) while those fasted have increased AgRP mRNA expression and more 
AgRP-immunolabelled neurons (103, 106).  
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Figure 5. Schematic diagram illustrating the interactions between the metabolic and reproductive 
neurons of the arcuate nucleus of the hypothalamus (ARC) and their effects on energy 
homeostasis. Abbreviations: ARC, arcuate nucleus; POA, preoptic area; AgRP, agouti-related 
peptide; POMC, proopiomelanocortin; KNDy, kisspeptin, neurokinin B, dynorphin; GnRH, 
gonadotropin releasing hormone. 
 
 
 
AgRP and POMC neurons also express nuclear androgen receptors (AR) (107), 
indicating a possible site of action for androgenic regulation of the metabolic neuronal 
circuitry as well as a potential for disturbance by excess prenatal testosterone (T) 
exposure. Our lab has shown that prenatal T treated ewes have a significantly higher 
number of AgRP-expressing neurons in the ARC, but no change in POMC neurons 
compared to controls (107). This finding reveals that prenatal T exposure differentially 
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alters the metabolic neurons of the ARC and also provides a framework for ongoing 
metabolic studies with the prenatal T sheep model. 
 
1.8 Overview of reproductive circuitry (Kisspeptin/KNDy and GnRH 
neurons) and effects of prenatal T treatment 
In sheep, kisspeptin neurons are located in the hypothalamus, with two distinct 
populations-one in the preoptic area (POA) and the other in the arcuate nucleus (ARC) 
(108-109).  In the ARC, but not in the POA (110), kisspeptin is colocalized with two 
other neuropeptides: the opioid peptide, dynorphin and the tachykinin peptide, neurokinin 
B (NKB). The colocalization of these three peptides is nearly 100% in the ARC, and thus 
this subpopulation has been collectively termed the “KNDy” (kisspeptin, neurokinin B, 
dynorphin) neurons (110). ARC KNDy neurons also show a high degree of colocalization 
with the gonadal hormone steroid receptors estrogen receptor alpha (ERα, >90%) (111), 
progesterone receptor (PR, >80%) (112), and androgen receptor (AR, >60%) (113). The 
colocalization of steroid receptors with kisspeptin has also been shown in the POA, but to 
a lesser extent (ERα> 50% and AR>25%) (111, 113). Our lab has recently shown that 
both populations of kisspeptin neurons (ARC and POA) are activated during the GnRH 
surge, but only ARC kisspeptin (KNDy) neurons are activating during pulsatile secretion 
of GnRH (114).  In support of this, our lab has also shown that GnRH neurons receive 
inputs form POA kisspeptin neurons as well as ARC KNDy neurons (115) (Fig. 6). 
Furthermore, GnRH is directly stimulated by kisspeptin, and GnRH neurons express the 
kisspeptin receptor (116-117). In terms of coordinating GnRH pulsatile activity, the 
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KNDy neuropeptides are believed to collectively to modulate GnRH release, each 
playing distinct a role in conveying the feedback signals of estrogen and progesterone 
onto GnRH neurons (118). As a network, the ARC KNDy neurons are also reciprocally 
connected and thus may play a role in the synchronous activity of the ARC, an aspect 
which is associated with the pulsatile release of GnRH.  Based on this and other features, 
the KNDy population has been proposed to be a critical component of the “GnRH pulse 
generator” with the three peptides serving roles as the start signal (NKB), stop signal 
(dynorphin) and output (kisspeptin) responsible for each pulse (110, 115, 118-121).  
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Figure 6. Schematic diagram illustrating the interactions between the arcuate (ARC) and preoptic 
area (POA) kisspeptin neurons with gonadotropin releasing hormone (GnRH) neurons and their 
effects on the hypothalamo-pituitary-gonadal (HPG) axis and reproductive function. 
 
 
 
Previously, our lab showed that prenatal T treatment reduces the number of dynorphin, 
neurokinin B (NKB), and progesterone receptor-ir neurons in the ewe ARC, however the 
number of kisspeptin neurons remains high and at levels similar to control females (122). 
Thus, there is an imbalance between inhibitory (dynorphin) and stimulatory (kisspeptin) 
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neuropeptides in this population, and that this imbalance may play a role in the disrupted 
steroid feedback that is typical of the prenatal T model.  Throughout my master’s studies 
I continued to explore the effects of prenatal T treatment on the KNDy-GnRH circuitry 
and showed that prenatal T treatment decreased the reciprocal connections between 
KNDy neurons and their contacts to GnRH neurons. This reduced connectivity may alter 
the synchronicity of the KNDy neurons and result in a dilution of the signal to the GnRH 
neurons. This could partially explain the delayed and dampened GnRH/LH surge seen in 
prenatal T treated females and possibly the absence of ovulatory cycles seen in women 
with PCOS.  During my master’s studies I also found that the KNDy neurons of prenatal 
T females had an increased soma size. This change was restricted to the ARC KNDy 
neurons, as no soma size differences were found in POA kisspeptin, AgRP or POMC 
neurons. This selective hypertrophy is also seen in the hypothalamus of postmenopausal 
women (123) and is believed to be a secondary response to ovarian failure (124-125) and 
associated with declining levels of circulating E2 concentrations (126). Overall, prenatal T 
treatment results in morphological changes both in the synaptology of the KNDy 
population and its connections to GnRH, as well as its neuronal size. These changes may 
contribute to defects in the ability of the KNDy population to convey steroid feedback 
signals to GnRH neurons. 
While the KNDy neuronal population is a target for the organizational effects of prenatal 
T (127), the specific mechanisms by which this programming occurs are still under 
investigation.  
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1.9 Leptin and insulin as regulators of metabolic activity 
Metabolism and energy homeostasis are regulated by the hormones leptin and insulin, 
which circulate at levels proportional to body fat stores (128-129). Levels of these 
circulating hormones serve as an indicator of energy stores to the brain and act to 
increase or suppress food intake and energy expenditure (130). The appetite stimulatory, 
AgRP, and inhibitory, POMC neurons of the ARC are key targets of leptin and insulin as 
they both express leptin and insulin receptors (131-134) (Figure 5). Normally, increases 
in leptin and insulin are associated with increased POMC expression (98, 135) and with 
decreased AgRP/NPY expression, which ultimately decreases food intake (98, 135).  
 
1.10 Insulin signalling in the brain 
Insulin is a metabolic hormone involved in the homeostatic control of energy balance 
(136). Insulin acts both acutely - to inhibit food intake, and chronically - as it circulates in 
proportion to fat stores to regulate body weight (137). When a meal is consumed, blood 
glucose is increased and insulin is rapidly secreted from beta (β) cells in the islets of 
Langerhans in the pancreas to promote glucose uptake from the blood (129). 
Accordingly, insulin secretion is increased during food intake and increased energy states 
and decreased during periods of food restriction. 
Insulin acts both peripherally and centrally. To enter the brain, insulin crosses the blood-
brain barrier (BBB), in levels proportional to circulating insulin, by a saturable receptor-
mediated transport mechanism (138-140). Insulin can also access the brain by 
circumventricular regions which lack the BBB (141-142). The concentration of insulin in 
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the brain is influenced by diet in both animals and humans. Eating increases insulin in the 
hypothalamus (143), while fasting decreases brain insulin levels (144-145). Central 
administration of insulin causes a reduction in food intake in rodents (146), sheep (147), 
and nonhuman primates (148) and ultimately results in decreased body weight (149). 
Insulin receptors (IR) are expressed in neurons and glia (145) and distributed throughout 
the brain (150-152). The highest proportions of IRs are found in the hypothalamus, 
particularly in the arcuate nucleus (ARC) (153); however the cerebral cortex, cerebellum, 
hippocampus, and olfactory bulb also contain high levels of IR (154). Insulin receptor 
mRNA is found in the somata of the neurons, whereas protein is present in cell bodies 
and axon terminals (145, 155). In rodents, various populations of neurons in the brain that 
are involved in energy homeostasis express insulin receptors, including ARC AgRP (156) 
and POMC neurons (133). As previously mentioned, insulin acts to increase POMC gene 
expression (133) and decrease AgRP release (157). The insulin receptor signalling 
pathway consists of an extracellular alpha subunit that binds the insulin and an 
intracellular beta subunit that relays the signal to the cell (158-159). Binding of insulin 
induces a conformational change in the receptor inducing autophosphorylation of the b-
subunit, subsequently activating intrinsic tyrosine kinase activity of the receptor. Insulin 
receptor substrate (IRS) proteins are then recruited to the plasma membrane, which 
become phosphorylated on tyrosine residues, subsequently recruiting additional 
signalling proteins regulated by various protein kinases (160). The two major kinases 
involved are phosphoinositide-3kinase (PI3K) and the mitogen-activated protein kinase 
(MAPK) (161-162). Biological responses are then initiated through phosphorylation and 
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activation of these major cellular signal transduction cascades, which regulates gene 
transcription implicated in growth and metabolism as depicted in Fig. 7 (163-165).  
 
 
Figure 7. Insulin receptor signaling pathways: binding of insulin to the α-subunit of the insulin 
receptor activates tyrosine autophosphorylation of the β-subunit and subsequent downstream 
signalling pathways. Abbreviations: pY, phospho-tyrosine; IRS, insulin receptor substrates; 
MAPK, mitogen-activated protein kinase; PI3K, phosphoinositide-3 kinase. Adapted from Chiu 
and Cline (2010) (165). 
 
 
 
1.11 Insulin Resistance 
The strong link between insulin resistance, subsequent hyperinsulinemia and obesity has 
been recognized for more than 50 years (166-167).  Insulin resistance is a physiological 
condition in which the body’s cells become resistant or insensitive to the actions insulin 
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(via alterations in insulin receptors). When tissues do not appropriately respond to 
physiologic concentrations of insulin, higher concentrations of insulin are required to 
maintain normal blood glucose levels. This characterizes insulin resistance and 
hyperinsulinemia (168-170).  
Insulin resistance is one of the most common symptoms of PCOS, as marked by impaired 
glucose transported into skeletal tissue (171-173). It is estimated that about 50-70% of all 
women with PCOS have some degree of insulin resistance (174-175). Treatment with 
insulin-sensitizing drugs improves insulin resistance as well as ovulatory function and 
fertility (58, 176), even without associated weight loss (177). Thus, it is believed that 
insulin resistance is an important component in the development of PCOS and intensity 
of the phenotype. Insulin sensitizers have also been show to also reduce androgen levels 
and alleviate symptoms associated with hyperandrogenemia (178). As such, insulin 
resistance and subsequent hyperinsulinemia are now recognized as indicators of 
hyperandrogenism in the majority of PCOS women (48, 179). In support of this, 
hyperinsulinemia, together with elevated LH levels, has been shown to exacerbate 
hyperandrogenemia by increasing androgen production in theca cells of the ovary (180-
182). This activates the enzyme P450c17α in the ovary, which is critical in the 
biosynthesis of androgens (183). Moreover, insulin suppresses sex hormone binding 
globulin (SHBG) produced by the liver, permitting an increase in unbound plasma 
testosterone (184). Obesity and increased visceral fat distribution (which has been 
implicated in the development of insulin resistance (185-186)) may also contribute to site 
specific androgen excess (187). Human adipose tissue is capable of synthesizing 
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androgens via the enzyme 17β-hydroxy steroid dehydrogenase (17β-HSD), which can 
catalyzes the conversion of Androstenedione (A) to T (188). In this way, increased 
visceral fat, insulin resistance and hyperandrogenemia form a self-perpetuating cycle, 
further intensifying the PCOS phenotype. Indeed, more than 50% of women with PCOS 
display both insulin resistance and abdominal obesity (189).  
 
1.12 Leptin signalling in the brain 
Leptin is a protein hormone encoded by the ob gene that is expressed primarily in adipose 
tissue, but also in the stomach, placenta and mammary gland (190). Circulating leptin 
levels are proportional to fat stores (135, 191) and therefore, higher leptin levels are 
observed in obese individuals (192). In the brain, leptin also serves as an indicator of 
peripheral energy stores and signals suppression of food intake and increased energy 
expenditure (193). Leptin operates in a regulatory feedback loop to maintain body weight 
and metabolic homeostasis (194). During states of weight gain and increased fat depots, 
leptin secretion is increased from adipose tissue and acts on leptin receptors in the brain 
to signal a decrease food intake and increasing energy output in attempt to lose weight 
and maintain metabolic homeostasis. In states of weight loss, leptin secretion is decreased 
permitting increased food intake and decreased energy expenditure to promote weight 
gain and achieve metabolic homeostasis.  
Leptin mediates its effect through specific leptin receptor isoforms, which are widely 
distributed in many tissues (190, 195). The short form of the leptin receptor (LepRa) is 
expressed in the choroid plexus and transports leptin into the CSF by a saturable transport 
24 
 
system past the BBB (195), however leptin can also enter the brain through 
circumventricular organs that lack BBB. The long form of the leptin receptor (LepRb) is 
expressed abundantly in the hypothalamus and is involved in metabolic regulation (135, 
196). 
Binding of leptin to the extracellular domain of its receptors mediates the activation of 
the intracellular associated Janus Kinase (JAK) resulting in JAK2 autophosphorylation on 
tyrosine residues (193). This is a critical step in leptin signalling as LepRb does not have 
any enzymatic activity of its own (197). Activated JAK stimulates the phosphorylation of 
residues on the intracellular domain of the receptor Tyr985, Tyr1077, and Tyr1138. 
When phosphorylated, each of these residues recruits downstream signalling proteins. 
Signal transducer and activator of transcription (STAT) 3 is recruited to the 
phosphorylated Tyr1138 residue (Fig. 8). This recruitment subsequently mediates 
phosphorylation and activation of STAT3.  When activated, STAT3 translocates to the 
nucleus and activates transcription of target genes (198).   
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Figure 8. Long form of the leptin receptor and signalling pathway. Binding of leptin to the 
extracellular domain of the long form of the leptin receptor mediates phosphorylation of the 
intracellular domain of the receptor and results in transcription of target genes. Abbreviations: 
LRb: leptin receptor b; p: phospho-tyrosine; Jak2: Janus Kinase 2, STAT3: signal transducer and 
activator of transcription 3. Adapted from Villanueva and Myers (2008) (199). 
 
 
 
1.13 Link between metabolism and reproduction 
As previously discussed, reproductive function is regulated by the complex interaction of 
the hypothalamus, pituitary and gonads, or the HPG axis. Proper function of the HPG 
axis is gated by metabolic and nutritional factors. Hence, fertility is dependent on 
nutrition and stored energy availability. If energy reserves are insufficient, the 
reproductive axis is suppressed and appetite is stimulated to compensate. Caloric 
restriction not only decreases insulin secretion, it also reduces levels of the  
gonadotropins, luteinizing hormone (LH) and follicle stimulating hormone (FSH) (200). 
Our knowledge of the neurohormonal pathways that are responsible for the metabolic 
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control of gonadotropic function has increased substantially since the early 1990’s. 
Among the many endocrine regulators involved in the control of reproduction and 
metabolism, the hormones leptin (201-204) and insulin (205-206) play an essential role in 
communicating energy homeostasis to the reproductive axis and modulation of GnRH 
secretion.  
For example, female mice with neuron-specific knockout of the insulin receptor 
(NIRKO) exhibit obesity, reduced LH secretion and impaired ovarian follicle maturation 
(205). However, it has not yet been shown in vivo that (GnRH) neurons express insulin 
receptor (IR), suggesting that the influence of insulin on GnRH secretion and 
reproductive function may involve afferent insulin sensitive neurons. One of the first 
links between leptin and reproduction came from the observation that mice with a 
mutation in the ob gene (ob/ob mice) are infertile (207). These mice are also obese, 
hyperphagic and have a lowered metabolic rate (208-209). Correcting leptin deficiency in 
these mice by leptin administration, restores fertility (210).  
Leptin activates the neuroendocrine reproductive axis in many species including rodents 
(210-212) and primates (213) by stimulating GnRH and LH secretion. However, various 
studies have shown that few, if any GnRH neurons expressing leptin receptors (132, 213). 
Therefore, leptin's influence on GnRH secretion and reproductive function  may likely 
involve and indirect mechanism of communication with GnRH, possibly via leptin 
sensitive interneurons upstream of GnRH-releasing neurons (214).  
It is tempting to hypothesize that the ARC populations comprising of KNDy, AgRP and 
POMC neurons and the POA kisspeptin neurons may be targets of leptin and insulin 
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signaling. As previously discussed, both leptin and insulin mediate AgRP and POMC 
activity and these neurons have been shown to play a role in regulating GnRH secretion. 
In sheep, NPY fibers (co-expressed with AgRP (94)) directly contact GnRH neurons 
(215) and this interaction has been shown to have an inhibitory effect on LH secretion 
(216). In fact, chronically elevated levels of NPY can block the GnRH/LH preovulatory 
surge (216).  The ARC POMC neurons have also been shown to make direct connections 
to GnRH neurons and regulate GnRH activity in the mouse (217) and hamster (218). 
However, unlike NPY, the melanocortins (post-translational products of POMC) 
stimulate reproductive function (219). 
Nutritional status can also influence kisspeptin expression. In rodents, fasting decreases 
kisspeptin mRNA (220-221), while leptin administration increases kisspeptin mRNA 
(222). However, there have been discrepancies in determining how leptin acts to 
stimulate GnRH, whether through a direct or indirect mechanism acting on kisspeptin 
neurons. The extent of LepRb expression with kisspeptin neurons has been a topic of 
debate for some time. In the mouse, it has been reported that the AVPV kisspeptin 
neurons do not coexpress LepRb, but that up to 40% of ARC kisspeptin neurons 
coexpress LepRb (223). Our research group has previously shown that in mice and sheep, 
leptin treatment does not directly activate ARC or AVPV (POA) kisspeptin neurons or 
GnRH neurons, via induction of pSTAT3 (224). As such, leptin signals influencing 
reproductive function may be relayed to the kisspeptin and/or GnRH neurons indirectly, 
via upstream leptin-sensitive neuronal populations. 
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The direct modulation of GnRH activity by insulin signaling has been highly debated as a 
direct link between insulin and GnRH activity has only been shown in vitro, in an 
immortalized GnRH cell line (225). As such, kisspeptin has been proposed as one of the 
key candidates in relaying insulin signals to the GnRH neurons. A recent study in mice 
showed that more than 20% of ARC kisspeptin neurons colocalized IR (226). Although, 
deletion of IR specifically from these neurons does not affect fertility; it does delay the 
onset of puberty.  Moreover, male and female mice with GnRH specific IR deletions also 
display normal pubertal timing and fertility (227). These studies suggest that IR 
expression in kisspeptin or GnRH neurons do not play a critical role in the maintenance 
of reproductive function in mice. However, in a separate animal such as the sheep, the 
role of insulin signaling in these neurons has not been explored. A decrease in IR with 
kisspeptin or GnRH may very well interfere with reproductive as well as metabolic 
function, especially in a disease model where these basic functions have been 
programmed in an abnormal manner.  
Nevertheless, prenatal T-treated sheep show metabolic and reproductive dysfunctions 
involving complex systems that are highly interlinked. Disruptions in the organization 
and development of these systems can exacerbate reproductive and metabolic 
dysfunctions during adulthood.  
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1.14 My Research Goals: 
 
There is a remarkably close link between the homeostatic metabolic and reproductive 
neuroendocrine systems. Female animals show dramatic decreases in the rates of 
reproduction during periods of continual negative energy balance (228-231), suggesting 
that the state of energy balance has an important role in determining when and if it is 
appropriate for an animal to take on the energetically expensive demands of reproducing. 
Alterations of energy balance are associated with clear changes in activity of the 
reproductive axis. During negative energy balance, there is suppression of pulsatile 
GnRH/LH secretion (229-230, 232) and both leptin (233-234) and insulin (235-236) can 
affect GnRH/LH pulse frequency. Thus, it may be that some or all of the reproductive 
defects as a result of prenatal T are in fact due to metabolic dysfunction at the level of the 
brain or periphery. Therefore, to further understand how prenatal T organizes the female 
brain, I will be investigating the effects of prenatal T on the reproductive as well as 
metabolic neural circuitry of the brain, focusing on two critical peptide hormones: insulin 
and leptin.  
My dissertation work is divided into four main parts.  
1) Prenatal T treated females are noticeably masculinized and display male-type 
behaviors; however we cannot accurately measure circulating androgen levels in 
these females. Therefore, the first objective aims to show that prenatal T ewes display 
functional hyperandrogenemia by characterizing AR-immunoreactivity (ir) in areas of 
the brain controlling reproduction and metabolism (ARC and POA) as well as areas 
controlling sexual behaviours behaviors (Amygdala and Basal nucleus of the stria 
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terminalis), with the expectation that AR-ir will be sexually dimorphic and prenatal 
T-treated ewes will have increased AR-ir compared to control females. Furthermore, 
because prenatal T treated females show distinct alterations in the AgRP and KNDy 
populations, this aim will also examine the effects of prenatal T treatment on AR 
colocalization in these populations. 
2) Insulin plays an important role in maintaining energy balance relaying energy 
availability signals to the reproductive axis. However, prenatal T treated sheep show 
impaired insulin signalling displayed as insulin resistance and hyperinsulinemia. As 
such, the second objective aims to i) determine if ARC KNDy, AgRP and POMC 
neurons, POA kisspeptin neurons and GnRH neurons express insulin receptor (IR) 
and ii) the effects of prenatal T treatment on the degree of IR colocalization with 
these populations.  
3) Hyperandrogenemia and hyperinsulinemia have been shown to play a significant role 
in the programming and maintenance of the symptoms associated with PCOS as well 
as prenatal T treatment. As such, the third objective aims to examine if prenatal and 
postnatal interventions with the androgen receptor blocker, Flutamide (F) and the 
insulin sensitizer, Rosiglitazone (R) are able to reverse the effect of prenatal T on the 
colocalization of AR and IR with the reproductive and metabolic neurons of the 
arcuate, the KNDy and AgRP neurons, respectively. 
4) Leptin is an important metabolic signal regulating reproductive function; however the 
hypothalamic pathways through which leptin relays its influence on GnRH secretion 
remain to be defined. The fourth objective aims to characterize the hypothalamic 
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neuronal populations directly and indirectly targeted by leptin within the AgRP, 
POMC, KNDy and GnRH neuronal populations in order to elucidate a possible 
mechanism through which leptin can influence GnRH secretion.   
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2.1 Abstract 
 
Sex steroids play a key role in the development and function of the brain. Therefore, 
inappropriate exposure to excess steroid hormones is a major concern, especially in the 
female. In the brain, changes in steroid receptor expression can alter the pathways and 
mechanisms which regulate behavioral and physiological functions. Using prenatal 
testosterone (T), dihydrotestosterone (DHT) and estrogen (E)-treated female sheep as 
model systems, we tested the hypothesis that prenatal T excess alters androgen receptor 
(AR)-immunoreactivity (ir) in several areas of the brain including: the arcuate nucleus 
(ARC), the preoptic area (POA), the ventromedial hypothalamus (VMH), the amygdala 
(Am), and the bed nucleus of the stria terminalis (BNST) and compared our findings with 
rams and castrated (CAST) rams. We also analyzed the effects of prenatal T on AR-ir in 
kisspeptin and agouti-related peptide (AgRP) neurons as these populations play a key role 
in conveying reproductive and metabolic signals in the brain, respectively. Pregnant 
Suffolk ewes were injected twice weekly with T propionate, DHT propionate (a non-
aromatizable androgen) or E in cottonseed oil, from days 30 to 90 of gestation. Changes 
in AR were analyzed at adult age (21 months) using immunohistochemistry. Control 
rams showed the highest AR-ir in all brain areas analyzed. Prenatal T and DHT, but not 
E, treatment resulted in an increase in AR-ir in the ARC and POA compared to control 
ewes and CAST rams. AR expression in kisspeptin and AgRP neurons was also increased 
in prenatal T females. Prenatal T and DHT treatment induced changes in AR-ir in the 
hypothalamus and specifically within kisspeptin and AgRP neurons and co-treatment 
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with the androgen blocker, flutamide reversed this effect, suggesting that prenatal 
organization of AR distribution and expression is organized by the androgenic actions of 
testosterone. Furthermore, its effects are restricted to hypothalamic regions and do not 
extend to associated limbic area such as Am and BNST. These findings provide us with a 
characterization of AR-ir in the brain as a consequence of different prenatal steroidal 
environments.  In turn, this information will allow us to focus on the specific mechanisms 
targeted by prenatal T exposure that lead to altered behavioral and endocrine phenotypes 
seen in prenatal T treated female sheep.   
 
 
 
 
 
 
 
 
Matsumoto, A. and Arai, Y. (1981) Effect of androgen on sexual 
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2.2 Introduction 
 
Sex steroids play a key role in the development and function of the brain. Therefore, 
inappropriate exposure to excess steroid hormones is a major concern, especially in the 
female.  It has been previously shown that exposure to excess T during a critical period of 
prenatal development results in phenotypic, behavioral and reproductive abnormalities in 
humans (1-3) and other species such as monkey (4-5), sheep (6-9), rat (10), mouse (11), 
and guinea pig (12). For example,  ewes prenatally treated with testosterone (T)  from 
days 30-90 of gestation (T60) display multiple neuroendocrine and ovarian disruptions 
such as LH hypersecretion, disrupted estrogen negative feedback, disrupted positive 
feedback (manifested as a delayed and dampened LH surge) (7), and metabolic 
disruptions such as hyperinsulinemia and insulin resistance (13). In addition to 
reproductive and metabolic disturbances, these females also display altered sexual 
behavior presented as high numbers of male-typical mating behaviors directed at estrous 
females and aggression towards males (14). In the brain, changes in steroid receptor 
expression can alter the pathways and mechanisms which regulate behavioral and 
physiological functions. Thus, is it important to determine if prenatal T-treated ewes are 
hyperandrogenic during adulthood, as prenatal alterations in neuroendocrine organization 
may alter reproductive, metabolic and sexual behaviours by rendering these females more 
sensitive to the actions of androgens. As such, we focused on the main reproductive and 
metabolic centers of the brain, the arcuate nucleus (ARC) and preoptic area (POA), as 
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well as areas associated with sexual behavior, the ventromedial hypothalamus (VMH), 
amygdala (MeA) and bed nucleus of the stria terminalis (BnST), to determine whether 
these areas contain AR positive neurons and whether prenatal T treatment alters AR-
immunoreactivity (ir). Furthermore, we analyzed AR-ir in two neuronal populations that 
have been shown to be critical in reproductive and metabolic function: ARC and POA 
kisspeptin neurons and the appetite stimulating agouti-related peptide (AgRP) neurons. 
The kisspeptin neurons (also co-expressing the neuropeptides neurokinin B and 
dynorphin in the ARC and known as KNDy neurons) have been shown to play a critical 
role in conveying steroid hormone information to GnRH neurons and thus play a critical 
role in the development and maintenance of normal reproductive behavior and fertility 
(15-17). In fact, kisspeptin is essential for the full preovulatory LH surge (18) (19), a 
mechanism that is impaired in prenatal T treated females (6). Furthermore, prenatal T 
treatment alters the balance of the KNDy neuropeptides resulting in a  reduction in the 
expression of dynorphin and neurokinin B (NKB), but not kisspeptin within these 
neurons (20). Moreover, the KNDy neurons show a high degree of colocalization with 
the AR (21), suggesting that this population is a target for the programming effects of T. 
Along with reproductive dysfunctions, prenatally T-treated sheep are also metabolically 
compromised and show reduced insulin sensitivity and subsequent hyperinsulinemia (13, 
22). Previously, our lab showed that prenatal T treatment significantly increases the 
number of AgRP neurons in adult females and these neurons also colocalize AR (23). As 
such, prenatal T, acting via AR during a critical period of brain organization may lay the 
framework for various neuroendocrine and behavioural alterations during adulthood. In 
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this study, we use prenatal T treated sheep as model systems, testing the hypothesis that 
prenatal T excess alters AR-ir in the ARC, POA, VMH, Am, and BnST, as well as with 
ARC and POA kisspeptin neurons and AgRP neurons. 
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2.3 Materials and Methods 
2.3.1 Animals  
Two experiments were included. Experiment 1 included control females (n=6), prenatal T 
females (n=6), prenatal dihydrotestosterone (DHT) females (n=4), prenatal estradiol (E) 
females (n=4), control males (n=5), and castrated males (n=4). To generate prenatal T-
treated ewes, pregnant Suffolk ewes were administered twice weekly i.m. injections of 
testosterone propionate (100 mg/injection, catalog item T1875; Sigma- Aldrich, St. 
Louis, MO) suspended in cottonseed oil (catalog item C7767; Sigma-Aldrich) during 
gestational days 30–90 (term = 147 d), as previously described (20, 22-26). This dose of 
testosterone propionate results in levels of T in the female fetus comparable to those seen 
in fetal males (27). Females treated prenatally with dihydrotestosterone (DHT) received 
two weekly 2 ml intramuscular injections of 100 mg dihydrotestosterone propionate 
(Steraloids, Inc., Newport, RI, USA) in cottonseed oil and females treated prenatally with 
estradiol (E) were implanted with one 30-mm Silastic implant (i.d. 0.22 cm; o.d. 046 cm; 
sealed with Silastic adhesive Type A, Dow-Corning corp., midland, MI) containing 
crystalline 17ß-estradiol (Sigma, St. Louis, MO) between days 30-90 of gestation. 
Control ewes received an equal volume of vehicle (2 ml cottonseed oil). All lambs were 
born in March and April. After weaning, they were maintained outdoors under natural 
photoperiods with a daily maintenance feeding and free access to water at the Sheep 
Research Facility of the University of Michigan (Ann Arbor, MI) until the age of 2 yr. 
Three-four weeks prior to tissue collection, endogenous steroid levels were normalized 
by bilateral ovariectomy and 17β-estradiol implants were inserted to mimic late follicular 
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phase of the estrous cycle as previously described (28). Control males and Castrated 
males were maintained under similar housing conditions.  
Experiment 2 included four groups of females: control (n=5) and prenatal T-treated 
females (n=5) (as described above), females prenatally co-treated with T and androgen 
receptor antagonist flutamide (15 mg ⁄ kg; Sigma-Aldrich) (n=5), or females treated with 
flutamide alone (n=5) during gestational days 30-90. Flutamide was dissolved in 
dimethylsulfoxide (400 mg ⁄ ml) and injected s.c. daily as previously described (29). 
Lambs were born in March and April and were maintained outdoors under natural 
photoperiods with a daily feeding schedule and free access to water until the age of 2 yr. 
Three-four weeks prior to tissue collection, endogenous steroid levels were normalized 
by bilateral ovariectomy and 17β-estradiol implants were inserted to mimic late follicular 
phase of the estrous cycle as previously described (28). 
 
2.3.2 Tissue collection  
Animals received two i.v. injections of heparin (25,000 U given 10 min apart; catalog 
item 402588B; Abraxiz Pharmaceutical Products, Schumberry, IL), were deeply 
anesthetized with sodium pentobarbital (390 mg/ml/kg; Fatal Plus, Vortech, Dearborn, 
MI) and were decapitated. The heads were immediately perfused via both internal 
carotids with 6 liters of 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.3) 
containing 0.1% sodium nitrate (Sigma- Aldrich). The brains were removed,  placed in 
4% paraformaldehyde in 0.1 M PB overnight for post fixation at 4° C, and transferred 
into 30% sucrose in 0.1 M PB for cryoprotection. Frozen coronal sections through tissue 
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blocks containing preoptic area, septal nuclei, hypothalamus, or temporal lobe were cut 
(45 μm) using a freezing microtome (Microm HM400R; Walldorf, Germany) in 12 
parallel series and stored at -20
o
C in a cryopreservative solution (30) until being 
processed.  
 
2.3.3 Immunohistochemistry for AR, AR/kiss or AR/AgRP 
Sections were processed free floating with gentle agitation and all steps were performed 
at room temperature. Antibodies were dissolved in incubation solution consisting of 0.1M 
PBS, 0.4% Triton X-100 (catalog item BP151- 500; Sigma-Aldrich) containing 4% 
normal goat serum (NGS) (catalog item 005-000-121; Jackson Immuno Research 
Laboratories, West Grove, PA) and sections were washed extensively with 0.1 M PBS 
(pH 7.35) between steps. Prior to incubation with first primary antibody sections were 
incubated with 1% hydrogen peroxide (10 min, H2O2; catalog item H325; Fisher 
Scientific, Pittsburgh, PA) and incubation solution (1hr) to prevent non-specific 
background labeling. Within each experiment, tissue sections from all experimental 
groups were processed simultaneously. 
 
One series of tissue sections was incubated with rabbit anti-AR (1: 200 dilution, 17 h; 
Santa Cruz, sc-816, lot F1711), biotinylated goat anti-rabbit IgG (1:500, 1 hr; catalog 
item BA-9200; Vector Laboratories, Burlingame, CA), avidin-biotin horseradish 
peroxidase complex (ABC ; 1:500, 1 hr, catalog item PK-6100; Vector Laboratories), and 
0.02% 3, 3’-diaminobenzidine tetrahydrochloride (DAB, Sigma-Alderich) with 0.08% 
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nickel sulfate (10 min; diluted in PB containing 0.012% H2O2). One series of tissue 
sections was first immunoprocessed for AR and subsequently incubated with rabbit anti-
kisspeptin (1:300,000 dilution, 17 h; kp10, lot 564; gift from Dr. Alain Caraty, Nouzilly, 
France) or guinea pig anti-AgRP (1:1000 dilution, 17 h, C-GPAAGRP, Lot AS-506, 
Antibodies Australia), biotinylated goat anti-rabbit IgG (1:500, 1 hr; catalog item BA-
9200; Vector Laboratories, Burlingame, CA), ABC (1:500, 1 hr, catalog item PK-6100; 
Vector Laboratories), and 0.02% 3, 3’-diaminobenzidine tetrahydrochloride (DAB, 
Sigma-Alderich,10 min; diluted in PB containing 0.012% H2O2). Tissue sections were 
mounted onto Superfrost/Plus Microscope Slides (Fisher Scientific), dehydrated with 
alcohol and cover-slipped with Depex Mountant (Electron Microscopy Sciences, Fort 
Washington, PA). 
 
2.3.4 Analysis 
AR-ir: Quantitative analysis was performed to analyze numbers of AR-ir neurons in 
standard areas of analysis in POA (1000µm x1000µm), VMH (1000µm x1000µm), 
BNST (500µm x 1750µm), medial amygdala (500µm x 1750µm), and ARC (1000µm 
x1250µm; rostral and middle levels (20, 23)), Counts were performed in 3-6 hemi-
sections per animal per region, using Neurolucida software (Microbrightfield Inc.) 
attached to a motorized Leica DM5000B (Leica Microsystems). Number of AR-ir 
neurons were averaged per animal and compared between treatment groups, within each 
brain region, using one-way ANOVA and Dunn’s or Holm-Sidak method post hoc 
analyses, with 95% confidence levels (SigmaStat version 3.0.1). In experiment 1A, 
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numbers of AR-ir neurons were compared between control males, control females, 
prenatal T females, and castrated males; in experiment 1B, AR-ir was compared between 
control and prenatal T females (using same tissues as in experiment 1A), prenatal DHT 
and E-treated females. Finally, in experiment 2, control and prenatal T-treated females 
were compared to F or TF females. 
 
Colocalization AR/kiss or AR/AgRP neurons: All kisspeptin (in POA and ARC) and 
AgRP neurons (in ARC) were analyzed for colocalization of AR using a LeicaDM5000B 
at 20X magnification, in 3-4 hemisections per animal. Percentages of kisspeptin or AgRP 
neurons that colocalized AR were calculated for each section and averaged per animal. 
Comparisons between treatment groups were conducted within each brain region, using 
ANOVA, and Dunn’s or Holm-Sidak, with 95% confidence levels. 
 
2.3.5 Images 
All images were captured using Neurolucida software (Microbrightfield Inc.) attached to 
a motorized Leica DM5000B (Leica Microsystems) microscope and Leica DFC420 
camera. Figures were prepared using Adobe Photoshop CS2. Images were not altered in 
any other way, except for occasional adjustment of brightness. 
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2.4 Results 
2.4.1 Effects of prenatal T treatment on AR immunoreactivity (ir) 
In experiment 1a, a sex difference and effect of prenatal T treatment were observed in 
AR-ir in POA, ARC, VMH, BnST, and MeA (F(3,19):28.6-63.9, p<0.05-<0.001) Figures 
9 and 10. Control males had more AR-ir neurons in all areas compared to control females 
(p<0.001), and castration significantly reduced AR-ir in all areas (p<0.001) to levels 
comparable to control females.  Prenatal T treated females had more AR-ir neurons 
compared to control females in the POA (p<0.001) and ARC (p<0.001), but not in the 
VMH, BnST, or MeA. However, prenatal T treatment did not increase AR-ir to male 
levels, as AR-ir was significantly lower in all areas compared to control males (p<0.001), 
although significantly higher than castrated males in the POA (p<0.001), ARC (p<0.001) 
and VMH (p=0.009). 
To confirm that prenatal T organizes AR-ir in adult ewes via androgenic actions, AR-ir in 
POA and ARC in the same control and prenatal T females was also compared with 
females treated prenatally with DHT or E (experiment 1b; F(3,16):21.56-37.87, p<0.001). 
Prenatal DHT treated females had similar expression of AR-ir compared to prenatal T 
females, and were significantly higher than control females (p<0.001). In contrast, 
prenatal E treatment did not affect AR-ir (Table 1).  
Next (experiment 2), it was determined if the effects of prenatal T on AR-ir are reversed 
by co-treatment with flutamide, and hence are via blocking the androgenic actions of T. 
Prenatal T treated females had a significantly higher number of AR-ir neurons in the 
ARC (F(3,18):10.21; p=0.004) and POA (F(3,19):15.22; p<0.001) compared to control 
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females, confirming results from experiment 1. Furthermore, co-treatment with F 
attenuated the effects of prenatal T, as AR-ir in TF females were similar to control 
females and significantly lower compared to prenatal T females (p<0.001). Finally, F 
treatment alone had no effect on numbers of AR-ir neurons (Fig. 10).  
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Figure 9. A) Mean ±SEM number of AR-immunoreactive (ir) neurons in the preoptic area (POA), 
arcuate (ARC; rostral and middle levels (20, 23), ventromedial hypothalamus (VMH), bed 
nucleus of the stria terminalis (BnST), and medial amygdala (MeA) compared between control 
females, prenatal T females, control males, and castrated males. * describes significant difference 
from controls, # describes significant difference from prenatal T. Representative images of AR-
immunoreactive neurons in the ARC of B) control female, C) control male, D) castrated male, 
and E) prenatal T female. Scale bar represents 50µm. 
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Brain region Number of AR-ir neurons 
Control Prenatal T Prenatal DHT Prenatal E 
POA 135.9±7.1 275.8±11.0*(p<0.001) 239.5±21.3*(p=0.004) 110.9±9.3 
ARC 86.2±6.3 177.3±15.6*(p<0.001) 198.5±10.3*(p<0.001) 63.3±15.0 
 
Table 1.Mean ±SEM number of AR-immunoreactive neurons in the preoptic area (POA) and 
rostral arcuate (20, 23) (ARC) of control, prenatal testosterone (T), prenatal dihydrotestosterone 
(DHT), and prenatal estradiol (E) treated females. * describes significant difference from 
controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
A) B) 
 
Figure 10. Mean ±SEM number of AR immunoreactive cells in the arcuate nucleus (A) and preoptic 
area (POA) (B) compared between control, prenatal testosterone (T), prenatal flutamide (F) and prenatal 
TF females. 
 
* 
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2.4.2 Effects of prenatal T treatment on AR immunoreactivity in kisspeptin 
or AgRP neurons 
Prenatal T treatment significantly increased AR expression in kisspeptin neurons in the 
ARC (F(3,18):19.87, p=0.001) and POA (F(3,19):12.72, p<0.001) as well as ARC AgRP 
neurons (F(3,18):19.60, p<0.001), compared to control females. Furthermore, effects of 
prenatal T treatment were attenuated by co-treatment with Flutamide (TF), as expression 
of AR-ir in POA kiss, ARC kiss, and ARC AgRP neurons in TF-treated females was 
significantly lower compared to prenatal T females (p<0.001), and comparable to control 
or F-treated females (Fig. 11). In addition, total numbers of AgRP and kisspeptin neurons 
were counted and compared between groups. Prenatal T treated females had significantly 
more AgRP-ir neurons compared to control females (p=0.001) and prenatal TF treatment 
was able to reverse this effect (p=0.06). Numbers of kiss neurons did not differ between 
groups. These results are consistent with our previous findings (20, 23). 
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A) B) 
C) 
ARC Kiss POA Kiss 
Figure 11. Mean ±SEM percent colocalization of AR with kisspeptin neurons in the arcuate nucleus 
(ARC) (A) and preoptic area (POA) (B) and AgRP neurons in the ARC (C) compared between 
control, prenatal testosterone (T), prenatal flutamide (F) and prenatal TF females. 
 
* 
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2.5 Discussion 
 
In this study, we examined the expression of AR-immunoreactive (ir) neurons in the 
hypothalamus and other limbic regions of the sheep brain and describe sex differences in 
AR-ir as well as alteration in AR-ir as a result of prenatal T treatment. Finally, we show 
an increase in AR-ir with ARC and POA kisspeptin and ARC AgRP neurons as a result 
of prenatal T treatment.  
Specifically, we show that adult females, prenatally exposed to T show an increased 
number of AR-ir neurons in the POA and ARC and a trend towards more AR-ir neurons 
in the VMH. Although adult rams showed the highest AR-ir in all brain areas analyzed, 
prenatal T treated females showed more AR-ir neurons than CAST rams. Throughout the 
prenatal period, testosterone increases androgen receptor AR expression in males 
resulting in greater AR density in males compared with females (31). Scott et al. (2004) 
also found a sex difference in the level of AR-mRNA containing neurons, with a greater 
level of AR mRNA expression in the medial preoptic area and BNST of rams compared 
with ewes (32). These sex differences, along with the effects of prenatal T treatment 
suggest a masculinization of the female brain by T and more than likely influence 
reproductive and metabolic neuroendocrine function and behavior in adulthood. Indeed, 
prenatal T induced changes in AR-ir were mimicked by prenatal dihydrotestosterone 
(DHT), but not estradiol (E) treatment and reversed by prenatal co-treatment with the 
androgen receptor blocker, flutamide, strongly suggesting that these changes were 
programmed via the androgenic actions of T.  
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As a reliable and functional model, ewes exposed to T from prenatal days 30-60 show 
various reproductive and metabolic deficits manifested as early reproductive failure and 
oligo-ovulation (7, 33-36), neuroendocrine feedback defects (6, 34, 37-40), and decreased 
insulin sensitivity (13, 22). Moreover, these females display altered sexual behavior 
exhibited male-typical mating behaviors directed at estrous females and aggression 
towards males (14). In this study we show that like rams, prenatal T treated ewes have 
significantly more AR-ir neurons in the ARC and POA and show a strong trend for 
increased AR-ir neurons in the VMH compared to control females. In the sheep, these  
areas are critical in the control of metabolic (41-43) and reproductive (18-19, 21, 44-47) 
neuroendocrine functions as well as proceptive and receptive sexual behavior (48), 
respectively. As such, early life alterations in neuroendocrine functions and 
masculinization of sexual behavior in the sheep are most likely programmed during a 
critical period of prenatal development and/or maintained by high levels of circulating T 
during adulthood.  
Although control rams showed the highest AR-ir in all brain areas analyzed, castrated 
rams had comparable or lower numbers of AR-ir neurons than control ewes. It is difficult 
to say whether the increase in AR-ir that we observe in the adult sheep brain is an 
indication of circulating testosterone or an organizational effect of exposure to T during a 
critical period. Indeed, removal of the gonads (ovariectomy or castration) eliminates a 
main source of testosterone in both rams and ewes. Therefore, since control ewes and 
castrated rams (naturally exposed to T prenatally) have comparable low AR-ir and 
prenatal T treated ewes have increased AR-ir, this suggests an activational effect of 
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testosterone during adulthood. However, we cannot dismiss the role of the adrenal glands 
in the production of circulating androgens (49), which may be sexually dimorphic. In 
fact, it has been shown that during fetal life, female sheep show an increased rate of 
androgen synthesis from the adrenals when compared to males (50). Furthermore, 
prenatal T exposure programs both ovarian (51) and adrenal (52) hyperandrogenism in 
the ewe. Nevertheless, adrenalectomy is not plausible in our current sheep model, leaving 
this question to be addressed in future studies. 
 
Next, we focused on two neuronal populations found in the ARC and POA, the kisspeptin 
and AgRP neurons, and found an increase in AR colocalization with both populations. 
This increase was not seen in prenatal T females that were co-treated with the androgen 
blocker, flutamide (TF), suggesting that prenatal T acts via an androgenic mechanism to 
lay the framework for these changes seen during adulthood. The ARC kisspeptin 
subpopulation (also known as the KNDy neurons) have been shown to play an important 
role in the surge and pulsatile secretion of GnRH, while POA kisspeptin neurons have 
been shown to be critical for the GnRH ovulatory surge (17, 19, 21, 53-54). Prenatal T 
treated female sheep show increased GnRH/LH pulsatile (55-56) secretion  and a 
dampened and delayed GnRH/LH ovulatory surge (6, 56), both parameters which can be 
mediated via kisspeptin neurons. Moreover, circulating testosterone levels have been 
shown to differentially mediate KNDy neuropeptide expression. In the male mouse, 
testosterone acts through both AR and ERα to inhibit Kiss1(encoding kisspeptin) (57) and 
Pdyn (encoding Dynorphin) mRNA expression (58) in ARC KNDy neurons. However, in 
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other regions that contain kisspeptin neurons such as the anteroventral periventricular 
nucleus (AVPV), T stimulates the expression of Kiss1 mRNA. These findings show that 
kisspeptin neurons are direct targets for T, which likely plays a role in mediating both 
pulsatile and surge mechanisms. Furthermore, Navarro et al. (2011) found that AR 
knockout (KO) mice had higher levels of Kiss1, Tac2 (encoding NKB), and Pdyn mRNA 
in the ARC compared to wild type controls, suggesting that AR plays a role during the 
developmental period of the of KNDy neurons (59), possibly regulating peptide 
expressing during this sensitive period (60). Previous work from our lab showed that 
prenatal T treatment decreases the number of dynorphin and NKB, but not kisspeptin 
immunoreactive neurons in the ARC of the ewe (20), providing further support for the 
lasting effects of T on the KNDy neurons.  
In this study, we show that prenatal T treated females had higher AR colocalization with 
arcuate AgRP neurons, orexigenic neurons which signal increased food intake and 
decreased energy expenditure (61). Our lab has previously shown that prenatal T 
treatment increases the number of AgRP neurons to more than double the amount seen in 
control ewes and co-treatment with flutamide (TF) significantly lowers AgRP neurons 
numbers, suggesting that this change is largely programmed via the androgenic actions of 
T (23). These prenatal T females also show a decrease in insulin receptor (IR) 
colocalization in the same neurons (62). Although much less is known about the role of 
testosterone in the regulation of AgRP expression, the increase in AR colocalization with 
these neurons may reflect a means by which testosterone acts to modulate these changes. 
In castrated male rats, T replacement increases ARC neuropeptide Y (NPY) mRNA, an 
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orexigenic neuropeptide which is highly colocalized with AgRP (23, 63), suggesting 
regulation of this peptide by T (64). One possibility is that early life exposure to prenatal 
T, acting via AR, alters AgRP and IR expression in this population and contributes to the 
insulin resistance displayed by out prenatal T sheep (13, 22). This is supported by the 
finding that prenatal TF treatment blocks the increase in AR and decreased IR 
colocalization with AgRP neurons, as well as the increase in AgRP neuronal number 
(23). These findings suggest an androgenic of T action on the ARC AgRP population; 
however the mechanisms which program these alterations merit further investigation. 
In summary, there are well documented metabolic and reproductive deficits stemming 
from excess exposure to T during the prenatal period of development in the sheep. The 
present study shows that prenatal T treatment increases AR-ir in areas of the ewe brain 
that are critical in the control of reproductive and metabolic functions as well as sexual 
behavior. However, the mechanism by which prenatal T alters postnatal development of 
these systems is not yet known. One possibility is that prenatal T masculinizes the female 
brain, rendering it more sensitive to circulating androgens and thus, altering control of 
neuroendocrine functions in the adult female. Prenatal T exposure may also result in 
abnormal programming of androgen producing tissues, such as the ovaries and adrenals, 
resulting in increased circulating androgens (51-52). Therefore, the increased AR-ir seen 
in prenatal T females could be a programmed prenatal effect and/or a reflection of high 
levels of circulating androgens. Nevertheless, this study is the first to provide a measure 
of androgenism in the brain of the prenatal T treated sheep, therefore confirming 
hyperandrogenism in this model. 
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3.1 Abstract 
 
Insulin serves as a link between the metabolic and reproductive systems, communicating 
energy availability to the hypothalamus and enabling reproductive mechanisms. Prenatal 
testosterone (T)-treated Suffolk sheep display an array of reproductive and metabolic 
dysfunctions including insulin resistance, similar to those of women with polycystic 
ovarian syndrome (PCOS).  Prenatal T-treated sheep show alterations in KNDy (co-
expressing kisspeptin, neurokinin B/dynorphin) and agouti-related peptide (AgRP) 
neurons in the arcuate nucleus (ARC), two populations that play key roles in the control 
of reproduction and metabolism, respectively. In this study, we examined if prenatal T-
treatment perturbed insulin receptor localization in preoptic area (POA) kisspeptin 
neurons, ARC KNDy neurons, agouti-related peptide (AgRP), pro-opiomelanocortin 
(POMC), and gonadotropin-releasing hormone (GnRH) neurons. Analysis of 
immunohistochemical visualization of the beta subunit of insulin receptor (IRβ), revealed 
that KNDy, AgRP and POMC, but not GnRH or POA kisspeptin neurons, colocalize IRβ. 
Moreover, prenatal T treatment decreased percentages KNDy and AgRP neurons that 
colocalized IRβ, consistent with reduced insulin sensitivity. Co-administration of the 
anti-androgen flutamide during prenatal T treatment prevented the reduction in IRβ 
colocalization in AgRP, but not in KNDy neurons, indicating that the effects of prenatal 
T on these two populations are programmed differentially by androgenic and estrogenic 
actions of T, respectively. These findings indicate that defects in insulin signaling at the 
level of the brain likely contribute to the insulin resistance of this PCOS model.  
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3.2 Introduction 
 
Fertility is dependent on sufficient energy supply. Insulin is a key communicator of 
energy availability to the hypothalamus and specifically gonadotropin-releasing hormone 
(GnRH) neurons, enabling reproductive function in times of sufficient energy supply (1). 
In women with polycystic ovary syndrome (PCOS), infertility and insulin resistance are 
major concerns and are exacerbated by excess weight (2-5). The sheep model of PCOS, 
in which ewes are exposed to excess T during fetal life from day 30–90 of gestation, 
replicates the reproductive and metabolic deficits seen in women with PCOS (6-8). The 
reproductive disruptions include intermittent to absent ovulation (9-12), early 
reproductive failure (9-13), neuroendocrine feedback defects (14-19), and functional 
hyperandrogenism (20). In addition, prenatal T-treated sheep are metabolically 
compromised and manifest reduced insulin sensitivity and compensatory 
hyperinsulinemia (21-22). Although the reproductive and metabolic outcomes of prenatal 
T exposure are well described in the ewe, the mechanisms responsible for these 
detrimental effects, and the neural contribution to these deficits, are not well understood.  
 
In sheep and other mammals, the arcuate nucleus (ARC) of the hypothalamus is a major 
center of convergence for reproductive and metabolic signals. This region contains two 
key populations of appetite regulating neurons, the orexigenic agouti-related peptide 
(AgRP) and the anorexigenic proopiomelanocortin (POMC) neurons. Previous work from 
our lab has shown that both AgRP and POMC neurons express insulin receptors (82% 
and 92%, respectively, Lehman M.N. preliminary data) and prenatal T-treated females 
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show an increase in both AgRP-immunoreactive neurons and fiber density in the ARC 
(23).  In addition to the metabolic control neurons, the ARC also contains a key neuronal 
group involved in the control of GnRH secretion, the KNDy (co-expressing the 
neuropeptides kisspeptin, neurokinin B (NKB), dynorphin) neuronal population.  
Kisspeptin, NKB and dynorphin have each been proposed to serve distinct roles in 
modulating GnRH release depending on the steroid hormone milieu, mediating pulsatile 
and/or surge secretion of GnRH (24-29). Previous work has found that prenatal T-treated 
females show a reduction in dynorphin and neurokinin B immunoreactivity in KNDy 
neurons (30), but no change in kisspeptin (30). This peptide imbalance has been 
postulated to contribute to the steroid feedback dysregulation and reproductive deficits 
seen in prenatal T-treated females. In addition to these findings, it has been shown that 
insulin sensitizer treatment improves reproductive function in prenatal T-treated females 
(31) as in women with PCOS (32-33), suggesting that insulin signaling is an important 
component of the PCOS phenotype, and may have impact on both metabolic and 
reproductive functions.  There is evidence from rodent studies that insulin can have 
significant effects on reproduction, acting at a neural level.  For example, diabetic female 
rats show decreased luteinizing hormone (LH) surges and fewer ovulatory cycles (4). 
Moreover, deletion of neuronal insulin receptors in mice results not only in increased 
food intake, body weight, diet-sensitive obesity, and insulin resistance, but also infertility 
(1, 34).  Restoration of insulin receptor expression in the brain is required to maintain 
fertility in these females (35). These actions may be mediated by direct insulin action on 
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GnRH neurons or by input from afferent insulin sensitive neurons, as GnRH neurons 
have not yet been shown to express insulin receptor in vivo. 
In this study, we examined whether insulin has the potential to act directly on KNDy and 
GnRH neurons in the adult sheep brain by determining if immunoreactivity for insulin 
receptors is present in these neuronal populations.  In addition, we hypothesized that 
percentage of insulin receptor colocalization in these neuronal populations, and/or in 
AgRP and POMC neurons, would be altered by exposure to excess prenatal T.   Because 
insulin appears to play an important role in relaying energy availability to the 
reproductive axis, we predicted that prenatal T-treated ewes would show a decreased 
expression of insulin receptors in metabolic and reproductive neurons of the ewe, 
rendering these neurons less sensitive to insulin and thereby affecting processes that 
require specific information about energy availability.  
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3.3 Materials and Methods 
3.3.1 Animals and experimental groups 
Suffolk ewes were cared for at the University of Michigan Sheep Research Facility (Ann 
Arbor, MI). Details of housing, nutrition, breeding, lambing and prenatal treatment have 
previously been described (12, 36-37). Prenatal treatment involved administration of 
hormones to the pregnant mother between days 30 and 90 of gestation of a 147 day 
gestation period. The three experimental groups used in this study consist of adult female 
offspring treated: prenatally with T (T group; n=5), with T and flutamide (TF; n=5), or 
flutamide alone (F; n=5). Control females (n=5) received an equal volume of vehicle (2 
ml cottonseed oil). If twin births occurred, only one offspring from the pair was included. 
All procedures conducted were approved by the Institutional Animal Care and Use 
Committee of the University of Michigan and were in accordance with the National 
Research Council’s Guide for the Care and Use of Laboratory Animals. 
 
T (T-propionate; Sigma-Aldrich, St. Louis, MO) was injected i.m. twice weekly (100 
mg/2ml dissolved in cottonseed oil). Previous analysis of maternal and fetal blood 
circulation has demonstrated that this dosage of T produces levels similar to adult males 
and fetal males, respectively (38). Females in the F group received daily injections of 
flutamide (15mg/kg, Sigma-Alderich) dissolved in dimethylsulfoxide (400mg/ml, Sigma-
Aldrich) administered subcutaneously. Females in the TF group received T-propionate as 
described above in addition to daily injections of flutamide. 
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3.3.2 Tissue Collection 
Brains were collected during the breeding season when females were 2 years of age. 
Three-four weeks prior to tissue collection, animals were ovariectomized and were 
treated sequentially for 11–12 d with two controlled internal drug release P4 implants 
(CIDR) (InterAG, Hamilton, Waikato, New Zealand) and then for 1day with four 3-cm-
long E2 implants to simulate ovarian steroid levels during the late follicular phase of the 
cycle. Eighteen hours after the E2 implants, animals were sacrificed. At time of tissue 
collection, all ewes received two intravenous injections (at 10 min intervals) of 25,000 U 
heparin (catalog # 402588B; Abraxiz Pharmaceuticals, Schumberry, IL). Ewes were 
anaesthetized intravenously with sodium pentobarbital (390 mg/ml/kg; Fatal Plus, 
Vortech, Dearborn, MI) and rapidly decapitated. The heads were immediately perfused 
through the internal carotid artery with 6L of 4% paraformaldehyde (Sigma-Aldrich) 
dissolved in 0.1M phosphate buffer (PB; Sigma- Aldrich) containing 0.1% sodium nitrate 
(Sigma- Aldrich), and 10 U/ml heparin (Abraxiz Pharmaceuticals). Brains were 
submerged in the same fixative at 4C for 18hr. Blocks of tissue containing hypothalami 
were transferred in 30% sucrose (Caledon, Georgetown, Ont., Canada) at 4C and 
sectioned coronally (45 µm) using a freezing microtome (Microm, Walldorf, Germany) 
into 12 parallel series for each animal. Sectioned tissues were stored in cryoprotectant 
(30% ethylene glycol, 0.1% sodium azide, 30% sucrose in PB) at -20C until further 
processing. 
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3.3.3 Immunohistochemistry: general  
One series of every sixth section containing ARC, POA and MBH from each animal were 
processed for immunohistochemistry. All incubations occurred at room temperature with 
gentle agitation. Free-floating sections were rinsed thoroughly with 0.1 M phosphate-
buffered saline (PBS) between incubations. Antibodies were dissolved in incubation 
solution consisting of 0.1M PBS, 0.4% Triton X-100 (catalog item BP151- 500; Sigma-
Aldrich) containing 4% normal goat serum (NGS) (catalog item 005-000-121; Jackson 
Immuno Research Laboratories, West Grove, PA). Unless otherwise specified, tissue 
sections were washed extensively with 0.1 M PBS (pH 7.35) between steps. Prior to 
incubation with first primary antibody sections were incubated with 1% hydrogen 
peroxide (10 min, H2O2; catalog item H325; Fisher Scientific, Pittsburgh, PA) and 
incubation solution (1hr) to prevent non-specific background labeling. See Table 1 
(Supplemental Material) for detailed information on all antibodies used. 
3.3.4 Immunohistochemistry: triple-label immunofluorescence for 
AgRP/IRβ/POMC 
Sections were incubated overnight (17 hours) with antibody specifically recognizing 
AgRP (raised in Guinea Pig, 1:800 dilution in incubation solution with 4% NGS; 
Antibodies Australia, catalogue # GPAAGRP.1, Lot # AS506), and with goat anti-guinea 
pig Alexa 488 (1:100 dilution, 30 minutes, Molecular
 
Probes, Inc., Carlsbad, CA). Next, 
sections were incubated overnight with antibody recognizing the beta sub-unit of the 
insulin receptor (IRβ, raised in Rabbit, 1:300 dilution, Santa Cruz, C-19, SC-711), with 
biotinylated goat anti-rabbit (1:500 dilution, 1 hour, Vector Laboratories, Burlingame, 
83 
 
CA, USA), ABC-elite (1:500 dilution in PBS, 1 hour, Vector Laboratories), biotinylated 
tyramide (BT; 1:250 dilution in PBS with 1 µl of 3% H2O2/ml, 10 minutes, Perkin Elmer 
Life Sciences, Woodbridge, Ont., Canada), and Alexa 555 conjugated streptavidin (1:100 
dilution in PBS, 30 mins., Molecular Probes). Finally, sections were incubated with 
antibody specifically recognizing POMC (raised in rabbit, 1:4,000 in incubation solution 
with 4% normal donkey serum, Phoenix Pharmaceuticals, Burlingame, CA, USA, 
catalogue # H-029-30) and donkey anti-rabbit Cy5 (1:100 dilution in PBS, 30 minutes, 
Molecular Probes). Sections were mounted on plus charged slides and cover slipped with 
gelvatol (39).  
Specificity of primary antibodies for POMC and AGRP has previously been 
demonstrated in sheep hypothalamic sections (39). Pre-absorption of IRβ antibody with 
its corresponding peptide antigen (Santa Cruz) at concentration of 10 µg/ml for 24 hours 
at 4°C eliminated all immunoreactive staining (Supplemental Fig. 1). Finally, elimination 
of any single primary antibody while performing all other steps of the protocol eliminated 
all staining for the corresponding antigen and no others, demonstrating lack of cross-
reactivity. 
 
3.3.5 Immunohistochemistry: dual-label immunofluorescence for 
kisspeptin/GnRH with IRβ 
Sections were incubated overnight with antibody specifically recognizing IRβ (raised in 
rabbit, 1:300 dilution, Santa Cruz, C-19, SC-711). Next sections were incubated with 
biotinylated goat anti-rabbit (1:500 dilution, 1 hour, Vector Laboratories, Burlingame, 
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CA, USA), ABC-elite (1:500 dilution in PBS, 1 hour, Vector Laboratories), biotinylated 
tyramine (BT; 1:250 dilution in PBS with 1 µl of 3% H2O2/mL, 10 minutes, Perkin Elmer 
Life Sciences, Woodbridge, Ont., Canada), and Alexa 555 conjugated streptavidin (1:100 
dilution in PBS, 30 minutes, Molecular Probes). Finally, sections were incubated 
overnight with antibody specifically recognizing kisspeptin (raised in rabbit, 1:200,000 
dilution, 17 h; kp10, lot 564; gift from Dr. Alain Caraty, Nouzilly, France) or antibody 
specifically recognizing GnRH (raised in Mouse, 1:400 dilution, 17 h, Sternberger 
Monoclonals, Inc., catalogue #SMI-41R, Lot #3). The next day, sections were washed 
and incubated with either goat anti-rabbit or goat anti-mouse Alexa 488 (1:100 dilution, 
30 mins., Molecular
 
Probes). Sections were mounted on plus charged slides and cover 
slipped with gelvatol (39).  
3.3.6 Analysis 
Colocalization of IRβ-immunoreactivity (ir) within AGRP, POMC, kisspeptin, and 
GnRH neurons was examined by confocal microscopy (as previously described in (40)). 
Using a Zeiss LSM-510 laser-scanning confocal microscope system (Zeiss, Heidelberg, 
Germany), images of the arcuate nucleus of the hypothalamus (ARC), preoptic area 
(POA) and medial basal hypothalamus (MBH) were captured in Z-stacks comprised of 1 
µm optical sections. Alexa 555 fluorescence (IRβ) was imaged with a HeNe1 laser and a 
543 nm emission filter. Alexa 488 fluorescence (kisspeptin, GnRH or AgRP) was imaged 
with an Argon laser and a 488 nm emission filter. Cy5 fluorescence (POMC) was imaged 
with a HeNe2 laser and a 633 nm emission filter. Cell counts were performed in sections 
through the POA at the level of the organum vasculosum of the lamina terminalis (3 
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sections/animal), the middle ARC at the level of the tuberoinfundibular sulcus (5 
sections/animal), and the MBH at levels of the rostral to middle arcuate nucleus (3 
sections/animal).  In the ARC, between 30-60 neurons were examined for co-localization 
of IRβ for each phenotype (kisspeptin, AgRP, POMC) per animal (see Table 2, 
Supplemental Material).  For POA and MBH sections, every single GnRH (POA and 
MBH) and kisspeptin (POA) neuron was analyzed for co-localization. Percentages of the 
kisspeptin, GnRH, AgRP or POMC-ir neurons that colocalize IRβ-ir were calculated per 
animal. Differences between groups were determined using Two Way Analysis of 
Variance. For pairwise comparisons between treatment groups, Dunn’s Method or Fisher 
LSD Method post hoc tests were performed. 95% confidence levels were applied to all 
tests. 
 
3.4 Results 
3.4.1 Colocalization of AgRP and POMC with IR: effects of prenatal T 
In the ARC, 85% ± 1.46 of AgRP and 92% ± 2.01 of POMC neurons colocalized IRβ 
(Figs.12 and 13). Prenatal T treatment significantly decreased IRβ colocalization within 
AgRP (F(3,22):4.35; C versus T: p=0.003), but not POMC neurons (Figure 13). Co-
treatment with androgen antagonist blocked the effects of prenatal T, with prenatal TF 
treated females showing a similar percentage of IRβ colocalization with AgRP neurons as 
controls and a significantly greater percentage of colocalization than prenatal T females 
(p=0.015). Androgen antagonist treatment alone had no effect on the percentage of IRβ 
colocalization in either AgRP or POMC neurons, relative to controls (Figure 13).  
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Figure 12. Triple-label fluorescence immunolabeling of AgRP- (green), POMC- (blue), and IRβ-
immunoreactive neurons (red) in the arcuate nucleus of a control ewe. Overlay image (bottom 
right) shows colocalization of IRβ with AgRP and POMC neurons. Scale bar = 10µm. 
 
 
Figure 13. Mean ± SEM percentage co-localization of AgRP (A) and POMC (B) with IRβ in the 
arcuate nucleus of control (n=5), prenatal T (n=5), prenatal TF (n=5), and prenatal F (n=5) ewes. 
* indicates significant difference (p<.05) from controls. 
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3.4.2 Colocalization of kisspeptin and GnRH with IR: effects of prenatal T 
In the ARC, 94% ±1.3 of kisspeptin neurons colocalized IRβ (Fig. 14, bottom panel, and 
16). In contrast, POA kisspeptin neurons (104 analyzed) in control animals (n=5) do not 
colocalize IRβ (Fig. 14, top panel).  Prenatal T treatment significantly decreased the 
percentage of IRβ colocalization in ARC kisspeptin neurons (F(3,19):9.07; C versus T 
p=0.001; Figure 16). Co-treatment with androgen antagonist did not reverse the effects of 
T on IRβ colocalization within ARC kisspeptin neurons, while females treated with 
androgen antagonist alone showed a similar percentage of colocalization as control 
females (Fig. 16).   Finally, while immunoreactive IRβ was expressed in areas of the 
POA and MBH where GnRH neurons were located, out of over 300 GnRH neurons 
examined in 5 control animals, none colocalized IRβ (Fig. 15). 
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Figure 14. Dual-label immunofluorescent detection of kisspeptin- (green) and IRβ-
immunoreactive (red) neurons and fibers in the arcuate nucleus (ARC) and preoptic area (POA) 
of the ewe. Dual-labeled kisspeptin/IRβ neuron in the ARC (yellow arrow) and a single-labeled 
kisspeptin (white arrow) neuron in the POA are indicated in the overlay images. Scale bar = 
10µm. 
 
 
 
Figure 15. Dual-label immunofluorescence detection of GnRH- (green) and IRβ- (red) positive 
neurons in the medial basal hypothalamus of the ewe. Single labelled neurons are indicated by 
white arrows. Scale bar = 10µm. 
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Figure 16. Mean ± SEM percentage co-localization of kisspeptin with IRβ in the arcuate nucleus 
of control (n=5), prenatal T (n=5), prenatal TF (n=5), and prenatal F (n=5) ewes. # indicates 
significant difference (p<0.05) from control, * indicates significant difference (p<0.05) from 
prenatal F group.  
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3.5 Discussion 
 
Findings from this study document that IRβ is colocalized within ARC kisspeptin 
(KNDy), AgRP and POMC neurons, but not within GnRH and POA kisspeptin neurons 
and prenatal T treatment decreased colocalization of IRβ in AgRP and KNDy, but not 
POMC, neurons. Importantly, co-treatment with androgen antagonist blocked the effects 
of prenatal T on IRβ colocalization with AgRP, but not KNDy neurons, indicating that 
these opposing effects may be organized by different actions of T, androgenic and 
estrogenic, respectively.  
 
3.5.1 Effects of prenatal T treatment on IR colocalization in AgRP and 
POMC neurons 
The results of this study provide evidence of long-term changes in the colocalization of 
insulin receptors within AgRP neurons as a consequence of prenatal exposure to excess 
T.  Prenatal T treatment significantly decreased the percentage of AgRP, but not POMC, 
neurons co-localizing IRβ in the ARC compared with controls (Fig. 13). The AgRP-
specific decrease in IRβ is consistent with our previous findings showing increased 
numbers of AgRP-ir neurons, but not POMC-ir neurons in prenatal T-treated females 
(23).  Since insulin decreases AgRP mRNA levels (41) and peptide release (42) in normal 
females, the decreased IRβ colocalization within AgRP neurons may be partly 
responsible for the increased AgRP peptide we see in prenatal T animals (23).  In turn, 
both reduced IR colocalization in AgRP neurons, and increased AgRP peptide 
expression, may be contributing factors to the metabolic and reproductive deficits seen in 
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these animals.  Previous studies have found that prenatal T-treated females are insulin 
resistant and develop compensatory hyperinsulinemia as adults (21-22).  Moreover, 
AgRP neurons may also play an important role relaying the influence of metabolic cues 
to the reproductive neuroendocrine system. AgRP neurons project directly to GnRH 
neurons in the rat (43) and inhibit reproduction by suppressing pulsatile LH release in the 
rhesus monkey (44). Similarly, neuropeptide Y (NPY), an orexigenic neuropeptide, 
which is largely colocalized with AgRP (23, 45), inhibits reproduction by hindering 
GnRH neuronal firing in mice (46-47) and tonic secretion of LH in the sheep (48-49).  
We do not know whether NPY peptide, like AgRP, is increased in prenatal T sheep, but it 
is conceivable that increased AgRP and/or NPY peptide and its release may be a means 
by which this population could potentially modulate GnRH release and reproductive 
function.  
 
Prenatal TF treatment was able to rescue the effects of T on IR colocalization with AgRP 
neurons, suggesting that the decrease in IRβ in this subpopulation is organized by the 
androgenic actions of T. These effects of T parallel organizational effects of prenatal T 
on AgRP expression, albeit more completely. We previously found that co-treatment of T 
with androgen antagonist (TF) was able to largely, but not completely, rescue the effects 
of prenatal T on AgRP neuronal numbers (23). Moreover, the effects of prenatal T on 
insulin resistance (22) and AgRP neuronal numbers (23) are mimicked by prenatal 
dihydrotestosterone (DHT, a non-aromatizable androgen) treatment, further implicating 
an androgenic programming role of T in this population.  
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3.5.2 Effects of prenatal T treatment of IR colocalization in KNDy neurons 
We show that approximately 94% of KNDy neurons colocalize IRβ and that prenatal T 
treatment results in a 21% decrease in IR colocalization in these neurons. Reproductive 
deficits in prenatal T-treated females include LH excess and a delayed and dampened LH 
surge culminating in ablation of ovulatory cycles (14-18). As noted earlier, postnatal 
insulin sensitizer treatment improves reproductive function in prenatal T-treated females 
(31). Insulin has been shown to stimulate GnRH / LH secretion in vivo (50) and in vitro 
(51), an effect which is mediated at the level of the hypothalamus and not the pituitary. 
Because GnRH neurons do not express IRβ, insulin signaling to the reproductive axis 
must be relayed to GnRH neurons via afferent neurons expressing this receptor. Although 
the specific site of insulin action is not yet known, the ARC KNDy neurons have some of 
the attributes for fulfilling these criteria.  KNDy neurons in the sheep have been 
implicated in the control of both pulsatile (52-53) and surge (54) secretion of GnRH.  
KNDy neurons have been shown to make direct contacts with AgRP and POMC neurons 
in the sheep ARC (55). Furthermore, ovine KNDy neurons are activated by leptin 
treatment (55) albeit indirectly (56), and colocalize IRβ (this study) rendering this 
subpopulation responsive to metabolic signals (57).  Finally, there is an array of 
substantial evidence in rodents that KNDy neurons play an important role in mediating 
metabolic control of reproduction (58-62).  However, recent findings that mice with 
kisspeptin specific deletion of PI3K catalytic subunits show normal weight gain and 
normal time of puberty(63), suggests that insulin signaling via kisspeptin neurons 
(including KNDy neurons) is not critical for normal pubertal development or body weight 
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control. Although the effects of insulin on kisspeptin mRNA or neuronal activity have not 
been reported, insulin-like growth factor-1 (IGF-1) has been shown to increase Kiss1 
expression in the anteroventral periventricular nucleus (AVPV) of prepubertal female 
rats, in the presence of estradiol (64). These findings are consistent with the positive 
feedback role of AVPV kisspeptin neurons in the generation of the GnRH/LH surge in 
rodents (28), and a role of insulin signaling in the facilitation of the GnRH/LH surge has 
been widely described (1, 4, 31). Recent studies of prenatal T-treated sheep found that 
postnatal insulin sensitizer treatment increased the magnitude of the LH surge (65). 
Nonetheless, it is worthwhile to note that insulin can act at the hypothalamic, pituitary, or 
ovarian level to regulate follicular development (66-67). Thus, alterations in IRβ 
expression in KNDy neurons and/or at other levels, may each contribute to defects in 
reproductive dysfunctions seen in this model.    
 
In contrast to IR co-localization in AgRP neurons, co-treatment with androgen antagonist 
did not rescue the effects of prenatal T on IR colocalization within KNDy neurons, 
suggesting that the decrease in this subpopulation is organized by the estrogenic actions 
of T.  An alternate possibility is that the changes in IRβ are programmed by androgenic 
effects of T, via other intermediaries, for example those leading to an increase in 
gestational insulin levels (65).  However, recent findings that prenatal co-treatment with 
insulin sensitizer fails to rescue the effects of prenatal T treatment on GnRH/LH surge 
(65) argue against this possibility. Nonetheless, increased insulin levels during the period 
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of fetal exposure to excess T, when insulin levels in the mother are also increased (65), 
might intensify the degree of disturbance in this model.  
3.5.3 Absence of IRβ localization in GnRH neurons and POA kisspeptin 
neurons 
In contrast to AgRP, POMC and KNDy neurons, we found no evidence of colocalization 
of IRβ in either GnRH neurons or POA kisspeptin neurons. The absence of IRβ 
colocalization with GnRH neurons suggests that metabolic signals controlling 
reproductive status are relayed via an upstream population of neurons. As noted above, 
KNDy neurons as well as AgRP neurons represent likely candidates, since both 
populations of neurons colocalize IRβ, have direct projections to GnRH neurons (28, 43, 
68), and have been shown to regulate GnRH activity (24, 28, 44, 46-47).   While we 
found no colocalization of IR in POA kisspeptin neurons, we cannot exclude the 
possibility that this subset of kisspeptin neurons may participate in these actions via 
inputs from other insulin-sensitive neurons.   
 
3.5.4 Conclusion  
A summary of our current knowledge of changes in insulin receptors and metabolic 
peptides as a consequence of exposure to prenatal T in the female sheep, and their 
relationship to the reproductive neuroendocrine system, is shown in Figure 17.  KNDy 
neurons have been posited as a major intermediary conveying metabolic signals to the 
GnRH neuron (58-62), although direct projections of AgRP and POMC neurons to GnRH 
neurons are present in rodents (43, 68-70).  As shown by the enclosed dotted circle, 
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KNDy neurons form a reciprocally interconnected neuronal population whose activity is 
hypothesized to play a key role in regulating GnRH pulsatile secretion, as well as 
participate in the control of the GnRH surge in sheep and primates (28).  Prenatal T leads 
to decreased IR in KNDy neurons, and also decreased expression of two of the three 
KNDy peptides, neurokinin B and dynorphin (not shown).  Prenatal T also results in 
decreased in IR in AgRP but not POMC neurons, and there is a corresponding increase in 
AgRP but not POMC peptide in these populations.  The precise functional impact that 
each of these changes has on the control of GnRH secretion remains to be determined, 
but a first step will be to determine whether pre- or postnatal treatments with insulin 
sensitizers, such as Rosiglitazone, can reverse any of these receptor/peptide changes.  
Ultimately, the challenge will be to understand the early developmental cascade of events 
initiated by exposure to excess T that result in adult reproductive and metabolic 
dysfunction, and to determine which of the long-term hypothalamic alterations seen in 
the adult offspring may contribute to these functional deficits. 
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Figure 17. Schematic diagram summarizing the effects of prenatal T treatment on insulin receptor 
(IR) colocalization within AgRP, POMC and KNDy neurons in the adult sheep hypothalamus.  
Decreased IR in AgRP neurons may, in part, underlie the increased AgRP peptide in prenatal T 
ewes previously described (23).  In turn, changes in AgRP and KNDy peptides may contribute to 
alterations in the steroid feedback control of GnRH secretion by way of inputs at the level of 
GnRH neuronal bodies or their terminals.  Direct projections from AgRP neurons onto GnRH 
neuronal bodies are not shown. 
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Appendices:  
 
Appendix 1. IRβ Antibody Controls  
The specificity of the antibody used for insulin receptor beta (IRβ) was verified by 
preabsorption of the diluted primary antibody (1:300) with immunizing peptide (Santa 
Cruz) at a concentration 10g/ml (Fig 18), which effectively eliminated immunostaining.  
 
 
Figure 18. Insulin receptor immunoreactivity in the ovine ARC of a control ewe (A) and 
following preabsorption of the diluted antibody with the peptide antigen at a concentration of 
10µg/ml (B). Scale bar = 100µm. 
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4.1 Abstract 
 
Similar to women with polycystic ovarian syndrome (PCOS), prenatal testosterone (T) 
treated ewes develop metabolic and reproductive defects such as insulin resistance, 
decreased hypothalamic sensitivity to gonadal steroid feedback, and deterioration of 
ovulatory cycles. These hallmark features are often accompanied by hyperinsulinemia 
and hyperandrogenemia, which are believed to act synergistically during the prenatal 
and/or postnatal periods to program and maintain the metabolic and reproductive 
dysfunctions mentioned above. Prenatal T treated adult ewes show an increase in 
androgen receptor (AR) and a decrease in insulin receptor (IR) colocalization within 
agouti-related peptide (AgRP) and KNDy (kisspeptin, neurokinin B and dynorphin) 
neurons in the hypothalamic arcuate nucleus.  AgRP and KNDy neurons play a key role 
in the control of metabolic homeostasis and reproductive function, respectively.  The 
current study examines whether treatment with the insulin sensitizer, Rosiglitazone (R) 
during the prenatal or postnatal period can reverse the increased AR and decreased IR 
colocalization seen within AgRP and KNDy neurons in prenatal T-treated ewes. Pregnant 
Suffolk ewes were administered twice weekly injections of T propionate (100 mg i.m.) 
from days 30 to 90 of gestation. In addition, separate groups of pregnant ewes received 
prenatal T combined with either R (8 mg/ewe/day, oral) or F (15 mg/kg/day, s.c.). An 
additional group of prenatal T-treated offspring received postnatal R (0.11 mg/kg/day, 
oral), beginning at 8 wk of age.  At 21 months of age, adult female offspring were 
ovariectomized and received hormonal implants to produce an artificial follicular phase 
prior to sacrifice, and brains were processed for immunocytochemistry. We show that 
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prenatal (TR), but not postnatal treatment with insulin sensitizer (T+R) treatment blocks 
the prenatal T induced effect on IR, but not AR colocalization, within AgRP and KNDy 
neurons. These findings suggest that IR expression in AgRP and KNDy neurons is 
prenatally programmed by a mechanism involving insulin signalling. Given the role of 
AgRP and KNDy neurons in the regulation of energy homeostasis and reproductive 
function, prenatal intervention with insulin sensitizer may alleviate some dysfunctions 
associated with PCOS. 
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4.2 Introduction 
 
 
Polycystic ovarian syndrome is one of the most common endocrine disorders, affecting 
more than 10% of reproductively aged women (1). Dysfunctions associated with PCOS 
include hyperandrogenism, polycystic ovaries, insulin resistance, compensatory 
hyperinsulinemia, irregular ovulation, and infertility (2-7). PCOS is a complex disorder 
stemming from genetic as well as environmental disturbances (8). Nonetheless, recent 
experiments using animal models (6, 9-11), along with supporting clinical evidence (1, 
12), have shown that exposure to excess androgens during a critical period of 
development can permanently disrupt metabolic and reproductive function during 
adulthood (1, 8, 13-15), resulting in a PCOS-like phenotype. Our animal model, the 
prenatal testosterone (T) treated ewe, allows us to study the mechanisms which are 
responsible for the prenatal organization of PCOS (9). Similar to women with PCOS, 
prenatal T treated sheep develop metabolic and reproductive deficits. These include 
insulin resistance and compensatory hyperinsulinemia (14, 15) as well as ovulatory 
dysfunctions (16-17) marked by a delayed a dampened preovulatory surge (16) and 
increased luteinizing hormone (LH) pulsatile secretion (18).  Various studies have shown 
that treatment with insulin sensitizers (ie. Rosiglitazone) (19-22) or anti-androgens (ie. 
Flutamide) (23-24) can alleviate certain reproductive and metabolic symptoms associated 
with PCOS. In prenatal T treated sheep, postnatal treatment with the insulin sensitizer 
Rosiglitazone (R) has been shown to improve reproductive function (25), reducing the 
deterioration in number of cycles from 80% to 20% in the second breeding season. 
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Another study found that postnatal treatment with Flutamide (F) and R were able to 
reverse the effects of prenatal T on the amplitude, but not the timing, of the LH surge 
(26). Specifically, prenatal T-treated females that were treated with the anti-androgen F 
or insulin sensitizer (R) postnatally (T+F or T+R) exhibited an LH surge of normal 
amplitude, a characteristic of the preovulatory surge which is typically dampened by 
prenatal T treatment; despite this improvement, however, the timing of the surge was still 
delayed. 
 
Prenatal interventions have also proven effective in reversing alterations seen at the level 
of the brain in prenatal T treated sheep. The focus of these studies has been on the arcuate 
nucleus (ARC) of the hypothalamus, a major center of convergence for reproductive and 
metabolic signals. This region contains two key populations of neurons involved in the 
regulation of metabolic and reproductive function, orexigenic agouti-related peptide 
(AgRP) neurons and KNDy (co-expressing the neuropeptides kisspeptin, neurokinin B 
(NKB), dynorphin) neurons. KNDy neurons are important regulators of GnRH secretion, 
with each of the KNDy peptides (kisspeptin, NKB and dynorphin) serving distinct roles 
in modulating GnRH release depending on the steroid hormone milieu, and mediating 
pulsatile and/or surge secretion of GnRH (27-32). Our lab has previously found that 
prenatal T treated sheep show an increase in the number of AgRP neurons (33) and a 
reduction in dynorphin and NKB, but not kisspeptin, within KNDy neurons (34). We also 
found that both AgRP and KNDy neurons of prenatal T treated sheep show an increased 
percentage of colocalization with androgen receptors (AR) (35)and a decreased 
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colocalization with insulin receptors (IR) (36). Flutamide co-administered with prenatal 
testosterone (TF) reverses the prenatal T induced increase in AgRP neuron number (33) 
as well as the decrease in insulin receptor (IR) colocalization in this population (36). 
However, TF treatment does not reverse the decrease in IR colocalization within KNDy 
neurons (36). Although prenatal interventions may be an effective method of reversing 
some effects of excess prenatal T exposure, postnatal interventions may provide another 
opportunity and time point where we can intervene and reverse some detrimental effects 
of prenatal T. In addition, recent observations of high circulating insulin levels induced 
by T treatment in the pregnant sheep (Abi Salloum, B., and V. Padmanabhan, 
unpublished data), suggest that insulin may also play a role in the programming of 
reproductive and metabolic functions during adulthood. Based on these observations, in 
this study we examined the effects of prenatal and postnatal treatments with the anti-
androgen Flutamide (F) and insulin sensitizer, Rosiglitazone (R) on prenatal T induced 
changes in AgRP and KNDy neuronal populations and specifically, on the colocalization 
of AR and IR within these neurons.  
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4.3 Materials and Methods 
 
All study procedures were approved by the Institutional Animal Care and Use Committee 
of the University of Michigan and are consistent with National Research Council's Guide 
for the Care and Use of Laboratory Animals. Suffolk ewes were cared for at the 
University of Michigan Sheep Research Facility (Ann Arbor, MI). Details of housing, 
nutrition, breeding, lambing and prenatal treatment have previously been described (37-
39).  Parturition of all lambs took place in early 2010 from March through April. 
Lactating ewes were fed 1 kg of shelled corn and 2–2.5 kg of alfalfa hay/ewe per day. 
Lambs were provided ad libitum with commercial feed pellets (Shur-Gain, Elma, NY) 
consisting of 18% of crude protein. Breeder ewes and lambs had ad libitum access to 
water and minerals, and were regularly treated with antihelminthics to minimize parasitic 
infection. 
 
4.3.1 Prenatal and Postnatal treatments 
Treatment groups included control (C) (n=6), prenatal rosiglitazone only (CR) (n=5), 
postnatal rosiglitazone only (C+R) (n=6), postnatal flutamide only (C+F) (n=5), prenatal 
testosterone (T) (n=5), prenatal testosterone and flutamide (TF) (n=9), prenatal 
testosterone and rosiglitazone (TR) (n=7), prenatal testosterone and postnatal 
rosiglitazone (T+R) (n=6). A prenatal testosterone and postnatal flutamide (T+F) group 
was omitted from the study due to uterine hypertrophy resulting in an inability to 
ovariectomize the animals prior to sacrifice. Prenatal T treatment involved twice weekly 
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i.m injections of T propionate (100 mg/2ml dissolved in cottonseed oil; Sigma-Aldrich, 
St. Louis, MO) suspended in corn oil from days 30 to 90 of gestation. The C group 
received similar volume of vehicle injections. Prenatal insulin sensitizer treatment 
involved daily oral treatment of insulin sensitizer at a dose of 8 mg/ewe. This dose of 
insulin sensitizer administered postpubertally improved reproductive function in prenatal 
T-treated females (25). Prenatal androgen antagonist treatment involved s.c injections of 
flutamide (15 mg/kg·d) as described earlier (40).  
Postnatal treatments with insulin sensitizer began at 8 weeks of age and involved daily 
oral administration of the insulin sensitizer (0.11 mg/kg). The administered dose is 
comparable with that given to women with polycystic ovary syndrome (PCOS) (41-42). 
The same dose administered postpubertally was effective in improving reproductive cycle 
attributes of prenatal T treated females (25). 
4.3.2 Tissue Collection  
Brains were collected during the breeding season when females were 2 years of age. In 
order to normalize endogenous hormone levels among the groups, 3 to 4 weeks prior to 
tissue collection, ewes were ovariectomized and were treated with two controlled internal 
drug release P4 implants (CIDR) (InterAG, Hamilton, Waikato, New Zealand) for 11–12 
d and then for 1 day with four 3-cm-long E2 implants to simulate ovarian steroid levels 
during the late follicular phase of the cycle. Ewes were sacrificed approximately 18 hours 
after E2 implants. At time of tissue collection, all ewes received two intravenous 
injections (at 10 min intervals) of 25,000 U heparin (catalog # 402588B; Abraxiz 
Pharmaceuticals, Schumberry, IL). Ewes were anaesthetized intravenously with sodium 
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pentobarbital (390 mg/ml/kg; Fatal Plus, Vortech, Dearborn, MI) and rapidly decapitated. 
The heads were immediately perfused through the internal carotid artery with 6L of 4% 
paraformaldehyde (Sigma-Aldrich) dissolved in 0.1M phosphate buffer (PB; Sigma- 
Aldrich) containing 0.1% sodium nitrate (Sigma- Aldrich), and 10 U/ml heparin (Abraxiz 
Pharmaceuticals). Brains were submerged in the same fixative at 4C for 18hr. Blocks of 
tissue containing hypothalami were transferred in 30% sucrose at 4C and sectioned 
coronally (45 µm) using a freezing microtome (Microm, Walldorf, Germany) into 6 
parallel series for each animal. Sectioned tissues were stored in cryoprotectant (30% 
ethylene glycol, 0.1% sodium azide, 30% sucrose in PB) at -20C until further 
processing. 
 
4.3.3 Immunohistochemistry: general  
A series of every sixth section through the rostral-caudal extent of the ARC from each 
animal were processed for immunohistochemistry. All incubations occurred at room 
temperature with gentle agitation. Free-floating sections were rinsed thoroughly with 0.1 
M phosphate-buffered saline (PBS) between incubations. Antibodies were dissolved in 
incubation solution consisting of 0.1M PBS, 0.4% Triton X-100 (catalog item BP151- 
500; Sigma-Aldrich) containing 4% normal goat serum (NGS) (catalog item 005-000-
121; Jackson Immuno Research Laboratories, West Grove, PA). Unless otherwise 
specified, tissue sections were washed extensively with 0.1 M PBS (pH 7.35) between 
steps. Prior to incubation with the first primary antibody, sections were incubated with 
1% hydrogen peroxide (10 min, H2O2; catalog item H325; Fisher Scientific, Pittsburgh, 
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PA) and incubation solution (1hr) to prevent non-specific background labeling. Negative 
controls were performed by omission of primary antibody, and resulted in elimination of 
all labeling corresponding to that antigen.   
 
4.3.4 Immunohistochemistry: triple-label immunofluorescence for 
IR/AgRP/Kiss 
Tissue sections were incubated overnight with primary antibody against the beta sub-unit 
of the insulin receptor (IRβ, raised in Rabbit, 1:300 dilution, Santa Cruz, C-19, SC-711), 
with biotinylated goat anti-rabbit (1:500 dilution, 1 hour, Vector Laboratories, 
Burlingame, CA, USA), ABC-elite (1:500 dilution in PBS, 1 hour, Vector Laboratories), 
biotinylated tyramide (BT; 1:250 dilution in PBS with 1 µl of 3% H2O2/ml, 10 minutes, 
Perkin Elmer Life Sciences, Woodbridge, Ont., Canada), and Alexa 555 conjugated 
streptavidin (1:100 dilution in PBS, 30 mins., Molecular Probes). Next, sections were 
incubated overnight (17 hours) with an antibody specifically recognizing AgRP (raised in 
Guinea Pig, 1:5000 dilution in incubation solution with 4% NGS; Antibodies Australia, 
catalogue # GPAAGRP.1, Lot # AS506), with biotinylated goat anti-Guinea Pig (1:500 
dilution, 1 hour, Vector Laboratories, Burlingame, CA, USA), ABC-elite (1:500 dilution 
in PBS, 1 hour, Vector Laboratories), biotinylated tyramide (BT; 1:250 dilution in PBS 
with 1 µl of 3% H2O2/ml, 10 minutes, Perkin Elmer Life Sciences, Woodbridge, Ont., 
Canada), and Cy5 conjugated streptavidin (1:100 dilution in PBS, 30 mins., Molecular 
Probes). Finally, sections were incubated overnight (17 hours) with an antibody 
specifically recognizing kisspeptin (raised in rabbit, 1:200,000 dilution; kp10, lot 564; 
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gift from Dr. Alain Caraty, Nouzilly, France) and then with goat anti-rabbit Alexa 488 
(1:100 dilution in PBS, 30 minutes, Molecular Probes). Sections were mounted on plus 
charged slides and cover slipped with gelvatol (43).  
 
Specificity of the primary antibody for AGRP was previously been demonstrated in sheep 
hypothalamic sections (43). Pre-absorption of IRβ antibody with its corresponding 
peptide antigen (Santa Cruz) at concentration of 10 µg/ml for 24 hours at 4°C eliminated 
all immunoreactive staining (Supplemental Fig. 1). Finally, elimination of any single 
primary antibody while performing all other steps of the protocol eliminated all staining 
for the corresponding antigen and no others, demonstrating lack of cross-reactivity. 
 
4.3.5 Immunohistochemistry: dual-label immunoperoxidase for 
AR/kisspeptin and AR/AgRP 
Tissue sections were incubated with rabbit anti-AR (1: 200 dilution, 17 h; Santa Cruz, sc-
816, lot F1711), biotinylated goat anti-rabbit IgG (1:500, 1 hr; catalog item BA-9200; 
Vector Laboratories, Burlingame, CA), avidin-biotin horseradish peroxidase complex 
(ABC; 1:500, 1 hr, catalog item PK-6100; Vector Laboratories), and 0.02% 3, 3’-
diaminobenzidine tetrahydrochloride (DAB, Sigma-Alderich) with 0.08% nickel sulfate 
(10 min; diluted in PB containing 0.012% H2O2). Next, sections were incubated 
overnight (17h) with rabbit anti-kisspeptin (1:300,000 dilution; kp10, lot 564; gift from 
Dr. Alain Caraty, Nouzilly, France) or guinea pig anti-AgRP (1:1000 dilution, C-
GPAAGRP, Lot AS-506, Antibodies Australia), biotinylated goat anti-rabbit IgG (1:500, 
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1 hr; catalog item BA-9200; Vector Laboratories, Burlingame, CA), ABC (1:500, 1 hr, 
catalog item PK-6100; Vector Laboratories), and 0.02% 3, 3’-diaminobenzidine 
tetrahydrochloride (DAB, Sigma-Alderich,10 min; diluted in PB containing 0.012% 
H2O2). Tissue sections were mounted onto Superfrost/Plus Microscope Slides (Fisher 
Scientific), dehydrated with alcohol and cover-slipped with Depex Mountant (Electron 
Microscopy Sciences, Fort Washington, PA). 
 
4.3.6 Analysis 
Colocalization of AR/kiss and AR/AgRP: All kisspeptin- and AgRP-positive neurons, in 
3-4 hemisections through the middle ARC for each animal, were analyzed for 
colocalization of AR using a LeicaDM5000B at 20x magnification. The middle ARC was 
defined as that rostral-caudal level of the nucleus directly adjacent to the tubero-
infundibular sulcus of the third ventricle. Co-localized neurons were defined by the 
presence of a blue-black AR-positive nucleus completely surrounded by brown kisspeptin 
or AgRP-positive cytoplasm, as examined in the same plane of focus. The percentages of 
kisspeptin and AgRP neurons that colocalized AR were calculated for each section and 
averaged per animal. Comparisons between treatment groups were conducted using 
ANOVA, and Dunn’s or Holm-Sidak post-hoc test, with 95% confidence levels. 
 
Colocalization of IR/kiss and IR/AgRP: Fluorescent images spanning the entire middle 
ARC in 3-4 hemi-sections per animal were captured using a cooled CCD camera 
(Microfire, Optronics) attached to a Leica microscope (DM5000B, Leica Microsystems; 
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Wetzlar, Germany) and Neurolucida software (MicroBrightfield Inc.) with fixed camera 
settings for all subjects (using 20x objectives).  The number of single-labeled kisspeptin 
and AgRP neurons, and double-labeled IR/kisspeptin and IR/AgRP neurons, were 
manually counted using Neurolucida software (MBF Bioscience, Williston, VT) and the 
percentage co-localization calculated in each animal. Group means of percent 
colocalization of IR/kisspeptin or IR/AgRP were compared using ANOVA and Dunn’s or 
Holm-Sidak, with 95% confidence levels. 
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4.4 Results 
 
4.4.1 AgRP neuronal numbers  
In agreement with previous finding (33) prenatal T treated females had significantly more 
arcuate AgRP neurons compared to control females (F(6,43):22.36; p<0.001) and TF 
treatment was able to reverse this effect (p<0.001) (Fig. 20). Prenatal (TR), but not 
postnatal Rosiglitazone treatment (T+R) was also able to reverse the effects of prenatal T 
on AgRP neuronal numbers in the ARC (p<0.001). There were no significant differences 
between any of the control groups (C, C+F, C+R, and CR).  
 
 
 
 
 
 
 
 
 
 
                    C        CR      C+R       T         TF       TR      T+R 
* 
* 
 
 
Figure 19.  Mean ± SEM number of arcuate AgRP neurons in control (C), prenatal rosiglitazone 
only (CR), postnatal rosiglitazone only (C+R), prenatal testosterone (T), prenatal testosterone and 
prenatal flutamide (TF), prenatal testosterone and prenatal rosiglitazone (TR), and prenatal 
testosterone and postnatal rosiglitazone (T+R) treated females. * describes significant difference 
from controls. 
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4.4.2 Androgen receptor colocalization with KNDy and AgRP neurons 
As shown previously (35), prenatal T treated females exhibited an increased percentage 
of AR colocalization within arcuate kisspeptin (KNDy) neurons (F(7,36):15.93; p<0.001) 
and AgRP neurons (F(7,37):27.02; p<0.001) and both effects were reversed by prenatal 
co-treatment with androgen blocker, Flutamide (TF) (p<0.001) (Fig. 18; Table 2). By 
contrast, prenatal or postnatal treatment with the insulin sensitizer, Rosiglitazone (TR) 
failed to reverse the effects of prenatal T on AR colocalization within KNDy or AgRP 
neurons, and these groups were not significantly different from controls. 
 
4.4.3 Insulin receptor colocalization with KNDy and AgRP neurons 
Again, our previous findings (36) were replicated in that prenatal T treated females had 
decreased IR colocalization within both KNDy (F(7,38):24.92; p<0.001) and AgRP 
(F(7,39):8.98; p<0.001) neurons (Fig. 19; Table 2). Prenatal co-treatment with androgen 
blocker, Flutamide (TF) reversed the effect of prenatal T on IR colocalization within 
AgRP (p<0.001), but not IR colocalization in KNDy neurons. Prenatal, but not postnatal 
(p=0.269) treatment with the insulin sensitizer, Rosiglitazone (TR) reversed the effects of 
prenatal T on IR colocalization within both KNDy (p<0.001) and AgRP (p<0.001) 
neurons.  
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Figure 20. Mean ± SEM percent colocalization of androgen receptor (AR) with arcuate KNDy 
(A) and AgRP (B) neurons  in control (C), prenatal rosiglitazone only (CR), postnatal 
rosiglitazone only (C+R), prenatal testosterone (T), prenatal testosterone and prenatal flutamide 
(TF), prenatal testosterone and prenatal rosiglitazone (TR), and prenatal testosterone and 
postnatal rosiglitazone (T+R) treated females. * describes significant difference from controls. 
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 Figure 21.  Mean ± SEM percent colocalization of insulin receptor (IR) with arcuate KNDy (A) 
and AgRP (B) neurons  in control (C), prenatal rosiglitazone only (CR), postnatal rosiglitazone 
only (C+R), prenatal testosterone (T), prenatal testosterone and prenatal flutamide (TF), prenatal 
testosterone and prenatal rosiglitazone (TR), and prenatal testosterone and postnatal rosiglitazone 
(T+R) treated females. * describes significant difference from controls. 
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 Prenatal Intervention, 
androgen blocker (F) 
Prenatal Intervention, 
insulin sensitizer (R) 
Postnatal 
Intervention, insulin 
sensitizer (R) 
AR/KNDy √ X X 
AR/AgRP √ X X 
IR/KNDy X √ X 
IR/AGRP √ √ X 
 
Table 2. Effects of pre- and postnatal treatment with the androgen blocker, Flutamide (F) and the 
insulin sensitizer, Rosiglitazone (R) on prenatal T induced effects on androgen receptor (AR) and 
insulin receptor (IR) colocalization with the arcuate KNDy and AgRP neurons 
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4.5 Conclusions 
 
The findings in this study show that prenatal, but not postnatal interventions increasing 
insulin sensitivity with Rosiglitazone were able to prevent the effects of prenatal T 
treatment on insulin receptor (IR) and androgen receptor (AR) colocalization with ARC 
KNDy and AgRP neurons as well as on AgRP neuronal numbers. Thus the effects of 
prenatal T on AgRP peptide, as well as colocalization of IR and AR in both AgRP and 
KNDy neurons, depends on insulin signaling.  This points to a convergence of both 
signals, T and insulin, at the level of the fetal brain to produce long-term changes in 
hypothalamic neuropeptide/receptor expression (Fig. 22). 
 
 
Figure 22. Schematic diagram illustrating the effects of prenatal exposure to excess  testosterone 
and insulin on androgen receptor (AR) and insulin receptor (IR) expression in arcuate (ARC) 
KNDy and AgRP neurons and the potential impact on reproductive and metabolic function. 
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4.5.1 Prenatal Interventions 
We replicated previous findings from our lab showing that prenatal T-treated ewes 
exhibit an increase in the number of AgRP (appetite stimulating), but not POMC 
(appetite suppressing) neurons in the ARC, an effect which is reversed by prenatal co-
treatment with Flutamide (TF) (33). We also replicated findings that prenatal T-treated 
ewes show a decrease in IR and increase in AR colocalization within AgRP and KNDy 
neurons (36). Each of these effects were blocked by co-treatment with androgen blocker 
(TF), with the exception of IR colocalization with KNDy neurons, suggesting that the 
majority of these alterations are programmed by a mechanism requiring the androgenic 
actions of T. This is consistent with our previous findings showing that prenatal 
dihydrotestosterone (DHT) treatment mimics the effects of T, while prenatal Estrogen (E) 
treatment has no effect on AR-ir (35). By contrast, the effect of prenatal T in decreasing 
colocalization of IR in KNDy neurons appears to depend on the estrogenic actions of the 
T treatment, presumably via aromatization of T.  The estrogenic nature of this effect, 
however, needs to be confirmed by either prenatal E treatment, or by the ability of 
aromatase inhibitors to block it. 
 
The ability of prenatal co-treatment with insulin sensitizer (TR) to block the effects of T 
on IR colocalization with AgRP and KNDy neurons as well as AgRP neuronal numbers 
suggests that IR expression in these neurons is organized by a mechanism requiring 
insulin signalling. Because prenatal treatments with either insulin-sensitizer or anti-
androgen can block the effects of prenatal T on the AgRP population (IR colocalization 
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and neuronal number), this indicates that a common mediator involving both androgen 
and insulin signaling is responsible for the long-term alterations in this population. 
Increases in circulating insulin levels in the mother associated with T treatment (Abi 
Salloum, B., and V. Padmanabhan, unpublished data) may provide a means by which 
insulin mediates some organizational programming in the developing fetus. It is also 
conceivable that exposure of the fetus to high levels of T as well as insulin may program 
certain aspects of the reproductive and metabolic system via a pathway that involves both 
influences. For example, it is well documented that hyperinsulinemia exacerbates 
hyperandrogenemia by acting synergistically with amplified LH levels to increase 
androgen production in theca cells of the ovary (44-47). Moreover, insulin suppress sex 
hormone binding globulin (SHBG) produced by the liver, permitting an increase in 
unbound plasma testosterone (48-49). Thus, increased insulin levels in the pregnant ewe 
may intensify the effects of T on the fetus, while acting in parallel to program aspects of 
the prenatal T phenotype. 
 
Prenatal co-treatment with insulin sensitizer (R) blocked the effects of T on IR 
colocalization with KNDy neurons, an effect that was not achieved with by prenatal co-
treatment with the anti-androgen, Flutamide.  As noted above, this suggests that the 
effects of prenatal T on IR in this population are programmed via a mechanism involving 
insulin signaling and perhaps the estrogenic actions of T. Indeed, fetuses exposed to T 
show an increase in circulating estrogen (50), providing a means for such estrogenic 
mediation. Previous studies have shown that prenatal T, acting via an androgenic 
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pathway, programs estradiol-negative feedback disruptions in the sheep, while 
disruptions in the GnRH/LH surge are programmed by the estrogenic actions of T (51). 
Because IR expression in KNDy neurons may be programmed via a mechanism 
involving estrogen and insulin signalling, it is tempting to speculate that restoring IR 
expression in KNDy neurons may partially restore the GnRH/LH surge. However, this 
does not appear to be the case as prenatal co-treatment with R does not reverse the effects 
of prenatal T treatment on the GnRH/LH surge (26). Moreover, a recent study in mice 
showed selective IR deletions from ARC kisspeptin (KNDy) neurons caused a delay in 
the onset of puberty, but fertility was not affected (52). These studies suggest that IR 
expression in KNDy neurons is not essential in the control of GnRH secretion, but may 
play an important role in the initiation of puberty. Although our group of females (ovary 
intact up to 2 years of age, then OVX) do not display alterations in the onset of puberty 
(16), prenatal T treated sheep that have been OVX and E-replaced shortly after birth 
display advanced puberty onset (53).  It may be that prenatal T induced decrease in IR 
expression within KNDy neurons contributes to the timing of puberty onset, but in our 
model additional ovarian factors counter the functional effect of the reduction in IR (16). 
Nevertheless, it would be worthwhile to compare the effects of prenatal T treatment on 
IR/KNDy colocalization on the onset of puberty between these two sheep models 
(OVX+E replaced and ovary intact).  
 
AgRP expression is regulated by insulin levels, with increased insulin levels suppressing 
AgRP and vice versa (54-56). Prenatal treatment with insulin sensitizer blocked the 
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prenatal T induced reduction of IR colocalization with AgRP. As such, it is tempting to 
assume that by normalizing IR signalling in this population, insulin can appropriately 
regulate AgRP, decreasing its expressing to levels comparable to control females. As 
such, blocking the effects of high maternal insulin on the developing fetus may decrease 
the probability for insulin resistance and improve metabolic function in the adult 
offspring. 
 
4.5.2 Postnatal treatments 
Failure of postnatal treatment with insulin sensitizer to reverse the effects of prenatal T 
on AR and IR colocalization within KNDY and AgRP neurons, as well as its effect on 
number of AgRP neurons, suggests that these components are programmed during the 
prenatal period. Insulin sensitizers are commonly used in the treatment of 
hyperinsulinemia and hyperandrogenemia in adolescent or adult women with PCOS (7, 
57-59). Given the close similarities between the metabolic and reproductive dysfunctions 
seen in prenatal T sheep and women with PCOS (ref), it was disappointing that postnatal 
treatment with rosiglitazone did not reverse the effects of prenatal T-treatment on the 
KNDy and AgRP populations in the sheep model. It may be that the organization of IR 
and AR expression in these populations is important during the early stages of 
development in order to set the framework for dysfunctions later in life. In this regard, it 
is interesting that although interventions with androgen antagonist (60), insulin sensitizer 
(61-63), or combined (41, 64) are able to improve ovulation rate in subjects with PCOS, 
optimal success with pregnancy rate are yet to be realized. It is possible that postnatal 
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interventions are able to alleviate some dysfunctions associated with PCOS; however, in 
cases where prenatal origins of this disease are a factor, it may be that some 
neuroendocrine mechanisms remain permanently altered by prenatal T treatment and alter 
the threshold for complete restoration of successful reproductive and metabolic function.  
 
Although we saw no effect of postnatal insulin sensitizer treatments on androgen or 
insulin receptor expression, or AgRP expression, this does not exclude an effect on other 
neuropeptide expression. Preliminary data from our lab indicates that postnatal treatment 
with insulin sensitizer reverses the effects of prenatal T treatment on some but not all 
KNDy neuropeptide expression, increasing numbers of Neurokinin B (NKB) neurons to 
levels comparable to controls but having no effect on the number of dynorphin neurons 
(Lehman, M.N., preliminary data). Therefore, it may be that different 
neuropeptide/receptor components of the KNDY are programmed during different critical 
periods, with AR and IR being programmed primarily during the prenatal period and 
setting the framework for later programming of NKB expression, which may be reversed 
by treatments during the postnatal period.  It is particularly interesting to note that the 
three KNDy peptides, all co-expressed a single set of neurons, are each regulated by 
different critical periods and signals: kisspeptin, whose expression is independent of 
prenatal T; NKB which is decreased by prenatal T and dependent on both pre- and post-
natal insulin signaling; and dynorphin, which is decreased by prenatal T and dependent 
on only prenatal insulin action.  Given the role of ovine KNDy neurons in both pulsatile 
and surge secretion of GnRH, it is likely that the functional impact of this differential 
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programming is likely seen at the level mechanisms controlling puberty, as well as adult 
estrous cyclicity, but the precise functional roles remain to be determined. 
 
4.5.3 Conclusions and clinical implications 
Due to the adverse side effects of the anti-androgens and the risk of feminization of a 
male fetus (65), the use of anti-androgens are contraindicated during pregnancy. 
However, insulin sensitizers, such as Rosiglitazone have been widely used in pregnant 
women with PCOS to reduce gestational complications such as miscarriage, gestational 
diabetes and pre-eclampsia in the mother (66-67). However, studies examining the effects 
of prenatal treatment with insulin sensitizers on offspring, during infancy and adult life, 
are limited. Carlsen and Vanky (2009) showed that newborns of mothers with PCOS 
treated with the insulin sensitizer Metformin during gestation had higher levels of SHBG, 
which is suppressed by hyperinsulinemia (49), but no change in androgen or estrogen 
levels (68-69), suggesting a role for insulin sensitizer in improving gestation 
hyperinsulinemia. However, due to the shortage of studies examining the effects of 
prenatal exposure to insulin sensitizers during adulthood, we cannot conclude whether 
this intervention influences testosterone levels or improves metabolic and reproductive 
functions later in life. 
 
The findings from this study provide evidence in the support of prenatal programming of 
receptors that are involved in insulin and androgen signaling within reproductive and 
metabolic neurons of the hypothalamus, the KNDy and AgRP neuronal populations, 
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respectively. The programming of these receptors provides a framework though which 
hyperandrogenemia and hyperinsulinemia are able to exert their effects on these neuronal 
populations. The ability of prenatal, but not postnatal intervention with insulin sensitizer 
to block the effects of prenatal T treatment on the IR and AR colocalization within KNDy 
and AgRP neurons suggests that the prenatal period may provide a critical time point to 
intervene and prevent long-term changes in hypothalamic peptide/receptor expression, 
which otherwise may remain permanently modified by prenatal T.  This study is among 
the first to show that prenatal interventions blocking fetal exposure to excess androgen or 
insulin levels may prevent some fundamental disturbances in receptor balance which, in 
turn, may subsequently alter the threshold required for normal metabolic and 
reproductive functions. In this way, the changes we identified may represent a potential 
neuroendocrine basis for the effectiveness of therapies that are already being used in the 
treatment of women with PCOS. 
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Chapter 5: Neural pathways by which leptin may 
modulate activity of kisspeptin (KNDy) neurons in the 
sheep: activation of AgRP and POMC neurons. 
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5.1 Abstract 
 
Leptin serves as an indicator of peripheral energy stores and a permissive metabolic 
signal for reproductive function and the initiation of puberty. Leptin modulates pulsatile 
gonadotropin secretion from the anterior pituitary via the regulation of hypothalamic 
gonadotropin releasing hormone (GnRH) neurons. The arcuate (ARC) KNDy neurons 
(co-expressing the neuropeptides kisspeptin, neurokinin B/dynorphin) are important 
neurons involved in the control of pulsatile GnRH secretion and may comprise one of the 
pathways by which leptin influences reproduction.  Neuronal activation by leptin can be 
studied by examining phosphorylation of STAT3 (pSTAT3), a direct consequence of the 
binding of leptin to its receptor.  In addition, induction of the immediate early gene 
product, cFos can be used as an indicator of general activation.  We examined leptin-
induced pSTAT3 and cFos in sheep brain to delineate the neural pathways by which 
leptin might regulate GnRH secretion in this species.  Adult, ovary-intact ewes received 
injections of either leptin (1mg/kg, i.v.) or vehicle, and two hours later were euthanized 
and their brains perfused for immunocytochemistry.  Alternate series of sections were 
processed for dual immunoperoxidase detection of pSTAT3 or cFos with either 
kisspeptin, agouti-related peptide (AgRP), proopiomelanocortin (POMC), or GnRH.  
Leptin-treated sheep showed pSTAT3 expression in a majority of AgRP neurons (84%) 
and a subset of POMC neurons (30%), but not in kisspeptin or GnRH neurons; control, 
vehicle-injected animals exhibited no pSTAT3 in any of these neurons.  By contrast, 
leptin induced cFos expression in a majority of ARC kisspeptin (70%) and POMC (92%) 
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neurons, while control animals showed 20-30% basal levels of co-expression. AgRP 
neurons showed high levels expression of cFos in both leptin and control animals (70-
90%).  GnRH neurons were not examined for cFos expression.  In summary, leptin 
appears to directly activate AgRP and POMC, but not kisspeptin and GnRH, neurons by 
activation of leptin receptors (LepR) and STAT3.  Moreover, ARC kisspeptin neurons are 
also activated by leptin but indirectly, presumably by afferents from other neurons that in 
turn are leptin-responsive. These results suggest that leptin may modulate GnRH 
secretion in sheep by a pathway that starts with AgRP and POMC neurons, but may also 
include projections to KNDy neurons and their inputs to GnRH neurons. 
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5.2 Introduction  
 
Leptin is an important metabolic signal of energy stores and an indicator to the 
reproductive axis whether sufficient energy is available to initiate puberty, permit 
reproductive activity and maintain reproductive functions (1-5). High leptin 
concentrations, often linked with obesity or polycystic ovarian syndrome (PCOS), can 
partially explain the negative impact of these pathologies on fertility (6-7). Although 
leptin can regulate reproduction via actions that ultimately control the secretion of 
hypothalamic gonadotropin releasing hormone (GnRH) , this influence is indirect (8) and 
the exact mechanisms through which leptin affects GnRH neuronal activity remain 
unclear. Animal models can provide a means of studying the signaling pathways of leptin 
in the brain. Leptin-deficient (Lep
ob/ob
) mice are infertile (8) and this is most likely due 
reduced circulating gonadal steroids (9) and decreased sensitivity of the hypothalamic-
pituitary system to steroidal signals (10). Reversing leptin deficiency in these mice by 
peripheral leptin injections, stimulates the reproductive axis, reverses the 
hypogonadotropic hypogonadism and restores fertility (11-14). A wide variety of studies 
have shown that leptin activates the neuroendocrine reproductive axis in many species 
including rodents (12, 15-16) and primates (17) by stimulating GnRH and LH secretion. 
However, dual-labeling studies using in-situ hybridization and immunohistochemistry 
have shown few, if any GnRH neurons expressing leptin receptors (LepR) in rats (18) 
and monkeys (17). While this does not dismiss the probability that leptin can act directly 
on GnRH neurons, a more likely mechanism may involve indirect influence via 
interneurons upstream of GnRH (19).  
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The ARC KNDy neurons (expressing the neuropeptides, kisspeptin, dynorphin and 
neurokinin B) have emerged as a key population of neurons involved in relaying the 
feedback influence of gonadal hormones onto GnRH neurons (20-22). GnRH is directly 
stimulated by kisspeptin and GnRH neurons express the kisspeptin receptor, Kiss1R (23-
26). Furthermore, mutations of Kiss1R result in reproductive dysfunction such as delayed 
or absent pubertal maturation, low circulating gonadotropin levels, and hypogonadotropic 
hypogonadism in humans (27) and mice (25, 28-31). Kisspeptin is also influenced by 
nutritional status and circulating leptin levels. Lep
ob/ob
 mice show decreased Kiss1 
expression, while central administration of leptin increases kisspeptin mRNA (32-33). 
Although the expression of LepR in kisspeptin neurons has been a topic of debate, recent 
work has shown that very few ARC KNDy neurons express LepRb and directly respond 
to leptin (by activation of signal transducer and activator of transcription (STAT) 3)(34), 
suggesting that leptin’s influence on kisspeptin may be indirect via inputs from afferent 
leptin-sensitive neurons. The appetite stimulatory and inhibitory neurons of the ARC, 
agouti-related peptide (AgRP) and proopiomelanocortin (POMC) neurons, respectively, 
are key targets of leptin as they express high affinity leptin receptors (18, 35). Moreover, 
direct synaptic connections exist between the ARC KNDy neurons and AgRP and POMC 
neurons (36-37). In this study, we determined which neuronal populations in the sheep 
hypothalamus are directly activated by leptin by examining phosphorylation of STAT3 
(pSTAT3) expression, a direct consequence of the binding of leptin to its receptor. In 
addition, we examined induction of the immediate early gene product, cFos, as a general 
marker of neuronal activation in the same animals.  In conjuncture with our previous 
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findings (38), our goal was to characterize direct and indirect leptin signalling in the ewe 
brain within neurons implicated in metabolism and reproduction, and by doing so 
delineate the neural pathways by which leptin may regulate GnRH secretion in this 
species.   
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5.3 Materials and Methods 
5.3.1 Animals and experimental groups 
Adult Suffolk ewes (2.5-3 years of age) were cared for at the University of Michigan 
Sheep Research Facility (Ann Arbor, MI). Details of housing and nutrition have 
previously been described (39-41). For this experiment, the animals were ovary intact and 
sacrificed during the anestrous season. Twenty-four hours before sacrifice animals were 
placed off-feed. Two hours prior to sacrifice, sheep were administered peripheral 
injections (i.v.) of leptin (0.8ml/mg in 15mM HCl and 7.5mM NaOH (pH 5.2) human 
recombinant leptin, Sigma-Alderich catalogue # L4146; n=4). Control ewes received i.v. 
injection of vehicle (0.5 ml HCl and 0.3 ml NaOH; n=1) or no injection (n=3). To 
examine the effects of short-term food restriction on neuronal activity in the brain, an 
additional control group of animals was added, which was provided ad-libitum food up to 
the time of sacrifice.   
5.3.2 Tissue Collection 
At time of tissue collection, all ewes received two intravenous injections (at 10 min 
intervals) of 25,000 U heparin (Abraxiz Pharmaceuticals). Ewes were heavily 
anaesthetized intravenously with sodium pentobarbital (390 mg/ml/kg; Fatal Plus, 
Vortech, Dearborn, MI) and killed by rapid decapitation. Ewe heads were perfused 
through the internal carotid artery with 6L 4% paraformaldehyde (Sigma-Alderich) 
dissolved in 0.1M sodium phosphate buffer (PB; Sigma-Alderich) containing 0.1% 
sodium nitrate (Sigma-Alderich). Brains were submerged in the same fixative at 4 
degrees C for 18hr. Blocks of tissue containing hypothalami were then kept in 30% 
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sucrose (Caledon) at 4C and sectioned coronally using a freezing microtome (Microm, 
ctioned tissues 
were stored in cryoprotectant (30% ethylene glycol, 0.1% sodium azide, 30% sucrose in 
PB) at -20C until further processing. 
5.3.3 Dual-label immunoperoxidase staining: GnRH, Kisspeptin, POMC, or 
AgRP with pSTAT3 or cFos 
Series of every six section through the hypothalamus of each animal were processed 
using immunohistochemistry. All incubations occurred at room temperature with gentle 
agitation. Free floating sections were rinsed thoroughly with 0.1 M sodium phosphate-
buffered saline (PBS) between incubations. Tissue was incubated in 100% methanol (10 
min; Caledon) and 30% H2O2 (10 min; Fisher Scientific), then blocked for an hour in 
incubation solution (PBS containing 0.4% Triton-X (Fisher Scientific) containing 4% 
normal goat serum (NGS, Jackson ImmunoResearch, West Grove, PA, USA). Sections 
were incubated overnight (17 hours) with antibody specifically recognizing pSTAT3 
(raised in rabbit, 1:100 in incubation solution; Cell Signaling, Danvers, MA) or cFos 
(raised in rabbit, 1:1000, in incubation solution, Santa Cruz SC-52), with biotinylated 
goat anti-rabbit (1:250 in incubation solution with 4% NGS, 1 hour, Vector 
Laboratories), ABC-elite (1:250 in PBS, 1 hour, Vector Laboratories). Nuclear pSTAT3 
staining was visualized with 0.02% 3, 3’-diaminobenzidine tetrahydrochloride (DAB, 
Sigma-Alderich) with 0.08% nickel sulfate (10 min; diluted in PB containing 0.012% 
H2O2). Finally, sections were incubated overnight with antibody specifically recognizing 
POMC (raised in rabbit, 1:120,000 in incubation solution with 4% NGS, Phoenix 
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Pharmaceuticals, catalogue # H-029-30), AgRP (raised in guinea pig, 1:5000, incubation 
solution with 4% NGS, Antibodies Australia, C-GPAAGRP), kisspeptin (raised in rabbit, 
1:100,000 in MBH, 1:20,000 in POA, in incubation solution with 4% NGS, gift from Dr. 
Alan Caraty, France, #564), or GnRH (raised in mouse, 1:2000, in incubation solution 
with 4% NGS, Covance, city, state). Next, sections were incubated with biotinylated goat 
anti-rabbit (for POMC and Kisspeptin; 1:500 in incubation solution with 4% NGS, 1 
hour, Vector Laboratories) or biotinylated goat anti-rabbit (for GnRH; 1:300 in 
incubation solution with 4% NGS, 1 hour, Vector Laboratories), with ABC-elite (1:500 
in PBS, 1 hour, Vector) and with DAB to visualize reaction product (10 minutes, 0.02% 
diluted in PB containing 0.012% H2O2). Tissue sections were mounted onto 
Superfrost/Plus Microscope Slides (Fisher Scientific), dehydrated with alcohol and cover-
slipped with Depex Mountant (Electron Microscopy Sciences, Fort Washington, PA). 
Specificity of the primary antibodies for POMC, AgRP, kisspeptin, and GnRH has 
previously been demonstrated in sheep hypothalamic sections using preabsorption and 
omissions controls (42-44). Specificity of the pSTAT3 labeling was confirmed by 
preabsorption of the diluted antiserum with pSTAT3 immunizing peptide (Cell Signaling, 
catalogue # 1195) at concentration of 10μg/mL, for 24 h at 4° C; this procedure 
eliminated all labeling (Fig. A.2). 
5.3.4 Triple-label fluorescence staining: Kisspeptin, AgRP and POMC 
To confirm close contacts between kisspeptin, AgRP and POMC, triple label 
immunofluorescence was conducted on 3-5 tissue sections from the middle ARC. Briefly, 
to detect AgRP, tissue sections were incubated in guinea pig anti-AgRP serum (1:750; 
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Antibodies Australia, C-GPAAGRP; Lot-AS506) for 17 hr. AgRP was visualized with 
goat anti-guinea pig Alexa 488 (1:100; 30 min; Invitrogen, Carlsbad, CA). Next, tissue 
sections were incubated with polyclonal rabbit anti-kisspeptin-10 serum (1:200,000; gift 
from A. Caraty) for 17 hr. Next, kisspeptin was visualized by incubating sections with 
goat anti-rabbit (1:250; 1hr., Vector laboratories, Burlingame, CA), ABC (1:500; 1hr., 
Vector Laboratories, Burlingame, CA), biotinylated tyramide (TSA; 1:250; 10 min., 
diluted in PBS with 1 μl of 3% H2O2 per ml of total volume; PerkinElmer Life Sciences, 
Cat # NEL700A), and Alexa 555-conjugated streptavidin (1:100; 30 min; Jackson 
Immunoresearch Laboratories). Next, POMC was detected using rabbit anti-POMC 
(1:4000, catalog # H-029-30, Phoenix Pharmaceuticals, Burlingame, CA) for 17 hr. To 
visualize POMC, sections were incubated with donkey anti-rabbit Cy5 (1:100; 30 min; 
Jackson Immunoresearch Laboratories). Sections were mounted on gelatinized slides, 
dried and coverslipped with gelvatol. Specificity and validation of these antibodies in 
sheep tissues has been previously described (12, 44). Additional controls included 
omission of one of the primary antibodies from the protocol; this resulted in complete 
elimination of labelling for the corresponding antigen without any effect on the others. 
 
5.3.5 Analysis 
3-5 hemi-sections from each area of interest were quantitatively analyzed for 
colocalization of AgRP, POMC, kisspeptin and GnRH with pSTAT3 and cFos in leptin 
treated and control females. Single- and dual-labelled neurons were counted in the ARC 
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(AgRP, POMC, kisspeptin), POA (kisspeptin, GnRH), MBH (GnRH) and AHA (GnRH), 
and percent co-localization was determined.  
5.3.6 Quantitative analysis of pSTAT3 and cFos colocalization within GnRH 
neurons 
All GnRH neurons in POA, lateral hypothalamus (LH), anterior hypothalamic area 
(AHA), and MBH were analyzed for colocalization of pSTAT3 (already published (38)) 
and cFos using a LeicaDM5000B at 10-20x magnification. Percentages of GnRH neurons 
that co-expressed pSTAT3 and cFos were calculated for each brain region for each 
animal. Double-labeled neurons were defined as those in which a pSTAT or cFos-
positive nucleus was seen within an immunoreactive GnRH neuronal body, both viewed 
under the same plane of focus.  Comparisons between leptin-injected and control groups 
were conducted using ANOVA with 95% confidence levels. 
5.3.7 Quantification of pSTAT3 and cFos with kisspeptin, POMC and AgRP 
 For each animal (control n=3; leptin n=3), the numbers of kisspeptin, POMC, and AgRP-
ir neurons colocalizing pSTAT3 and cFos were counted in 3-5 hemi-sections taken from 
each of the rostral, middle, and caudal levels of the ARC, and in 3-5 sections through the 
POA, using Neurolucida software (Microbrightfield Inc., Williston, VT) attached to a 
motorized Leica DM5000B (Leica Microsystems,Wetzlar, Germany) microscope and 
Leica DFC420 camera. As for GnRH neurons, dual-labeled neurons were defined as 
those in which a pSTAT or cFos-positive nucleus was seen completely surrounded by 
kisspeptin-, POMC-, or AgRP-immunoreactive cytoplasm, when viewed under the same 
plane of focus. Percentages of kisspeptin, POMC, or AgRP neurons colocalizing pSTAT3 
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and cFos were calculated for each animal per brain area and/or per rostral-caudal level. In 
the ARC, effects of treatment and rostral-caudal level were analyzed using two-way 
ANOVA. In POA, treatment effects were analyzed using t-tests. 
5.3.8 Images  
All images were captured using Neurolucida software (Microbrightfield Inc.) attached to 
a motorized Leica DM5000B (Leica Microsystems) microscope and Leica DFC420 
camera. Figures were prepared using Adobe Photoshop CS2. Images were only adjusted 
for brightness and contrast, and not altered in any other way. 
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5.4 Results 
5.4.1 pSTAT3 colocalization within AgRP, POMC, kisspeptin and GnRH 
neurons 
Leptin-treated sheep showed pSTAT3 expression in a majority of AgRP (84% ±2.17) and 
POMC (30% ±2.33) neuron, By contrast, we failed to detect any pSTAT3 out of over 
1000 kisspeptin neurons examined in the ARC and POA, and similarly failed to see 
pSTAT3 in over 500 GnRH neurons examined, regardless of their location in the POA, 
AHA or MBH. In addition, control and vehicle-injected animals were devoid of pSTAT3 
staining in any hypothalamic region.   
5.4.2 Regional differences in pSTAT3 colocalization within POMC and AgRP 
neurons 
Within the ARC, there were significant differences in the percentage of pSTAT3/POMC 
colocalization depending on rostral-caudal level of the nucleus (F(2,17; p = 0.004). 
Specifically, we saw a higher degree of colocalization of pSTAT3/POMC in the rostral 
and middle ARC compared to the caudal ARC in leptin injected animals (p < 0.001 and 
0.002, respectively). By contrast, there were no significant regional differences among 
rostral-caudal levels of the ARC in percentage of pSTAT3/AgRP colocalization 
(p=0.675).  In addition, there were no differences in number of POMC-ir or AgRP-ir 
neurons between leptin and control groups.  
5.4.3 cFos colocalization within POMC, AgRP, and Kisspeptin Neurons 
Leptin induced cFos colocalization (e.g., Figs. 24 and 25) in a majority of ARC 
kisspeptin (70% ±6.68), POMC (92% ±1.82) and AgRP (88% ±0.72) neurons 
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(F(2,9):41.63-73.21, p<0.001), while fed control animals showed 1.6% ±0.78, 13.62% 
±4.96, and 5.66% ±0.78  level of cFos colocalization with kisspeptin, POMC and AgRP, 
respectively (Fig. 24). There were no significant differences between rostral, middle and 
caudal regions for any of the populations. Off-feed control females showed increased 
cFos co-localization in both AgRP (75% ±10.03) and ARC kisspeptin (26% ±5.27) 
neurons (p=0.021, p<0.001), but not POMC neurons. In contrast, leptin treatment or 
feeding state did not induce cFos colocalization with POA kisspeptin neurons and GnRH 
neurons. 
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 Figure 23. Mean (±SEM) percentage of A) kisspeptin B) AgRP and C) POMC cells colocalizing cFos 
in the arcuate nucleus in control fed (FED C), control off-feed (OFF-Feed C) and leptin treated 
females. * indicates significant difference from fed controls, # indicated significant difference from off-
feed controls. 
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Figure 24. Representative image of ARC KNDy neurons colocalized with cFOS in (A) Control 
FED, (B) Control OFF FEED and (C) Leptin treated females. Arrows indicate double labelled 
neurons. Scale bar is 20µm. 
 
 
 
 
 
 
AgRP Kiss 
(KNDy) 
Overlay 
Kiss (KNDy) AgRP Overlay 
 Figure 25. Confocal image showing close contacts between arcuate kisspeptin/KNDy (red) and AgRP 
(green) cells. Panel (1) shows AgRP close contacts on kisspeptin (KNDy) cell; and panel (2) shows 
Kisspeptin (KNDy) close contacts onto AgRP cell. Scale bar=10µm. 
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5.5 Discussion 
 
Findings from this study show that in the ewe, AgRP and POMC neurons are directly 
activated by leptin (as indicated by induction of pSTAT3 in these populations), while 
ARC kisspeptin neurons are indirectly activated by leptin (as indicated by induction of 
cFos in these neurons in the same animals). Moreover, we show that ARC kisspeptin and 
AgRP neurons are activated during states of negative energy balance. 
5.5.1 Leptin-induced activation of ARC kisspeptin, AgRP and POMC 
neurons 
Given the significant influence of leptin on the reproductive neuroendocrine system, it 
was of interest for us to examine kisspeptin neurons as potential targets of leptin 
signalling. It was recently shown that in the sheep, no GnRH neurons and <8% of ARC 
kisspeptin neurons are activated by leptin (as indicated by pSTAT3)(38). Indeed, it has 
been shown in other species that GnRH neurons do not colocalize the leptin receptor 
(17). Therefore, these results are consistent with the view that leptin’s influence on 
GnRH neuroendocrine secretion and the reproductive axis must be indirect via inputs 
from leptin-sensitive afferent neurons. The effects of leptin on kisspeptin neurons in the 
sheep differ from the data in the mouse, where 40% of kisspeptin neurons co-express 
LepRb (45), but consistent with transgenic mouse experiments that have shown only 5-
6% colocalization of kisspeptin with LepRb (46). In the present study, we show that 
leptin treatment induces a 40% increase in cFos colocalization with ARC kisspeptin 
neurons when compared to fed control females. This suggests a role for the ARC 
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kisspeptin neurons in metabolic homeostasis and is consistent with our hypothesis that 
kisspeptin neurons are activated by leptin, but this activation is indirect and mediated by 
upstream neurons.  
The ARC AgRP and POMC neurons (orexigenic and anorexigenic, respectively) have 
been proposed as one of the main targets of leptin’s actions (47-48). Indeed, leptin 
activates POMC (35) and inhibits AgRP neurons (49). In this study, we show that leptin 
induces pSTAT3 colocalization in ~30% of POMC neurons and ~84% of AgRP neurons, 
suggesting a direct action of leptin on these neurons. This activation was confirmed by 
cFos colocalization within 88% of AgRP and 92% of POMC neurons in the same 
animals. The difference in colocalization between pSTAT3 and cFos within the 
respective neuron populations may stem from various sources. One explanation may be 
that leptin treatment activates numerous neuronal populations throughout the ARC and 
other regions that may in turn activate a majority of both AgRP and POMC neurons. 
Leptin receptors are widespread throughout hypothalamic nuclei including the 
paraventricular, periventricular, and supraoptic nuclei (50). In the sheep, leptin induces 
pSTAT3 in the ventromedial and dorsomedial hypothalamus, as well as in the ARC (38). 
A recent study has shown that leptin can act in the ventral tegmental area (VTA) to 
induce pSTAT3 expression in the MBH, suggesting an integrated leptin signaling 
pathway between these two regions (51). Moreover, the ventral premammillary nucleus 
has been linked to fasting-induced changes in leptin levels that regulate luteinizing 
hormone secretion (52-53). Therefore, leptin targets neurons in multiple areas in the 
brain, and it is likely that these multiple populations act in concert with each other; 
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however the specific role(s) played by each in the pathways by which leptin influences 
the reproductive axis merits further investigation. 
5.5.2 Effects of metabolic state on AgRP and POMC activation ? 
In this study we show that a 24 hours food restriction increases cFos expression within 
AgRP, but not POMC neurons, suggesting an activation of the orexigenic pathway 
induced by a state of low energy balance. This is consistent with previous findings 
showing that nutritional status can modulate AgRP and POMC activity; AgRP activity is 
increased after a period of fasting (54-56), while POMC activity is increased during 
satiety or refeeding after a period of fasting (57). This nutritional information can be 
relayed to the kisspeptin neurons and the reproductive axis via direct connections from 
both AgRP (Fig. 26) and POMC neurons (unpublished data) and vice versa (58-59). 
Another possibility is that AgRP and POMC directly modulate GnRH secretion. Direct 
contacts from both POMC (60) and NPY (colocalized with AgRP) (61-63) neurons to 
GnRH have been previously described in rodents and sheep as well as the effects of these 
neuropeptides on GnRH neuron excitability (64-65). Although this is a possibility, the 
increased cFos colocalization we observed within ARC kisspeptin neurons in leptin-
injected ewes suggests that projections from this subpopulation to GnRH neurons (66) 
play a role in relaying metabolic information as well.  
5.5.3 Effects of metabolic state on kisspeptin activation 
A 24 hour off-feed regimen resulted in a >25% induction of cFos colocalization with 
ARC kisspeptin neurons when compared with fed control females. This suggests that 
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ARC kisspeptin neurons are activated during states of negative energy balance and may 
participate in the control of metabolic homeostasis. Studies in rodents (66-67) and 
primates (68) have shown that food deprivation reduces Kiss-1 mRNA immunoreactivity. 
However, we observed no differences in the numbers of kisspeptin immunoreactive 
neurons between fed and off-feed controls. Although changes in peptide expression do 
not always parallel changes in activation, our results showing an increase in cFos 
colocalization with ARC kisspeptin neurons were different than what has been previously 
noted in the literature. Future experiments will determine whether the other two 
neuropeptides co-expressed with kisspeptin in the ovine ARC (NKB and dynorphin) are 
altered by short-term food deprivation. In mice, short-term fasting (48 hrs.) decreases 
Kiss-1 and Tac2 mRNA during puberty (69), suggesting that regulation of NKB is 
closely linked to that of kisspeptin. The orexigenic neuropeptide dynorphin (70), 
however, appears to be regulated differently. Pre-prodynorphin mRNA is significantly 
increased after a 24 hour fast in areas of the hypothalamus involved in energy 
homeostasis (71-72). Moreover, there is evidence that dynorphin may mediate the 
orexigenic effects of NPY in rodents (73). In addition, selective blockade of kappa-opioid 
receptors (the primary receptor for dynorphin) significantly reduces fasting-induced 
hyperphagia in rats (74) and reduces food intake and body weight in obese rodent models 
(75-76). As such, an increase in cFos with kisspeptin/KNDy neurons may reflect an 
increase in dynorphin activation.  It is also conceivable that there is increased influence 
of melanocortins during the anestrous season and this is causing an increase in 
kisspeptin/KNDy neuronal activation. In fact, POMC mRNA is increased in anestrous 
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ewes (77) and melanocortins stimulate the reproductive axis (78-79), providing a 
mechanism where an increase in POMC activation can induce an increase in kisspeptin 
activation.  
It is probable that differences in digestive systems (polygastric/ruminant vs. monogastric) 
could account for some inconsistencies among similar studies examining the activity of 
ARC kisspeptin neurons following food restriction (increased vs. decreased expression). 
Indeed, monogastrics (rats and primates) are more acutely responsive to short-term 
changes in dietary energy intake than ruminants. For example, both chronic under-
nutrition and acute fasting result in a rapid suppression of the GnRH system and a 
cessation of LH pulsatility in monogastrics (80). Nonetheless, LH pulsatility can be 
inhibited when prepubertal heifers (81) and rams (82) are made hypoglycemic under 
short term fasting conditions. Moreover, mature cows show metabolic responses to acute 
feed deprivation such decreased leptin mRNA transcription in adipose tissue and 
decreased plasma concentrations of leptin and insulin, but no reduction in pulsatile 
secretion of LH (83). 
 
5.5.4 Conclusion 
In the present study we show that leptin treatment directly activates the AgRP and POMC 
neurons and indirectly activates the kisspeptin neurons in the arcuate nucleus of the 
sheep. We also show that short term food deprivation activates the ARC kisspeptin 
(KNDy) neurons, possibly implicating this population in metabolic control of 
reproductive function. As such, we propose that leptin’s influence on the reproductive 
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axis and GnRH secretion involves a pathway comprised of arcuate AgRP and POMC 
neurons as well as KNDy neurons. Also important to note is that the activation of KNDy 
neurons appears to be biphasic in response to energy balance. That is, both negative 
energy balance (short term food restriction) and positive energy balance (leptin) induce 
activation (cFos) of KNDy neurons. Considering the crucial role that these neurons play 
within the reproductive axis, it is tempting to speculate that this type of biphasic activity 
pattern plays an important role in the inhibition of reproductive function during times 
when energy levels are not ideal. Nevertheless, it is evident that the reproductive and 
metabolic axes are tightly linked and may involve many intermediary neuronal 
populations, one of which appears to be the KNDy neurons. Furthermore the leptin 
signalling pathway within the arcuate nucleus is complex and may involve the 
contribution of additional metabolic signals. Understanding the neural circuitry involved 
in this pathway and the neuronal populations that could be involved in this process  
remains to be answered in future studies.  
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Appendices:  
 
Appendix 2. Antibody Controls  
The specificity of the antibody used for pSTAT3 was verified by preabsorption of the 
diluted primary antibody (1:100) with immunizing peptide (Cell Signaling) at a 
concentration 5g/ml (Fig. 26), which effectively eliminated all nuclear immunostaining.  
 
 
Figure 26. pSTAT3 immunoreactivity in the ovine ARC of a leptin-injected ewe (A) and 
following preabsorption of the diluted antibody with the peptide antigen at a concentration of 
5µg/ml (B). Scale bar = 100µm. 
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Chapter 6: Discussion 
 
For this dissertation, I successfully completed a collection of studies to examine the 
effects of prenatal exposure to testosterone (T) on hypothalamic neurons involved in the 
regulation of the reproductive and metabolic functions in the sheep.  
6.1 Overview 
Throughout these studies, I examined the effects of prenatal T treatment on androgen 
receptor (AR) and insulin receptor (IR) expression with the reproductive and metabolic 
neurons of the hypothalamus, the ARC KNDy, AgRP and POMC neurons, the POA 
kisspeptin neurons, and the GnRH neurons. I showed that prenatal T treatment increases 
AR-immunoreactivity (ir) in the ARC and POA as well as colocalization of AR with 
KNDy and AgRP and POA kisspeptin neurons. In addition, prenatal T treatment 
decreases IR colocalization with KNDy and AgRP neurons, but not POMC neurons, 
while POA kisspeptin and GnRH neurons do not colocalize IR.  I also showed that 
prenatal, but not postnatal, interventions blocking androgen action or increasing insulin 
sensitivity can prevent the prenatal T induced alterations in KNDy and AgRP neurons. 
Lastly, I showed that leptin indirectly activates KNDy neurons through a pathway that 
may include the leptin-sensitive AgRP and POMC neurons. Overall, these results indicate 
that prenatal exposure to T increases androgen sensitivity and decreases insulin 
sensitivity in the reproductive and metabolic neurons of the ARC and highlights the 
importance of prenatal interventions in preventing these effects. These changes may 
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contribute the reproductive and metabolic dysfunctions associated with the PCOS 
phenotype.  
6.2 Effects of Prenatal T treatment on AR-ir in the brain 
In the sheep, measuring testosterone levels has proved to be challenging due to the lack 
of sensitive assays available (Padmanabhan, observation). Moreover, It has been 
proposed that total serum testosterone measurements are unreliable in screening to detect 
the presence of hyperandrogenemia (1). As such, examining AR-immunoreactivity in the 
brain provides us with a measure of functional hyperandrogenemia in the adult sheep. 
The findings of this study reveal that adult females, prenatally exposed to T show an 
increased number of AR-ir neurons in the POA and ARC as well as increased AR-ir in 
ARC and POA kisspeptin and ARC AgRP neurons.  This increase in AR-ir appears to be 
programmed by the androgenic action of T, as prenatal treatment with DHT mimics the 
effects of T while prenatal co-treatment with androgen antagonist (TF) bocks these 
effects. These sex differences, along with the effects of prenatal T treatment suggest a 
prenatal masculinization of the female brain by testosterone, which then influences 
reproductive and metabolic neuroendocrine function and behavior in adulthood.  
6.2.1 Does increased AR-immunoreactivity reflect organizational or 
activational effects of testosterone?  
Treatment of the pregnant mother with testosterone (T) from days 30–90 of gestation 
increases fetal exposure to androgens as well estrogens (2).  As such, it is reasonable to 
propose an organizational role for testosterone, possibly laying the framework for 
dysfunction in reproductive and metabolic function during adulthood. Although 
168 
 
measuring T levels in adult female sheep is problematic, it is reasonable to postulate that 
early life alterations in neuroendocrine function and masculinization of various systems 
may be maintained by high levels of circulating T.  
Although control rams displayed the highest AR-ir in all brain areas analyzed, castrated 
rams had comparable or lower numbers of AR-ir neurons than control ewes. It is difficult 
to say whether the increase in AR-ir that we observed in the adult sheep brain is an 
indication of higher circulating androgens or an organizational effect of exposure to T. 
Prenatal T treated ewes and controls were ovariectomized, removing the main source of 
androgens (3). However, when compared with castrated males, who were exposed to high 
T levels during gestations, prenatal T treated ewes displayed higher AR-ir in the brain. 
This suggests a few possibilities: 1) an activational effect of androgens in prenatal T 
treated females stemming from an adrenal source (4) (which has been shown to be higher 
in females than males, albeit during fetal life) (5) or from local biosynthesis of 
neurosteroids in the brain (6), or 2) an organizational effect of testosterone that is more 
pronounced in the female, rendering them more sensitive to circulating androgens, or 3) a 
combination of these factors. Regardless, we cannot dismiss a role for the adrenal glands 
in the contribution of androgens, an influence that is significantly increased in prenatal T 
treated sheep (4) and primates (7-8) as well as women with PCOS (9-11). However, 
adrenalectomy is not feasible in our current sheep model, leaving this question to be 
addressed in other animal models. Future studies could also address the activational 
effects of testosterone by exogenous administration of androgens during adulthood and 
examining AR-ir in the brain. Comparing females treated with T during adulthood with 
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ovariectomized prenatal T treated females might be useful to help determine whether 
organizational/permanent or activational/transient are responsible for increased AR-
immunoreactivity in the brain.  
6.2.2 How does functional hyperandrogenemia contribute to the PCOS 
phenotype in prenatal T treated sheep? 
Hyperandrogenism is one of the most common PCOS traits. We show that prenatal T 
treated sheep display functional hyperandrogenemia, manifested as an increase in AR-ir 
during adulthood, suggesting a masculinization of the brain. Functional 
hyperandrogenemia has also been shown at the level of the ovaries and adrenals in 
prenatal T treated sheep (12-13) and monkeys (8, 14). This masculinization, although not 
as pronounced as in the ram, likely influences reproductive, metabolic functions and 
social behaviours. Indeed, prenatal T treated ewes display masculinized modes of tonic 
and surge secretion of LH (15-16) and masculinized social behaviours (17). In support of 
this, androgens have been shown to inhibit the negative feedback effects of estrogen and 
progesterone on pulsatile LH secretions (18).  
6.2.3 Linking hyperandrogenemia and hyperinsulinemia 
Adult prenatal T treated sheep are hyperinsulinemic due to metabolic disruptions which 
result in decreased insulin sensitivity (19-22). Hyperinsulinemia exacerbates 
hyperandrogenemia by acting together with elevated LH to increase androgen production 
in theca cells of the ovary (23-26). Insulin can also suppress sex hormone binding 
globulin (SHBG) produced by the liver, resulting in an increase in unbound plasma 
testosterone (27). Moreover, weight gain can contribute to the increase in circulating 
170 
 
androgens. Human adipose tissue can synthesize androgens by means of 17β-hydroxy 
steroid dehydrogenase (17βHSD), an enzyme found in the liver, skin, and adipose tissue 
that catalyzes the conversion of Androstenedione (A) to T (28). This enzyme has been 
shown to have increased expression in obese women (29).  
 
The insulin-androgen feedback loop has also been shown to work the opposite way, 
where increased androgens promote hyperinsulinemia. For example, pregnant ewes 
treated bi-weekly with T show an increase in circulating insulin levels, which is believed 
to be a direct effect of testosterone (Abi Salloum, B. and V. Padmanabhan, unpublished 
data). Thus, the positive feedback loop between hyperinsulinemia and 
hyperandrogenemia may contribute to the propagation of the PCOS phenotype and 
increases its severity over time. This is reinforced by the studies showing improvements 
in hyperandrogenemia and ovulatory function with treatments that decrease insulin levels 
or improve insulin signalling (30-33). Nevertheless, the relationship between 
hyperinsulinemia and hyperandrogenism is complex and requires further investigation in 
the context of metabolic and reproductive function.  
6.2.4 Evidence for androgen-dependent mechanisms regulating kisspeptin 
and AgRP activity? 
The ARC kisspeptin subpopulation (also known as the KNDy neurons) play an important 
role in regulating pulsatile and surge secretion of GnRH, while POA kisspeptin neurons 
are activated only during the GnRH surge (34-37). Prenatal T treated ewes display 
increased GnRH pulse frequency and a dampened and delayed GnRH surge, effects 
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which may be due to alterations within KNDy neurons. As such, an increase in AR-ir in 
these neurons, rendering them more sensitive to androgens, may impact GnRH secretion 
and subsequently, reproductive function. In the male mouse, testosterone acts through 
both AR and estrogen receptor alpha (ERα) to inhibit kisspeptin (Kiss1) (38) and 
Dynorphin (Pdyn) expression (39) in KNDy neurons. However, in the rostral kisspeptin 
population, which includes the anteroventral periventricular nucleus (AVPV), T 
stimulates the expression of Kiss1 mRNA (39). These findings suggest that kisspeptin 
neurons are direct targets for T, which likely plays a role in mediating both pulsatile and 
surge mechanisms of GnRH secretion. Furthermore, Navarro et al. (2011) showed that 
sham-treated AR knock-out (KO) mice had higher levels of Kiss1, Tac2 (NKB), and 
Pdyn (Dynorphin) mRNA in the ARC compared to wild-type (WT) controls, suggesting 
that androgens are important during the developmental period of KNDy neurons (40), 
possibly regulating peptide expression during this sensitive period (41). Previous work 
from our lab has shown that prenatal T treated ewes show a peptide imbalance in KNDY 
neurons, with a reduction in dynorphin and NKB expression, but not kisspeptin (42). 
Unpublished data from our lab indicates that prenatal co-treatment with Flutamide (F, 
androgen blocker) largely reverses the effects of prenatal T on NKB and dynorphin, 
suggesting that this peptide imbalance is largely organized by the androgenic actions of T 
(Lehman, unpublished) and these alterations are sustained into adulthood. 
 
The increase in AR colocalization within AgRP neurons suggests a means through which 
testosterone may act to modulate peptide expression in this ARC population as well. As 
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previously discussed, prenatal T treated ewes show an increase in the number of 
immunoreactive AgRP neurons compared to control ewes (43) and decreased 
colocalization with insulin receptor (IR) (44). Prenatal co-treatment with Flutamide 
reverses these effects on AgRP peptide and IR colocalization, suggesting that these 
changes are organized by the androgenic actions of T (acting on AR) (43). The effects of 
T on this population have also been shown in rodents and sheep. In male sheep, NPY (an 
orexigenic neuropeptide which is largely co-localized with AgRP (43, 45-46)), 
expression is increased during a long-day (LD) photoperiod in a T-dependent manner 
(47). In castrated male rats, T replacement increases NPY mRNA, suggesting regulation 
of this peptide by testosterone (48). Regulation of NPY/AgRP has also been found in 
humans, where anti-androgen treatment in patients with prostate cancer decreases NPY 
levels (49). One possibility is that prenatal exposure to T increases AR colocalization 
with AgRP, and this change lays the framework for testosterone actions in adulthood 
altering AgRP immunoreactivity and IR colocalization in this population. This, in turn, 
may contribute to the insulin resistance and increased risk of obesity observed in the 
prenatal T sheep model (21-22).  
 
6.2.5 Significance and future studies 
Since androgen excess is one of the main features of PCOS, it was of great importance to 
determine whether our prenatal T treated sheep displayed hyperandrogenemia. Results 
presented in Chapter 2 are the first to show that, in the sheep, prenatal T treatment results 
in functional hyperandrogenism at the level of the brain. Although we showed that 
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prenatal T treatment increases AR-ir in areas of the ewe brain that are critical for control 
of reproductive and metabolic functions as well as sexual behavior, the mechanism by 
which prenatal T alters postnatal development of these systems is not yet known. One 
possibility is that prenatal T masculinizes the female brain, rendering it more sensitive to 
circulating androgens and thus, altering control of neuroendocrine function in the adult 
female. Prenatal T exposure could also lead to abnormal programming of androgen 
producing tissues, such as the ovaries and adrenals, resulting in increased circulating 
androgens. Therefore, the increased AR-ir seen in the prenatal T females could be a 
programmed prenatal effect or it could be a reflection of high levels of circulating 
androgens, or a combination of both factors. Because our animals are ovariectomized and 
estradiol replaced, we can exclude androgen contribution from the ovaries; however 
excess androgen production by the adrenals may be a contributing factor to high 
circulating levels of T.  Future studies will aim to determine whether prenatal or postnatal 
androgens induce an increase in AR-ir in the brain. It would also be of interest to 
examine AR-ir in the sheep brain at major developmental stages, including during the 
prenatal and prepubertal period, with the goal to identify additional stages of brain 
organization and timepoints for interventions with anti-androgen treatments.   
 
6.3 Effects of prenatal T treatment on IR colocalization with KNDy and 
AgRP neurons 
Insulin serves as a signal between the metabolic and reproductive systems, 
communicating energy availability to the hypothalamus and thereby affecting 
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reproductive mechanisms. Prenatal T treated sheep display insulin resistance and 
hyperinsulinemia, factors which may contribute to the reproductive and metabolic 
dysfunctions seen in these females. In experiments of Chapter 3, we found that 1) ARC 
KNDy, AgRP and POMC, but not POA kisspeptin or GnRH neurons colocalize insulin 
receptor (IR), 2) prenatal T treatment reduces IR colocalization with KNDy and AgRP 
neurons and 3) this effect is blocked by prenatal T co-treatment with anti-androgen, but 
only in the AgRP population. Hence, different mechanisms are involved in the 
organization of IR in the two different neuronal populations, AgRP and KNDy neurons, 
via androgenic and estrogenic actions of T, respectively.   
 
6.3.1 What is the functional impact of the decrease in IR colocalization within 
KNDy and AgRP neurons?  
Prenatal T treated ewes show evident insulin resistance and hyperinsulinemia (21-22), as 
well as other reproductive and metabolic dysfunctions, similar to those seen in women 
with polycystic ovarian syndrome (PCOS). Together, infertility and insulin resistance are 
a major concern in women with PCOS and are exacerbated by excess weight (30, 50-52). 
The decrease in IR colocalization with the KNDy and AgRP neurons renders these 
populations less responsive to insulin signaling and in turn, may affect multiple systems 
which rely on this communication. For example, insulin signaling is important in the 
initiation of puberty and maintenance of normal reproductive function. As such, women 
with type I diabetes have an increased risk for reproductive dysfunctions and delayed 
puberty (53). Clinical research suggests that these reproductive disruptions may stem 
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from abnormalities in the GnRH pulse generator and not at the level of the pituitary (53). 
Recent findings from studies of transgenic mice reveal that cell-specific deletion of 
insulin receptors from kisspeptin neurons caused a delay in onset of puberty, but did not 
affect adult fertility (54).  Moreover, male and female mice with GnRH specific IR 
deletion display normal pubertal timing and fertility (55). These studies suggest that IR 
expression with kisspeptin or GnRH neurons is not essential for the maintenance of 
reproductive function in mice; however IR expression with kisspeptin plays a critical role 
in the initiation of puberty. Nevertheless, a role for insulin signalling in the regulation of 
GnRH secretion cannot be dismissed. For example, diabetic sheep with low peripheral 
insulin, display increased pulsatile LH secretion following central insulin 
supplementation (56). As such, insulin regulation of GnRH secretion may involve other 
insulin-responsive sets of neurons, such as AgRP (57-58) and POMC (59-60), which 
have been shown to influence GnRH activity. Additional studies are required to 
investigate the role of these populations in conveying insulin signals to the GnRH neuron.   
As a future direction, it would be of interest to examine the role of IR expression with 
KNDy as it pertains to the onset of puberty in the sheep. The role of NKB and kisspeptin 
in the initiation of female puberty has received considerable attention (61-63) and may 
involve the conversion of multiple signals, including insulin.  The group of females 
analyzed in our study (ovary intact up to 2 years of age, then OVX) do not present 
alterations in the onset of puberty (64); however, prenatal T treated sheep that have been 
OVX and E-replaced shortly after birth display advanced puberty onset (65).  Future 
studies might compare IR/KNDy colocalization between the OVX+E replaced and ovary 
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intact sheep models and in prenatal T females co-treated with insulin sensitizer. The 
OVX+E replaced prenatal T treated sheep may provide us with a model for studying 
pubertal onset in PCOS, as premature puberty is the earliest manifestation of this disorder 
(66-67). 
The significant but relatively modest decrease in insulin receptor colocalization within 
AgRP neurons suggests that other aspects of the insulin signaling pathway may mediate 
the dramatic increase in AgRP peptide expression seen in this animal model. In addition 
to alterations in IR at the level of the brain, prenatal T treated sheep also show decreased 
IR in the liver (68). Considering the modest decrease in IR colocalization with AgRP in 
these animals, it is unlikely that the reduced IR in the liver is a direct result of central IR 
decrease. Nonetheless, this provides us with a peripheral component of insulin signalling 
that is also altered by prenatal T treatment and together, these prenatal T induced changes 
may contribute to the insulin resistance in this animal model. In transgenic mice where IR 
are specifically knocked out of AgRP neurons, hepatic glucose production is increased in 
response to insulin (69). When IR is restored in these neurons, hepatic glucose production 
is decreased in response to insulin (70), suggesting that coexpression of IR with AgRP 
neurons in mice is an important modulator of hepatic glucose production. It is also 
possible that downstream signaling molecules in the insulin receptor pathway are altered 
by prenatal T treatment. In addition to decreased IR expression in the liver, prenatal T 
treated sheep show a decrease in IRS-II, AKt, mTOR, PPAR-γ mRNAs in this organ, all 
important components of the insulin pathway (68). Investigating the downstream insulin 
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signaling pathway in AgRP/NPY neurons would be beneficial to further understanding 
the insulin resistance in the brain conferred by excess prenatal testosterone exposure.  
6.3.2 What is the significance of the absence of IR from POA kisspeptin and 
GnRH neurons? 
In the sheep, colocalization of IR with GnRH has not been previously examined. Our 
results show that GnRH neurons in the POA, AHA or MBH do not colocalize IRβ. This 
results is in contrast to data in the mouse where insulin may regulate reproductive 
function by directly stimulating GnRH gene expression (71).  Thus, insulin signaling to 
GnRH neurons in the sheep likely involves inputs from afferent insulin sensitive neurons. 
Similarly, we showed that IR is not colocalized with POA kisspeptin neurons, further 
distinguishing this population of kisspeptin neurons from the ARC KNDy population. 
There are several other marked differences between the POA and ARC kisspeptin 
populations, which are consistent with their functions. Unlike the POA neurons, the ARC 
kisspeptin neurons (KNDy) are glutamatergic and co-express two other neuropeptides-
dynorphin and NKB (36), each playing a different role in the regulation of GnRH pulses 
(34).  Within the ARC, KNDy neurons also lie in close anatomical proximity to AgRP 
and POMC neurons, and direct connections between these three populations have been 
described (72-74). Differences between ARC and POA kisspeptin neurons have also been 
noted in their activation by insulin. In the sheep, a bolus injection of insulin (4 IU/Kg) 
during late follicular phase induces cFos activation in ARC, but not POA, kisspeptin 
neurons (Fergani, C. et al. in press). As such, the KNDy neurons are well suited to act as 
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a mediator by which insulin can influence the reproductive neuroendocrine function and 
regulate GnRH secretion.   
6.3.3  Significance and future studies 
This group of experiments reveals that at the level of the brain, insulin receptor 
colocalization within reproductive (KNDy) and metabolic (AgRP) neurons is decreased 
as a result of prenatal T treatment. A reduction in insulin sensitivity in these neurons may 
contribute to insulin resistance and hyperinsulinemia in the prenatal T sheep model and 
may subsequently influence reproductive function during adulthood. In addition to 
changes at the level of the brain, it has previously been shown that prenatal T treatment 
results in decreased IR in the liver and muscle (68), which also contributes to peripheral 
insulin resistance. Considering the strong link between insulin resistance, obesity and 
reproductive dysfunction (75-76), it is reasonable to speculate that a combination of 
decreased insulin sensitivity at the level of the brain and periphery contributes to the 
metabolic and reproductive dysfunctions seen in prenatal T sheep and, by inference, in 
women with PCOS. Because sheep in the present study are on a maintenance diet, normal 
body weight is sustained with no differences between control and prenatal T females. It 
would be of interest to examine IR expression with AgRP and KNDy neurons in the diet-
induced obesity prenatal T sheep model to determine if changes in IR expression with 
these neuropeptides are associated with exacerbation of the metabolic and reproductive 
phenotype linked to obesity (21).  
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6.4 Effects of prenatal and postnatal interventions  
This set of experiments suggests a neuroendocrine basis for the beneficial effects of 
therapies that are already used in the treatment of women with PCOS. The anti-androgen 
Flutamide (F) and/or the insulin sensitizer, Rosiglitazone (R) are often used to alleviate 
symptoms associated with PCOS. We show that prenatal, but not postnatal, interventions 
with these therapies were able to block the effects of prenatal T on AR and IR 
colocalization with KNDy and AgRP neurons, and AgRP neuronal numbers.  
6.4.1 Effectiveness of prenatal and postnatal interventions with Flutamide or 
Rosiglitazone in blocking the effects of prenatal testosterone 
The ability of pre- but not post-natal interventions with insulin sensitizer to block the 
effects of prenatal T treatment on the IR and AR colocalization with KNDy and AgRP 
neurons suggests that the prenatal period may provide a critical time point to intervene 
and block the effects of prenatal T seen later during adulthood. Nonetheless, the postnatal 
period may also provide us with an additional period for effective intervention.  For 
example, postnatal treatment with the insulin sensitizer Rosiglitazone (R) has been shown 
to improve reproductive function in prenatal T treated sheep (77), reducing the 
deterioration in number of cycles from 80% to 20% in the second breeding season. In 
another study, postnatal treatment with F and R was able to reverse the effects of prenatal 
T on some aspects of the preovulatory LH surge (78). Prenatal T treated ewes that 
received postnatal F or R treatment (T+F or T+R) showed an increase in LH surge 
magnitude, which is typically dampened by prenatal T treatment (78). The timing of the 
surge, however was still delayed, suggesting that the prenatal and postnatal period of 
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development are important for the programming of different aspects of the LH surge 
mechanism (78).  
In women with PCOS, insulin sensitizers are commonly used to alleviate some of the 
symptoms associated with hyperinsulinemia and hyperandrogenemia (79-82). As such, it 
is surprising that postnatal treatment with R did not reverse the effects of prenatal T-
treatment on the KNDy and AgRP populations in our animals. It may be that the 
organization of IR and AR expression in these populations is important during the early 
stages of development in order to set the framework for reproductive and metabolic 
functions later in life. In this regard, it is interesting that although interventions with 
androgen antagonist (83), insulin sensitizer (84-86), or combined (87-88) are able to 
improve ovulation rate in subjects with PCOS, optimal success with pregnancy rate are 
yet to be realized. It is possible that postnatal interventions are able to alleviate some 
dysfunctions associated with PCOS; however some neuroendocrine mechanisms remain 
permanently altered by prenatal T treatment and set the critical parameters for successful 
reproductive and metabolic function to a higher level.  
6.4.2 Future studies 
The ability of prenatal treatment with insulin sensitizer to block the effects of prenatal T 
on IR colocalization within KNDy and AgRP neurons suggests that insulin signalling, 
whether occurring via a mechanism involving androgen signalling or alone, can program 
some parameters of the neuroendocrine axis in prenatal T treated sheep. For example, 
insulin has been shown to inhibit aromatase (an enzyme which converts maternal or fetal 
adrenal androgens to estrogens ) activity in human cytotrophoblasts (89-90). Therefore, 
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hyperinsulinemia in pregnant ewes treated with T or women with PCOS may increase the 
androgenic actions of testosterone to which the female fetus is exposed (91). Moreover, 
The ability of prenatal treatments with either insulin-sensitizer or anti-androgen to block 
the effect of prenatal T indicate that a common mediator involving both androgen and 
insulin signalling is responsible for the long-term alteration in the AgRP population. One 
possibility may be that a common downstream component in the androgen and insulin 
signalling cascades is altered by prenatal T exposure. One example is Foxo1, a 
transcription factor that plays a key role in insulin-mediated regulation of metabolism 
(92). Foxo1 upregulates IR and activates insulin signalling (93), while having an 
inhibitory effect on androgen induced AR signalling (94). Moreover, by blocking Foxo1 
inhibition of AR signalling, insulin can exert a stimulatory effect on AR (94). As such, 
alterations in Foxo1 activity can disrupt both androgen and insulin signalling. 
Nevertheless, the complex interactions between insulin and androgen signalling require 
further investigation. Future studies will examine alterations in insulin and androgen 
signalling components in order to define possible mediators which may simultaneously 
influence both signalling pathways. Moreover, future studies will combine prenatal and 
postnatal interventions targeted at blocking androgen action or increasing insulin 
sensitivity or both, as combined treatments have proven the most effective in improving 
ovulation rates and insulin sensitivity in women with PCOS (88).  
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6.5 Direct and indirect activation by leptin in the ARC 
Our lab has previously shown that in the sheep, leptin does not directly activate 
kisspeptin (ARC or POA) or GnRH neurons (95). However, leptin’s influence on GnRH 
secretion and reproductive function has been widely described (96-97). This set of 
experiments expands on the previous findings by showing that in the sheep, AgRP and 
POMC neurons are directly activated by leptin (as indicated by induction of pSTAT3 in 
these populations), while ARC kisspeptin neurons are indirectly activated by leptin (as 
indicated by induction of cFos in these neurons). Moreover, ARC kisspeptin and AgRP 
neurons are activated during states of negative energy balance. 
 
6.5.1 Leptin signalling pathways in the arcuate: communication between the 
ARC AgRP, POMC and KNDy neurons 
The KNDy, AgRP and POMC neurons form a complex network within the arcuate (72-
74, 98). POMC and NPY/AgRP neurons mediate a diverse range of leptin’s actions in 
metabolism (99-104) and several studies have identified these populations also as key 
players linking leptin action and reproduction. As such, leptin’s influence on reproductive 
function and GnRH secretion may involve a pathway that includes the metabolic AgRP 
and POMC neurons as well as the KNDy neurons (95). It has been previously shown that 
the melanocortins (POMC derivatives) communicate with kisspeptin to relay the 
stimulatory influence of leptin to the reproductive axis (59, 98). Conversely, NPY has 
been shown to have an inhibitory influence on reproductive function (105). AgRP 
administration or pharmacologic blockade of the melanocortin 4 receptor (MC4R) 
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dampens the LH surge in female rats (106-107) and suppressed pulsatile release of LH in 
ovariectomized rhesus monkeys (108). Nevertheless, the influence of POMC and 
AgRP/NPY on reproductive function merits further investigation. For example, humans 
with loss-of-function mutations of melanocortin signaling show no reproductive deficits 
(109-111). In addition, mice with specific deletion of LepRb from POMC neurons, AgRP 
neurons, or both, show no reproductive dysfunctions (112). Therefore, our findings can 
be explained in two ways: 1) there exist non- POMC, non-AGRP/NPY neurons that 
express LepRb in the ARC and contribute to the control of feeding and reproductive 
function; and/or 2) LepRb expressing neurons outside the ARC significantly contribute to 
leptin’s actions on feeding and reproduction. The identity of non-POMC, non-
AGRP/NPY leptin sensitive neurons in the ARC remains to be established; however there 
are numerous extra-ARC sites that contain leptin responsive neurons (113-115).  Leptin 
may influence kisspeptin activity via projections from adjacent nuclei. One example is 
the ventral premammillary nucleus (PMV), a hypothalamic neuronal group that has been 
shown to play a critical role in leptin’s action on reproductive control (95, 116-118). In 
the rat, the PMV houses a high density of LepRb expressing neurons (119-120), most of 
which have been shown to directly innervate GnRH neurons (118). It would be of interest 
to examine the role of the PMV in mediating leptin’s influence on reproductive function 
in the sheep, and specifically its role with the AgRP, POMC, KNDy signalling pathway.  
Although we are proposing a pathway that comprises of direct activation by leptin of 
AgRP and POMC, and subsequently KNDy and GnRH, we cannot rule out the possibility 
of direct modulation of GnRH by POMC and NPY neurons. In rodents, POMC and 
184 
 
AgRP/NPY fibers innervate GnRH neurons (60, 121-123) and can directly regulate 
GnRH neuronal excitability (58), providing a direct pathway through which metabolic 
signals can regulate reproductive function.  
6.5.2 Increased ARC kisspeptin (KNDy) neuronal activation after a short-
term food deprivation  
Studies have implicated kisspeptin in mediating nutritional control of reproduction. Food 
restriction in rodents (124-125) and primates (126) reduces kisspeptin expression and 
kisspeptin treatment alleviates undernutrition-induced delayed puberty in female rats 
(127). Thus, our results showing an increase in cFos colocalization within ARC 
kisspeptin neurons in food restricted ewes was unexpected. However, in the sheep, where 
the three KNDy neuropeptides (kisspeptin, NKB, dynorphin) are almost 100% 
colocalized (36), an increase in KNDy activation may reflect changes in any of the three 
neuropeptides. In mice, short-term fasting (48 hrs.) decreases Kiss1 and Tac2 mRNA 
during puberty (61), suggesting that regulation of NKB is closely linked to that of 
kisspeptin. However, the orexigenic neuropeptide dynorphin (128), appears to be 
regulated differently. Pre-prodynorphin mRNA is significantly increased after a 24 hour 
fast in areas of the hypothalamus involved in energy homeostasis (129-130). Moreover, 
there is evidence that dynorphin may mediate the orexigenic effects of NPY as selective 
blockade of kappa-opioid receptors (the primary receptor for dynorphin) reduces fasting-
induced hyperphagia in rats (131-132) as well as food intake and body weight in obese 
rodent models (133-134). Although the source dynorphin was not established, it is 
possible that an increase in cFos with KNDy neurons may reflect an increase in 
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dynorphin activity. Further experiments will address whether short-term fasting 
differentially alters neuropeptide expression within the ARC KNDy neurons. It would 
also be of interest to examine the effects of short-term or long-term fasting on KNDy 
neuropeptide expression in the diet induced obesity sheep model or prenatal T model. 
 
6.5.3 Importance of leptin in women’s reproductive health and evidence for 
dysfunctional leptin signaling in women with PCOS 
Obese individuals are hyperleptinemic and leptin resistant (135-136). Nonetheless, the 
exact effects of high leptin levels on reproductive activity in obesity are not well defined. 
Considering the high prevalence of obesity in women with PCOS (137), it is reasonable 
to assume that leptin signalling is an important component in this disease model and may 
provide us with a point of intervention to alleviate some symptoms of PCOS. However, 
studies linking leptin and PCOS have yielded controversial results. One study found that 
leptin levels are elevated in women with PCOS (138), but subsequent studies were not 
able to reproduce these findings, challenging the concept that changes in leptin levels 
might play a role in the etiology of PCOS (139-143).  
 
Leptin also plays an important role in the initiation of puberty (144-146). Premature or 
early puberty is one of the earliest indications of PCOS (66-67). As such, it would be 
beneficial to examine the role of leptin signalling in the onset of puberty in prenatal T 
treated ewes. It has been previously shown that the time of neuroendocrine puberty is 
sexually differentiated in sheep, with males displaying earlier onset of puberty (65, 147). 
186 
 
Moreover, Prenatal T exposure also alters the timing of puberty and this has been shown 
in female rats (148), guinea pigs (149), and primates (150). In sheep, prenatal T treatment 
advances the time of the pubertal LH rise in females to an age that is equivalent to the 
initiation of testicular activity in the male (65). However, this observation is only 
apparent in the ovariectomized (OVX) E-replaced sheep model (where E2 concentrations 
are sustained at physiological levels using a continuous release device from shortly after 
birth) and not in the ovary intact prenatal T ewe (64). Nevertheless, the OVX-E replaced 
prenatal T treated sheep may provide us with a model for studying the contributions of 
leptin signalling in pubertal onset in PCOS.  
 
6.6 Conclusions 
For this dissertation I described the effects of prenatal T treatment of the reproductive 
(KNDy) and metabolic (AgRP) control neurons of the ewe hypothalamus and showed 
that prenatal exposure to T permanently alters receptor (AR and IR) expression in these 
populations, rendering them hypersensitive to androgen signalling and hyposensitive 
sensitive to insulin signalling (Fig. 27). These alterations can be blocked if interventions 
with insulin sensitizers and androgen blockers are established during the prenatal period. 
Although postnatal treatments did not reverse the prenatal T induced effects on the 
KNDy and AgRP neurons, other studies have found promising result with these 
treatments. As such, it is likely that postnatal interventions are able to alleviate some 
dysfunctions associated with PCOS; however some neuroendocrine mechanisms remain 
permanently altered by prenatal T treatment and alter the critical parameters required for 
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normal reproductive and metabolic function. These findings suggest that disruptions in 
the prenatal organization of critical hypothalamic parameters result in alterations in the 
development of the reproductive and metabolic systems of the brain and contribute to the 
PCOS phenotype during adulthood. Nonetheless, more work is required to understand the 
complex mechanisms though which prenatal T programs reproductive and metabolic 
dysfunctions at the level of the brain and periphery. 
 
 
 
Figure 27. Schematic representation illustrating the organizational effects of excess prenatal 
Testosterone and Insulin exposure on androgen receptor (AR) and insulin receptor (IR) 
expression in arcuate (ARC) KNDy and AgRP neurons and the potential impact on adult 
reproductive and metabolic functions. 
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PCOS is a complex endocrine disorder in women and a major contributor to ovulatory 
dysfunction, infertility, obesity, type 2 diabetes mellitus, and cardiovascular disease 
(151). Despite its prevalence, the etiology of PCOS remains unclear. Contributions from 
prenatal/environmental or genetic factors may result in insulin resistance, abnormal 
steroidogenesis and hypothalamic–pituitary–ovarian dysregulation. Investigating the 
dysfunctions associated with PCOS can help us develop appropriate interventions 
administered at the correct time-point to prevent the onset of PCOS-related co-
morbidities. Our hope is that by identifying the basic mechanisms involved in the long 
term changes induced by prenatal T exposure, we will identify targets for clinical 
intervention at the level of the brain, as well as periphery. Future studies will aim to 
prevent and/or reduce the symptoms associated with PCOS as well as transgenerational 
susceptibility to this disorder by providing appropriate prenatal and postnatal treatments.  
 
 
 
 
 
 
 
 
 
 
 
189 
 
Discussion: References 
 
1. Jayagopal, V., Kilpatrick, E. S., Jennings, P. E., Hepburn, D. A., and Atkin, S. L. (2003) The 
Biological Variation of Testosterone and Sex Hormone-Binding Globulin (SHBG) in 
Polycystic Ovarian Syndrome: Implications for SHBG as a Surrogate Marker of Insulin 
Resistance, Journal of Clinical Endocrinology & Metabolism 88, 1528-1533. 
2. Veiga-Lopez, A., Steckler, T. L., Abbott, D. H., Welch, K. B., MohanKumar, P. S., Phillips, 
D. J., Refsal, K., and Padmanabhan, V. (2011) Developmental Programming: Impact of 
Excess Prenatal Testosterone on Intrauterine Fetal Endocrine Milieu and Growth in 
Sheep, Biology of reproduction 84, 87-96. 
3. Hogg, K., Young, J. M., Oliver, E. M., Souza, C. J., McNeilly, A. S., and Duncan, W. C. 
(2012) Enhanced Thecal Androgen Production Is Prenatally Programmed in an Ovine 
Model of Polycystic Ovary Syndrome, Endocrinology 153, 450-461. 
4. Hogg, K., Connolly, F., Rae, M.T., McNeilly, A.S., and Duncan, W.C. (2012) Increased 
Adult Adrenal Androgen Secretion Is Programmed by Increased Prenatal Testosterone 
Exposure in an Ovine Model of Polycystic Ovary Syndrome Endocr Rev. 33, SUN-32. 
5. Ayromlooi, J. a. E., W.B. (1978) Sex differences in fetal sheep adrenal steroidogenesis, 
Int J Gynaecol Obstet. 17, 3-5. 
6. Baulieu, E.-E., and Robel, P. (1990) Neurosteroids: A new brain function?, The Journal of 
steroid biochemistry and molecular biology 37, 395-403. 
7. Abbott, D. H., Zhou, R., Bird, I.M., Dumesic, D.A., and Conley, A.J. (2009) Fetal 
programming of adrenal androgen excess: lessons from a nonhuman primate model of 
polycystic ovary syndromeDavid H Endocr Dev. 13, 145–158. 
8. Zhou, R., Bird, I. M., Dumesic, D. A., and Abbott, D. H. (2005) Adrenal hyperandrogenism 
is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary 
syndrome, J Clin Endocrinol Metab 90, 6630-6637. 
9. Köşüş, N., Köşüş, A., Kamalak, Z., Hızlı, D., and Turhan, N. Ö. (2012) Impact of adrenal 
versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome, 
Gynecological Endocrinology 28, 611-614. 
10. Puurunen, J., Piltonen, T., Jaakkola, P., Ruokonen, A., Morin-Papunen, L., and 
Tapanainen, J. S. (2009) Adrenal Androgen Production Capacity Remains High up to 
Menopause in Women with Polycystic Ovary Syndrome, Journal of Clinical 
Endocrinology & Metabolism 94, 1973-1978. 
11. Cedars, M. I., Steingold, K.A., de Ziegler, D., Lapolt, P.S., Chang, R.J., and Judd, H.L. 
(1992) Long-term administration of gonadotropin-releasing hormone agonist and 
dexamethasone: assessment of the adrenal role in ovarian dysfunction, Fertil Steril. 57, 
495-500. 
12. West, C., Foster, D. L., Evans, N. P., Robinson, J., and Padmanabhan, V. (2001) Intra-
follicular activin availability is altered in prenatally-androgenized lambs, Mol Cell 
Endocrinol 185, 51-59. 
13. Ortega, H. H., Salvetti, N.R. and Padmanabhan, V. (2009) Developmental programming: 
prenatal androgen excess disrupts ovarian steroid receptor balance, Reproduction  137, 
865-877. 
190 
 
14. Abbott, D. H., Dumesic, D. A., Eisner, J. R., Colman, R. J., and Kemnitz, J. W. (1998) 
Insights into the development of polycystic ovary syndrome (PCOS) from studies of 
prenatally androgenized female rhesus monkeys, Trends Endocrinol Metab 9, 62-67. 
15. Wood, R. I., Mehta, V., Herbosa, C. G., and Foster, D. L. (1995) Prenatal testosterone 
differentially masculinizes tonic and surge modes of luteinizing hormone secretion in the 
developing sheep, Neuroendocrinology 62, 238-247. 
16. Masek, K. S., Wood, R. I., and Foster, D. L. (1999) Prenatal dihydrotestosterone 
differentially masculinizes tonic and surge modes of luteinizing hormone secretion in 
sheep, Endocrinology 140, 3459-3466. 
17. Roberts, E. K., Padmanabhan, V., and Lee, T. M. (2008) Differential Effects of Prenatal 
Testosterone Timing and Duration on Phenotypic and Behavioral Masculinization and 
Defeminization of Female Sheep, Biology of reproduction 79, 43-50. 
18. Eagleson, C. A., Gingrich, M. B., Pastor, C. L., Arora, T. K., Burt, C. M., Evans, W. S., and 
Marshall, J. C. (2000) Polycystic Ovarian Syndrome: Evidence that Flutamide Restores 
Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by 
Estradiol and Progesterone, Journal of Clinical Endocrinology & Metabolism 85, 4047-
4052. 
19. Nada, S. E., Thompson, R.C., and Padmanabhan, V. (2010) Developmental Programming: 
Differential Effects of Prenatal Testosterone Excess on Insulin Target Tissues, 
Endocrinology 151, 5165-5173. 
20. Ortega, H. H., Rey, F., Velazquez, M. M. L., and Padmanabhan, V. (2010) Developmental 
Programming: Effect of Prenatal Steroid Excess on Intraovarian Components of Insulin 
Signaling Pathway and Related Proteins in Sheep, Biology of reproduction 82, 1065-
1075. 
21. Padmanabhan, V., Veiga-Lopez, A., Abbott, D. H., Recabarren, S. E., and Herkimer, C. 
(2010) Developmental Programming: Impact of Prenatal Testosterone Excess and 
Postnatal Weight Gain on Insulin Sensitivity Index and Transfer of Traits to Offspring of 
Overweight Females, Endocrinology 151, 595-605. 
22. Recabarren, S. E., Padmanabhan, V., Codner, E., Lobos, A., Durán, C., Vidal, M., Foster, D. 
L., and Sir-Petermann, T. (2005) Postnatal developmental consequences of altered 
insulin sensitivity in female sheep treated prenatally with testosterone, American 
Journal of Physiology - Endocrinology And Metabolism 289, E801-E806. 
23. Nelson-Degrave, V. L., Wickenheisser, J. K., Hendricks, K. L., Asano, T., Fujishiro, M., 
Legro, R. S., Kimball, S. R., Strauss, J. F., 3rd, and McAllister, J. M. (2005) Alterations in 
mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in 
theca cells contribute to excessive androgen production in polycystic ovary syndrome, 
Mol Endocrinol 19, 379-390. 
24. Nestler, J. E., Jakubowicz, D. J., de Vargas, A. F., Brik, C., Quintero, N., and Medina, F. 
(1998) Insulin stimulates testosterone biosynthesis by human thecal cells from women 
with polycystic ovary syndrome by activating its own receptor and using inositolglycan 
mediators as the signal transduction system, J Clin Endocrinol Metab 83, 2001-2005. 
25. Willis, D., Mason, H., Gilling-Smith, C., and Franks, S. (1996) Modulation by insulin of 
follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells 
of normal and polycystic ovaries, J Clin Endocrinol Metab 81, 302-309. 
26. Tosi, F., Negri, C., Perrone, F., Dorizzi, R., Castello, R., Bonora, E., and Moghetti, P. (2012) 
Hyperinsulinemia Amplifies GnRH Agonist Stimulated Ovarian Steroid Secretion in 
191 
 
Women with Polycystic Ovary Syndrome, Journal of Clinical Endocrinology & Metabolism 
97, 1712-1719. 
27. Botwood, N., Hamilton-Fairley, D., Kiddy, D., Robinson, S., and Franks, S. (1995) Sex 
hormone-binding globulin and female reproductive function, J Steroid Biochem Mol Biol 
53, 529-531. 
28. Burger, H. G. (2002) Androgen production in women, Fertil Steril 77 Suppl 4, S3-5. 
29. Quinkler, M., Sinha, B., Tomlinson, J. W., Bujalska, I. J., Stewart, P. M., and Arlt, W. 
(2004) Androgen generation in adipose tissue in women with simple obesity--a site-
specific role for 17beta-hydroxysteroid dehydrogenase type 5, J Endocrinol 183, 331-
342. 
30. Dunaif, A. (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and 
implications for pathogenesis, Endocr Rev 18, 774-800. 
31. Poretsky, L., Glover, B., Laumas, V., Kalin, M. and Dunaif, A. . (1988) The effects of 
experimental hyperinsulinemia on steroid secretion, ovarian insulin binding, and ovarian 
insulin-like growth-factor I binding in the rat, Endocrinology 122, 581–585. 
32. Azziz, R., Ehrmann, D., Legro, R. S., Whitcomb, R. W., Hanley, R., Fereshetian, A. G., 
O’Keefe, M., Ghazzi, M. N., and Group, f. t. P. T. S. (2001) Troglitazone Improves 
Ovulation and Hirsutism in the Polycystic Ovary Syndrome: A Multicenter, Double Blind, 
Placebo-Controlled Trial, Journal of Clinical Endocrinology & Metabolism 86, 1626-1632. 
33. Baillargeon, J.-P., Jakubowicz, D. J., Iuorno, M. J., Jakubowicz, S., and Nestler, J. E. (2004) 
Effects of metformin and rosiglitazone, alone and in combination, in nonobese women 
with polycystic ovary syndrome and normal indices of insulin sensitivity, Fertility and 
Sterility 82, 893-902. 
34. Lehman, M. N., Coolen, L. M., and Goodman, R. L. (2010) Minireview: 
kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in 
the control of gonadotropin-releasing hormone secretion, Endocrinology 151, 3479-
3489. 
35. Lehman, M. N., Merkley, C. M., Coolen, L. M., and Goodman, R. L. (2010) Anatomy of the 
kisspeptin neural network in mammals, Brain Res 1364, 90-102. 
36. Goodman, R. L., Lehman, M. N., Smith, J. T., Coolen, L. M., de Oliveira, C. V., 
Jafarzadehshirazi, M. R., Pereira, A., Iqbal, J., Caraty, A., Ciofi, P., and Clarke, I. J. (2007) 
Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and 
neurokinin B, Endocrinology 148, 5752-5760. 
37. Smith, J. T., Li, Q., Yap, K. S., Shahab, M., Roseweir, A. K., Millar, R. P., and Clarke, I. J. 
(2011) Kisspeptin is essential for the full preovulatory LH surge and stimulates GnRH 
release from the isolated ovine median eminence, Endocrinology 152, 1001-1012. 
38. Smith, J. T., Dungan, H. M., Stoll, E. A., Gottsch, M. L., Braun, R. E., Eacker, S. M., Clifton, 
D. K., and Steiner, R. A. (2005) Differential regulation of KiSS-1 mRNA expression by sex 
steroids in the brain of the male mouse, Endocrinology 146, 2976-2984. 
39. Navarro, V. M., Gottsch, M. L., Wu, M., García-Galiano, D., Hobbs, S. J., Bosch, M. A., 
Pinilla, L., Clifton, D. K., Dearth, A., Ronnekleiv, O. K., Braun, R. E., Palmiter, R. D., Tena-
Sempere, M., Alreja, M., and Steiner, R. A. (2011) Regulation of NKB Pathways and Their 
Roles in the Control of Kiss1 Neurons in the Arcuate Nucleus of the Male Mouse, 
Endocrinology 152, 4265-4275. 
40. Ciofi, P., Lapirot, O. C., and Tramu, G. (2007) An androgen-dependent sexual 
dimorphism visible at puberty in the rat hypothalamus, Neuroscience 146, 630-642. 
192 
 
41. Estrada, M., Varshney, A., and Ehrlich, B. E. (2006) Elevated Testosterone Induces 
Apoptosis in Neuronal Cells, Journal of Biological Chemistry 281, 25492-25501. 
42. Cheng, G., Coolen, L. M., Padmanabhan, V., Goodman, R. L., and Lehman, M. N. (2010) 
The kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: 
sex differences and effects of prenatal testosterone in sheep, Endocrinology 151, 301-
311. 
43. Sheppard, K. M., Padmanabhan, V., Coolen, L. M., and Lehman, M. N. (2011) Prenatal 
programming by testosterone of hypothalamic metabolic control neurones in the ewe, J 
Neuroendocrinol 23, 401-411. 
44. Cernea, M., Phillips, R., Padmanabhan, V., Coolen, L.M. and Lehman, M.N. . (2012) 
Prenatal testosterone decreases colocalization of insulin receptors in KNDy and AgRP 
neurons in adult ewes: implications for reproductive and metabolic dysfunctions, 
Endocrinology manuscript to be submitted. 
45. Hahn, T. M., Breininger, J.F., Baskin, D.G., and Schwartz, M.W. (1998) Coexpression of 
Agrp and NPY in fasting-activated hypothalamic neurons Nature Neuroscience  1, 271 - 
272. 
46. Mihály, E., Fekete, C., Tatro, J. B., Liposits, Z., Stopa, E. G., and Lechan, R. M. (2000) 
Hypophysiotropic Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Human 
Hypothalamus Are Innervated by Neuropeptide Y, Agouti-Related Protein, and α-
Melanocyte-Stimulating Hormone, Journal of Clinical Endocrinology & Metabolism 85, 
2596-2603. 
47. Dobbins, A., Lubbers, L.S., Jackson, G.L., Kuehl, D.E., and Hileman, S.M. (2004) 
Neuropeptide Y gene expression in male sheep: influence of photoperiod and 
testosterone, Neuroendocrinology 79, 82-89. 
48. Sohn, E. H., Wolden-Hanson, T., and Matsumoto, A.M. (2002) Testosterone (T)-induced 
changes in arcuate nucleus cocaine-amphetamine-regulated transcript and NPY mRNA 
are attenuated in old compared to young male brown Norway rats: contribution of T to 
age-related changes in cocaine-amphetamine-regulated transcript and NPY gene 
expression., Endocrinology 143, 954-963. 
49. Nowicki, M., Bryc, W., and Kokot, F. (2001) Hormonal regulation of appetite and body 
mass in patients with advanced prostate cancer treated with combined androgen 
blockade, J Endocrinol Invest. 24, 31-36. 
50. Holte, J. (1996) Disturbances in insulin secretion and sensitivity in women with the 
polycystic ovary syndrome, Baillieres Clin Endocrinol Metab. 10, 221-247. 
51. Steckler, T. L., Herkimer, C., Dumesic, D.A., and Padmanabhan, V. . (2009) 
Developmental programming: excess weight gain ampliﬁes the effects of prenatal 
testosterone excess on reproductive cyclicity -- implication to PCOS, Endocrinology 150, 
1456--1465. 
52. Franks, S. (1995) Polycystic ovary syndrome, N Engl J Med 333, 853-861. 
53. Griffin, M. L., South, S.A., Yankov, V.I., Booth, R.A.Jr., Asplin, C.M., Veldhuis, J.D., and 
Evans, W.S. (1994) Insulin-dependent diabetes mellitus and menstrual dysfunction., Ann 
Med. 26, 331-340. 
54. Qiu, X., Dowling, A. R., Marino, J. S., Faulkner, L. D., Bryant, B., Brüning, J. C., Elias, C. F., 
and Hill, J. W. (2013) Delayed Puberty but Normal Fertility in Mice With Selective 
Deletion of Insulin Receptors From Kiss1 Cells, Endocrinology 154, 1337-1348. 
193 
 
55. Divall, S. A., Williams, T.R., Carver, S.E., Koch, L., Brüning, J.C., Kahn, C.R., Wondisford, F., 
Radovick, S., and Wolfe, A. (2010) Divergent roles of growth factors in the GnRH 
regulation of puberty in mice, J Clin Invest 120, 2900-2909. 
56. Tanaka, T., Nagatani, S., Bucholtz, D. C., Ohkura, S., Tsukamura, H., Maeda, K.-I., and 
Foster, D. L. (2000) Central Action of Insulin Regulates Pulsatile Luteinizing Hormone 
Secretion in the Diabetic Sheep Model, Biology of reproduction 62, 1256-1261. 
57. Pralong, F. P. (2010) Insulin and NPY pathways and the control of GnRH function and 
puberty onset, Molecular and cellular endocrinology 324, 82-86. 
58. Roa, J., and Herbison, A. E. (2012) Direct Regulation of GnRH Neuron Excitability by 
Arcuate Nucleus POMC and NPY Neuron Neuropeptides in Female Mice, Endocrinology 
153, 5587-5599. 
59. Backholer, K., Bowden, M., Gamber, K., Bjørbæk, C., Iqbal, J., and Clarke, I.J. (2010) 
Melanocortins Mimic the Effects of Leptin to Restore Reproductive Function in Lean 
Hypogonadotropic Ewes, Neuroendocrinology 91, 27-40. 
60. Rondini, T. A., Baddini, S.P., Sousa, L.F., Bittencourt, J.C., and Elias, C.F.   . (2004) 
Hypothalamic cocaine- and amphetamine-regulated transcript neurons project to areas 
expressing gonadotropin releasing hormone immunoreactivity and to the anteroventral 
periventricular nucleus in male and female rats., Neuroscience 125, 735–748. 
61. Navarro, V. M., Ruiz-Pino, F., Sánchez-Garrido, M.A., García-Galiano, D., Hobbs, S.J., 
Manfredi-Lozano, M., León, S., Sangiao-Alvarellos, S., Castellano, J.M., Clifton, D.K., 
Pinilla, L., Steiner, R.A., and Tena-Sempere, M. (2012) Role of Neurokinin B in the 
Control of Female Puberty and Its Modulation by Metabolic Status, J Neurosci. 32, 2388–
2397. 
62. Kauffman, A. S., Navarro, V. M., Kim, J., Clifton, D., and Steiner, R. A. (2009) Sex 
Differences in the Regulation of Kiss1/NKB Neurons in Juvenile Mice: Implications for 
the Timing of Puberty, Am J Physiol Endocrinol Metab. 
63. Nestor, C. C., Briscoe, A. M. S., Davis, S. M., Valent, M., Goodman, R. L., and Hileman, S. 
M. (2012) Evidence of a Role for Kisspeptin and Neurokinin B in Puberty of Female 
Sheep, Endocrinology. 
64. Sharma, T. P., Herkimer, C., West, C., Ye, W., Birch, R., Robinson, J. E., Foster, D. L., and 
Padmanabhan, V. (2002) Fetal programming: prenatal androgen disrupts positive 
feedback actions of estradiol but does not affect timing of puberty in female sheep, 
Biology of reproduction 66, 924-933. 
65. Wood, R., and Foster, D. (1998) Sexual differentiation of reproductive neuroendocrine 
function in sheep, Rev Reprod 3, 130-140. 
66. Ibañez, L., Potau, N., Virdis, R., Zampolli, M., Terzi, C., Gussinyé, M., Carrascosa, A., and 
Vicens-Calvet, E. (1993) Postpubertal outcome in girls diagnosed of premature pubarche 
during childhood: increased frequency of functional ovarian hyperandrogenism, Journal 
of Clinical Endocrinology & Metabolism 76, 1599-1603. 
67. Ibáñez, L., DiMartino-Nardi, J., Potau, N., and Saenger, P. (2000) Premature 
Adrenarche—Normal Variant or Forerunner of Adult Disease?, Endocrine reviews 21, 
671-696. 
68. Nada, S. E., Thompson, R. C., and Padmanabhan, V. (2010) Developmental 
programming: differential effects of prenatal testosterone excess on insulin target 
tissues, Endocrinology 151, 5165-5173. 
194 
 
69. Konner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., 
Hampel, B., Barsh, G. S., Kahn, C. R., Cowley, M. A., Ashcroft, F. M., and Bruning, J. C. 
(2007) Insulin action in AgRP-expressing neurons is required for suppression of hepatic 
glucose production, Cell Metab 5, 438-449. 
70. Lin, H. V., Plum, L., Ono, H., Gutierrez-Juarez, R., Shanabrough, M., Borok, E., Horvath, T. 
L., Rossetti, L., and Accili, D. (2010) Divergent regulation of energy expenditure and 
hepatic glucose production by insulin receptor in agouti-related protein and POMC 
neurons, Diabetes 59, 337-346. 
71. Kim, H. H., DiVall, S. A., Deneau, R. M., and Wolfe, A. (2005) Insulin regulation of GnRH 
gene expression through MAP kinase signaling pathways, Molecular and cellular 
endocrinology 242, 42-49. 
72. Backholer, K., Smith, J. T., Rao, A., Pereira, A., Iqbal, J., Ogawa, S., Li, Q., and Clarke, I. J. 
(2010) Kisspeptin Cells in the Ewe Brain Respond to Leptin and Communicate with 
Neuropeptide Y and Proopiomelanocortin Cells, Endocrinology 151, 2233-2243. 
73. Fu, L. Y. a. v. d. P., A.N. (2010) Kisspeptin directly excites anorexigenic 
proopiomelanocortin neurons but inhibits orexigenic neuropeptide Y cells by an indirect 
synaptic mechanism, J Neurosci. 30, 10205-10219. 
74. Amstalden, M., Alves, B. R. C., Liu, S., Cardoso, R. C., and Williams, G. L. (2011) 
Neuroendocrine pathways mediating nutritional acceleration of puberty: insights from 
ruminant models, Frontiers in Endocrinology 2. 
75. Karam, J. H., Grodsky, G.M., and Forsham, P.H. . (1963) Excessive insulin response to 
glucose in obese subjects as measured by immunochemical assay, Diabetes 12, 197–
204. 
76. Rabinowitz, D., and Zierler, K.L.   . (1962) Forearm metabolism in obesity and its 
response to intra-arterial insulin. Characterization of insulin resistance and evidence for 
adaptive hyperinsulinism, J Clin Invest 41, 2173–2181. 
77. Veiga-Lopez, A., Lee, J. S., and Padmanabhan, V. (2010) Developmental Programming: 
Insulin Sensitizer Treatment Improves Reproductive Function in Prenatal Testosterone-
Treated Female Sheep, Endocrinology 151, 4007-4017. 
78. Abi Salloum, B., Herkimer, C., Lee, J. S., Veiga-Lopez, A., and Padmanabhan, V. (2012) 
Developmental Programming: Prenatal and Postnatal Contribution of Androgens and 
Insulin in the Reprogramming of Estradiol Positive Feedback Disruptions in Prenatal 
Testosterone-Treated Sheep, Endocrinology 153, 2813-2822. 
79. Fica, S., Albu, A., Constantin, M., and Dobri, G.A. (2008) Insulin resistance and fertility in 
polycystic ovary syndrome., J Med Life. 1, 415-422. 
80. Svendsen, P. F., Nilas, L., Nørgaard, K., and Madsbad, S. (2005) Polycystic ovary 
syndrome. New pathophysiological discoveries--therapeutic consequences., Ugeskr 
Laeger 167, 3147-3151. 
81. Tang, T., Lord, J.M., Norman, R.J., Yasmin, E., and Balen, A.H. (2012) Insulin-sensitising 
drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with 
polycystic ovary syndrome, oligo amenorrhoea and subfertility, Cochrane Database Syst 
Rev. 16;5:CD003053. doi: 10.1002/14651858.CD003053.pub5. 
82. Sharma, S. T., and Nestler, J. E. (2006) Prevention of diabetes and cardiovascular disease 
in women with PCOS: Treatment with insulin sensitizers, Best Practice & Research 
Clinical Endocrinology & Metabolism 20, 245-260. 
195 
 
83. De Leo, V., Lanzetta, D., D’Antona, D., la Marca, A., and Morgante, G. (1998) Hormonal 
Effects of Flutamide in Young Women with Polycystic Ovary Syndrome, Journal of 
Clinical Endocrinology & Metabolism 83, 99-102. 
84. Nestler, J. E., Jakubowicz, D. J., Evans, W. S., and Pasquali, R. (1998) Effects of Metformin 
on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome, 
New England Journal of Medicine 338, 1876-1880. 
85. Palomba, S., Falbo, A., Zullo, F., and Orio, F. (2009) Evidence-Based and Potential 
Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review, 
Endocrine reviews 30, 1-50. 
86. Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., 
Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., Gosman, G. G., Nestler, 
J. E., Giudice, L. C., Leppert, P. C., and Myers, E. R. (2007) Clomiphene, Metformin, or 
Both for Infertility in the Polycystic Ovary Syndrome, New England Journal of Medicine 
356, 551-566. 
87. Legro, R. S., Zaino, R.J., Demers, L.M., Kunselman, A.R., Gnatuk, C.L., Williams, N.I., and 
Dodson, W.C. . (2007) The effects of metformin and rosiglitazone, alone and in 
combination, on the ovary and endometrium in polycystic ovary syndrome. , Am J 
Obstet Gynecol 196, 402. 
88. Ibáñez, L., Valls, C., Ferrer, A., Ong, K., Dunger, D. B., and de Zegher, F. (2002) Additive 
Effects of Insulin-Sensitizing and Anti-Androgen Treatment in Young, Nonobese Women 
with Hyperinsulinism, Hyperandrogenism, Dyslipidemia, and Anovulation, Journal of 
Clinical Endocrinology & Metabolism 87, 2870-2874. 
89. Nestler, J. E. (1987) Modulation of aromatase and P450 cholesterol side-chain cleavage 
enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth 
factor I, Endocrinology 121, 1845-1852. 
90. Nestler, J. E. (1990 ) Insulin-like growth factor II is a potent inhibitor of the aromatase 
activity of human placental cytotrophoblasts, Endocrinology 127, 2064–2070  
91. Barnes, R. B., Rosenfield, R. L., Ehrmann, D. A., Cara, J. F., Cuttler, L., Levitsky, L. L., and 
Rosenthal, I. M. (1994) Ovarian hyperandrogynism as a result of congenital adrenal 
virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in 
women, Journal of Clinical Endocrinology & Metabolism 79, 1328-1333. 
92. Nakae, J., Barr, V., and Accili, D. (2000) Differential regulation of gene expression by 
insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid 
residue in the forkhead transcription factor FKHR, EMBO J 19, 989-996. 
93. Puig, O., and Tjian, R. (2005) Transcriptional feedback control of insulin receptor by 
dFOXO/FOXO1, Genes & Development 19, 2435-2446. 
94. Fan, W., Yanase, T., Morinaga, H., Okabe, T., Nomura, M., Daitoku, H., Fukamizu, A., 
Kato, S., Takayanagi, R., and Nawata, H. (2007) Insulin-like growth factor 1/insulin 
signaling activates androgen signaling through direct interactions of Foxo1 with 
androgen receptor, The Journal of biological chemistry 282, 7329-7338. 
95. Louis, G. W., Greenwald-Yarnell, M., Phillips, R., Coolen, L. M., Lehman, M. N., and 
Myers, M. G. (2011) Molecular Mapping of the Neural Pathways Linking Leptin to the 
Neuroendocrine Reproductive Axis, Endocrinology 152, 2302-2310. 
96. Barash, I. A., Cheung, C.C., Weigle, D.S., Ren, H., Kabigting, E.B., Kuijper, J.L., Clifton, 
D.K., and Steiner, R.A. (1996) Leptin is a metabolic signal to the reproductive system. , 
Endocrinology 137:3144–3147 137, 3144–3147. 
196 
 
97. Chehab, F. F., Lim, M.E., and Lu, R. (1996) Correction of the sterility defect in 
homozygous obese female mice by treatment with the human recombinant leptin. , Nat 
Genet 12, 318–320. 
98. Backholer, K., Smith, J., and Clarke, I. J. (2009) Melanocortins May Stimulate 
Reproduction by Activating Orexin Neurons in the Dorsomedial Hypothalamus and 
Kisspeptin Neurons in the Preoptic Area of the Ewe, Endocrinology 150, 5488-5497. 
99. Cone, R. D., Cowley, M.A., Butler, A.A., Fan, W., Marks, D.L., and Low, M.J. . (2001) The 
arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. , Int J 
Obes Relat Metab Disord. 25, S63–S67. 
100. Erickson, J. C., Hollopeter, G., and Palmiter, R. D. (1996) Attenuation of the Obesity 
Syndrome of ob/ob Mice by the Loss of Neuropeptide Y, Science 274, 1704-1707. 
101. Mizuno, T. M., and Mobbs, C. V. (1999) Hypothalamic Agouti-Related Protein Messenger 
Ribonucleic Acid Is Inhibited by Leptin and Stimulated by Fasting, Endocrinology 140, 
814-817. 
102. Schwartz, M. W., and Porte, D. (2005) Diabetes, Obesity, and the Brain, Science 307, 
375-379. 
103. Williams, K. W., Scott, M. M., and Elmquist, J. K. (2011) Modulation of the central 
melanocortin system by leptin, insulin, and serotonin: Co-ordinated actions in a 
dispersed neuronal network, European Journal of Pharmacology 660, 2-12. 
104. Woods, S. C., and D'Alessio, D. A. (2008) Central Control of Body Weight and Appetite, 
Journal of Clinical Endocrinology & Metabolism 93, s37-s50. 
105. Estrada, K. M., Pompolo, S., Morris, M. J., Tilbrook, A. J., and Clarke, I. J. (2003) 
Neuropeptide Y (NPY) Delays the Oestrogen-Induced Luteinizing Hormone (LH) Surge in 
the Ovariectomized Ewe: Further Evidence That NPY has a Predominant Negative Effect 
on LH Secretion in the Ewe, Journal of neuroendocrinology 15, 1011-1020. 
106. Schioth, H. B., Kakizaki, Y., Kohsaka, A., Suda, T., and Watanobe, H.   . (2001) Agouti-
related peptide prevents steroid-induced luteinizing hormone and prolactin surges in 
female rats, NeuroReport. 12, 687–690. 
107. Watanobe, H., Schiöth, H. B., Wikberg, J. E. S., and Suda, T. (1999) The Melanocortin 4 
Receptor Mediates Leptin Stimulation of Luteinizing Hormone and Prolactin Surges in 
Steroid-Primed Ovariectomized Rats, Biochemical and Biophysical Research 
Communications 257, 860-864. 
108. Vulliémoz, N. R., Xiao, E., Xia-Zhang, L., Wardlaw, S. L., and Ferin, M. (2005) Central 
Infusion of Agouti-Related Peptide Suppresses Pulsatile Luteinizing Hormone Release in 
the Ovariectomized Rhesus Monkey, Endocrinology 146, 784-789. 
109. Farooqi, S. a. O. R., S. (2006) Genetics of obesity in humans., Endocr Rev. 27, 710-718. 
110. Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., and Gruters, A. . (1998) 
Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by 
POMC mutations in humans. , Nat Genet. 19, 155–157. 
111. Yeo, G., Farooqi, I., Aminian, S., Halsall, D., Stanhope, R., and O’Rahilly, S. . (1998) A 
frameshift mutation in MC4R associated with dominantly inherited human obesity.  , 
Nat Genet. 20, 111-112. 
112. van de Wall, E., Leshan, R., Xu, A.W., Balthasar, N., Coppari, R., Liu, S.M., Jo, Y.H., 
MacKenzie, R.G., Allison, D.B., Dun, N.J., Elmquist, J., Lowell, B.B., Barsh, G.S., de Luca, 
C., Myers, M.G. Jr., Schwartz, G.J., Chua, S.C. Jr. (2008) Collective and individual 
197 
 
functions of leptin receptor modulated neurons controlling metabolism and ingestion, 
Endocrinology 149, 1773-1785. 
113. Scott, M. M., Lachey, J.L., Sternson, S.M., Lee, C.E., Elias, C.F., Friedman, J.M., and 
Elmquist, J.K. (2009) Leptin targets in the mouse brain, J Comp Neurol. 514, 518-532. 
114. Myers, M. G., Jr., Munzberg, H., Leinninger, G.M., and Leshan, R.L.   . (2009) The 
geometry of leptin action in the brain: more complicated than a simple ARC, Cell Metab. 
9, 117–123. 
115. Williams, L. M., Adam, C.L., Mercer, J.G., Moar, K.M., Slater, D., Hunter, L., Findlay, P.A., 
and Hoggard, N. (1999) Leptin receptor and neuropeptide Y gene expression in the 
sheep brain, J Neuroendocrinol. 11, 165-169. 
116. Donato, J., Cravo, R. M., Frazão, R., Gautron, L., Scott, M. M., Lachey, J., Castro, I. A., 
Margatho, L. O., Lee, S., Lee, C., Richardson, J. A., Friedman, J., Chua, S., Coppari, R., 
Zigman, J. M., Elmquist, J. K., and Elias, C. F. (2011) Leptin’s effect on puberty in mice is 
relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 
neurons, The Journal of Clinical Investigation 121, 355-368. 
117. Donato, J., Jr., Silva, R.J., Sita, L.V., Lee, S., Lee, C., Lacchini, S., Bittencourt, J.C., Franci, 
C.R., Canteras, N.S., and Elias, C.F. . (2009) The ventral premammillary nucleus links 
fasting-induced changes in leptin levels and coordinated luteinizing hormone secretion. , 
J Neurosci. 29, 5240–5250. 
118. Leshan, R. L., Louis, G.W., Jo, Y., Rhodes, C.J., Münzberg, H., and Myers Jr, M.G. (2009) 
Direct Innervation of GnRH Neurons by Metabolic- and Sexual Odorant-Sensing Leptin 
Receptor Neurons in the Hypothalamic Ventral Premammillary Nucleus, J Neurosci 29, 
3138–3147. 
119. Elmquist, J. K., Bjørbæk, C., Ahima, R. S., Flier, J. S., and Saper, C. B. (1998) Distributions 
of leptin receptor mRNA isoforms in the rat brain, The Journal of comparative neurology 
395, 535-547. 
120. Elias, C. F., Kelly, J.F., Lee, C.E., Ahima, R.S., Drucker, D.J., Saper, C.B., and Elmquist, J.K. 
(2000) Chemical characterization of leptin-activated neurons in the rat brain, J Comp 
Neurol. 432, 261-281. 
121. Leranth, C., MacLusky, N.J., Shanabrough, M., and Naftolin, F. . (1988) 
Immunohistochemical evidence for synaptic connections between pro-
opiomelanocortinimmunoreactive axons and LH-RH neurons in the preoptic area of the 
rat., Brain Res 449, 167–176. 
122. Chen, W. P., Witkin, J. W., and Silverman, A. J. (1990) Sexual dimorphism in the synaptic 
input to gonadotropin releasing hormone neurons, Endocrinology 126, 695-702. 
123. Tsuruo, Y., Kawano, H., Kagotani, Y., Hisano, S., Daikoku, S., Chihara, K., Zhang, T., and 
Yanaihara, N. (1990) Morphological evidence for neuronal regulation of luteinizing 
hormone-releasing hormone-containing neurons by neuropeptide Y in the rat septo-
preoptic area, Neuroscience letters 110, 261-266. 
124. Matsuzaki, T., Iwasa, T., Kinouchi, R., Yoshida, S., Murakami, M., Gereltsetseg, G., 
Yamamoto, S., Kuwahara, A., Yasui, T., and Irahara, M. (2011) Fasting reduces the kiss1 
mRNA levels in the caudal hypothalamus of gonadally intact adult female rats, Endocr J. 
58, 1003-1012. 
125. Quennell, J. H., Howell, C. S., Roa, J., Augustine, R. A., Grattan, D. R., and Anderson, G. 
M. (2011) Leptin Deficiency and Diet-Induced Obesity Reduce Hypothalamic Kisspeptin 
Expression in Mice, Endocrinology 152, 1541-1550. 
198 
 
126. Wahab, F., Ullah, F., Chan, Y.M., Seminara, S.B., and Shahab, M. (2011) Decrease in 
hypothalamic Kiss1 and Kiss1r expression: a potential mechanism for fasting-induced 
suppression of the HPG axis in the adult male rhesus monkey (Macaca mulatta). Horm 
Metab Res. 43, 81-85. 
127. Castellano, J. M., Navarro, V.M., Fernández-Fernández, R., Nogueiras, R., Tovar, S., Roa, 
J., Vazquez, M.J., Vigo, E., Casanueva, F.F., Aguilar, E., Pinilla, L., Dieguez, C., and Tena-
Sempere, M. (2005) Changes in hypothalamic KiSS-1 system and restoration of pubertal 
activation of the reproductive axis by kisspeptin in undernutrition. , Endocrinology 146, 
3917–3925. 
128. Gosnell, B. A., Levine, A.S., and Morley, J.E.  . (1986) The stimulation of food intake by 
selective agonists of mu, kappa and delta opioid receptors, Life Sci 38, 1081–1088. 
129. Berman, Y., Devi, L., Spangler, R., Kreek, M.J., and Carr, K.D. (1997) Chronic food 
restriction and streptozotocin-induced diabetes differentially alter prodynorphin mRNA 
levels in rat brain regions., Brain Res Mol Brain Res. 46, 25-30. 
130. Hervé, C., and Fellmann, D. (1997) Changes in rat melanin-concentrating hormone and 
dynorphin messenger ribonucleic acids induced by food deprivation, Neuropeptides 31, 
237-242. 
131. Lambert, P. D., Wilding, J. P., al-Dokhayel, A. A., Bohuon, C., Comoy, E., Gilbey, S. G., and 
Bloom, S. R. (1993) A role for neuropeptide-Y, dynorphin, and noradrenaline in the 
central control of food intake after food deprivation, Endocrinology 133, 29-32. 
132. Israel, Y., Kandov, Y., Khaimova, E., Kest, A., Lewis, S.R., and Pasternak,G.W., et al. . 
(2005) NPY-induced feeding: pharmacological characterization using selective opioid 
antagonists and antisense probes in rats, Peptides 26, 1167-1175. 
133. Cole, J. L., Leventhal, L., Pasternak, G. W., Bowen, W. D., and Bodnar, R. J. (1995) 
Reductions in body weight following chronic central opioid receptor subtype antagonists 
during development of dietary obesity in rats, Brain research 678, 168-176. 
134. Jarosz, P. A., and Metzger, B. L. (2002) The Effect of Opioid Antagonismon Food Intake 
Behavior and Body Weight in a Biobehavioral Model of Obese Binge Eating, Biological 
Research For Nursing 3, 198-209. 
135. McConway, M. G., Johnson, D., Kelly, A., Griffin, D., Smith, J., and Wallace, A.M. . (2000) 
Differences in circulating concentrations of total, free and bound leptin relate to gender 
and body composition in adult humans, Ann Clin Biochem. 37, 717-723. 
136. Shimizu, H., Oh, I.S., Okada, S., and Mori, M. . (2007) Leptin resistance and obesity. , 
Endocr J. 54, 17–26. 
137. Gambineri, A., Pelusi, C., Vicennati, V., Pagotto, U., and Pasquali, R. (2002) Obesity and 
the polycystic ovary syndrome, International Journal of Obesity 26 883-896. 
138. Brzechffa, P. R., Jakimiuk, A. J., Agarwal, S. K., Weitsman, S. R., Buyalos, R. P., and 
Magoffin, D. A. (1996) Serum immunoreactive leptin concentrations in women with 
polycystic ovary syndrome, Journal of Clinical Endocrinology & Metabolism 81, 4166-
4169. 
139. Glintborg, D., Andersen, M., Hagen, C., Frystyk, J., Hulstrøm, V., Flyvbjerg, A., and 
Hermann, A. P. (2006) Evaluation of metabolic risk markers in polycystic ovary syndrome 
(PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and 
controls, European Journal of Endocrinology 155, 337-345. 
140. Mantzoros, C. S., Dunaif, A., and Flier, J. S. (1997) Leptin Concentrations in the Polycystic 
Ovary Syndrome, Journal of Clinical Endocrinology & Metabolism 82, 1687-1691. 
199 
 
141. Pirwany, I., Fleming, R., Sattar, N., Greer, I., and Wallace, A. (2001) Circulating leptin 
concentrations and ovarian function in polycystic ovary syndrome, European Journal of 
Endocrinology 145, 289-294. 
142. Rouru, J., Anttila, L., Koskinen, P., Penttilä, T.-A., Irjala, K., Huupponen, R., and Koulu, M. 
(1997) Serum Leptin Concentrations in Women with Polycystic Ovary Syndrome, Journal 
of Clinical Endocrinology & Metabolism 82, 1697-1700. 
143. Sepilian, V. P., Crochet, J. R., and Nagamani, M. (2006) Serum soluble leptin receptor 
levels and free leptin index in women with polycystic ovary syndrome: relationship to 
insulin resistance and androgens, Fertility and Sterility 85, 1441-1447. 
144. HorlickK, M. B., Rosenbaum, M., Nicholson, M., Levine, L. S., Fedun, B., Wang, J., 
Pierson, R. N., and Leibel, R. L. (2000) Effect of Puberty on the Relationship between 
Circulating Leptin and Body Composition, Journal of Clinical Endocrinology & 
Metabolism 85, 2509-2518. 
145. Cheung, C. C., Thornton, J. E., Kuijper, J. L., Weigle, D. S., Clifton, D. K., and Steiner, R. A. 
(1997) Leptin Is a Metabolic Gate for the Onset of Puberty in the Female Rat, 
Endocrinology 138, 855-858. 
146. Elias, C. F. a. P., D. (2013) Leptin signaling and circuits in puberty and fertility, Cell Mol 
Life Sci. 70, 841-862. 
147. Foster, D. L., Padmanabhan, V., Wood, R. I., and Robinson, J. E. (2002) Sexual 
differentiation of the neuroendocrine control of gonadotrophin secretion: concepts 
derived from sheep models, Reprod Suppl 59, 83-99. 
148. Goy, R. W. a. M., B.S. 1980  (1980) Sexual differentiation of the brain., Cambridge: MIT 
Press. 
149. Resko, J. A. a. R. C. E. (1997) Prenatal hormones organise sex differences in the 
neuroendocrine reproductive system; observations on guinea pigs and non human 
primates., Cell Mol Neurobiol 17, 627-648. 
150. Herman, R. A., Jones, B., Mann, D.R., and Wallen, K.   . (2000) Timing of prenatal 
androgen exposure: anatomical and endocrine effects on juvenile male and female 
rhesus monkeys, Horm Behav. 38, 52-66. 
151. Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., and Azziz, R. (2011) Polycystic ovary 
syndrome: etiology, pathogenesis and diagnosis, Nat Rev Endocrinol 7, 219-231. 
 
 
 
 
 
 
 
 
 
200 
 
Maria Cernea 
 
Department of Anatomy and Cell Biology 
University of Western Ontario 
1151 Richmond St., London, Ontario 
N6A 3K7  
 
 
 
PhD Candidate, University of Western Ontario, Graduate Program in 
Anatomy and Cell Biology, London, ON 
 
Attended the University of Michigan (department of Molecular and Integrative 
Physiology) in Ann Arbor, Michigan and the University of Mississippi Medical 
Center (department of Neurobiology and Anatomical Sciences program) in 
Jackson, Mississippi as a visiting scholar. 
 
EDUCATIONAL BACKGROUNG 
 
PhD   June 2011 – August 2013 
   University of Western Ontario 
   Department of Anatomy and Cell Biology 
   Supervisor:  Dr. Michael Lehman 
 
MSc   Sept. 2009 – June 2011  
   University of Western Ontario 
   Graduate Program in Neuroscience 
   Supervisor:  Dr. Michael Lehman 
 
BSc               Sept. 2003 – May 2007 
University of Western Ontario 
             Department of Biology  
 
SCOLARSHIPS 
 
2009-2012- Schulich Graduate Scholarship - University of Western Ontario  
Sum of tuition fees up to six terms of a doctorate degree. 
Awarded to students with an academic average of 80+. 
 
2003-2007- Western Scholarship of Distinction – University of Western Ontario 
Admission scholarship: $1000 awarded to students with an 
academic average of 85+. 
 
201 
 
AREAS OF EXPERIENCE DETAILS 
 
Animal Handling 
 
Behaviour watching and recording of sheep, blood 
sampling from jugular vein, brain tissue removal, 
perfusion and fixation of brain, organ tissue removal and 
fixation  
Tissue processing Brain tissue sectioning, immunohistochemistry (enzyme 
and fluorescence) 
 
Statistical analysis Quantitative and qualitative analysis of immunostaining, 
Microscopy: phase contrast, fluorescence, confocal, data 
statistical analysis and presentation (Microsoft Word, 
SigmaStat, Excel, PowerPoint, and Image J Software) 
 
 
PUBLICATIONS 
 
1. Goodman, R.L., Hileman, S.L., Nestor, C.C., Porter, K.L., Connors, J.M., Hardy, 
S.L., Millar, R.P., Cernea, M., Coolen, L.M., and Lehman, M.N. 2013. Kisspeptin, 
neurokinin B, and dynorphin act in the arcuate nucleus to control activity of the 
GnRH pulse generator in ewes. Endocrinology, In Press.  
 
2. Cernea, M., Coolen, L.M., Padmanabhan, V., Merkley, C., Lee, T., and Lehman, 
M.N. 2012. Effects of prenatal testosterone on KNDy-GnRH circuitry in a sheep 
model of PCOS, Endocrinology (manuscript to be submitted). 
 
3. Cernea, M., Lee, T., Cheng, G., Padmanabhan, V., Lehman, M.N., and Coolen, 
L.M. 2012. Excess prenatal testosterone increases androgen receptor 
immunoreactivity in hypothalamic areas of the adult female sheep brain, 
Endocrinology (manuscript to be submitted). 
 
4. Cernea, M., Phillips, R., Padmanabhan, V., Coolen, L.M. and Lehman, M.N. 2012. 
Prenatal testosterone decreases colocalization of insulin receptors in KNDy and 
AgRP neurons in adult ewes: implications for reproductive and metabolic 
dysfunctions, Endocrinology (manuscript to be submitted). 
 
5. Cernea, M., Coolen, L, Phillips, R., and Lehman, M.N. 2012. Neural pathways by 
which leptin may modulate GnRH secretion in the sheep: activation of AgRP, 
POMC and kisspeptin (KNDy) neurons (in preparation). 
 
6. Cernea, M., Coolen, L.M., Padmanabhan, V., and Lehman, M.N. Prenatal and 
postnatal contribution of insulin in the programming of androgen and insulin 
receptor colocalization with KNDy and AgRP cells in the hypothalamus of 
prenatal testosterone-treated sheep (in preparation). 
202 
 
ABSTRACTS 
 
1. Cernea, M., Coolen, L.M., Padmanabhan, V., and Lehman, M.N. Co-treatment 
with insulin sensitizer or androgen antagonist blocks the effects of prenatal 
testosterone on AgRP cell number in female sheep hypothalamus. 43rd Annual 
Society for Neuroscience Meeting in San Diego, CA. Abstract and poster 
presentation 
 
2. Cernea, M., Phillips, R., Padmanabhan, V., Coolen, L.M. and Lehman, M.N. 
2012. Prenatal testosterone decreases co-expression of insulin receptors in 
KNDy neurons in adult ewes. 2
nd
 Kisspeptin World Conference: Kisspeptin 
signaling in the brain in Tokyo, Japan. Abstract and poster presentation. 
 
3. Cernea, M., Phillips, R., Padmanabhan, V., Coolen, L.M. and Lehman, M.N. 
2012. Prenatal testosterone decreases co-expression of insulin receptors in 
KNDy neurons in adult ewes. 42
nd
 Annual Society for Neuroscience Meeting in 
New Orleans, LA. Abstract and poster presentation. 
 
4. Cernea, M., Coolen, L, Phillips, R., and Lehman, M.N. 2012.  Neural 
pathways by which leptin may modulate GnRH secretion in the sheep: 
activation of AgRP, POMC and kisspeptin (KNDy) neurons. 94
th
 Annual 
Endocrinology Conference in Houston, TX. Abstract and poster presentation. 
 
5. Cernea, M., Lee, T., Cheng, G., Padmanabhan, V., Lehman, M.N., and Coolen, 
L.M. 2011. Excess prenatal testosterone increases androgen receptor expression 
in hypothalamic areas of the female sheep brain. 41
st
 Annual Society for 
Neuroscience Meeting in Washington, DC. Abstract and poster presentation. 
 
6. Cernea, M., Padmanabhan, V., Merkley, C., Coolen, L.M., Lee, T., and 
Lehman, M.N. 2011. Effects of prenatal testosterone on KNDy-GnRH circuitry 
in a sheep model of PCOS. 93
rd
 Annual Endocrinology Conference in Boston, 
MA. 2011. Abstract and poster presentation. 
 
7. Cernea, M., Merkley, C., Coolen, L.M., Lee, T., Padmanabhan, V., and 
Lehman, M.N. 2011. Effects of prenatal testosterone on KNDy-GnRH circuitry 
in the sheep hypothalamus. The 1
st
 Annual Michigan Alliance for Reproductive 
Technologies and Science (MARTS) Research Symposium, 2011. Michigan 
State University, Abstract and Poster. 
 
8. Cernea, M., Merkley, C., Coolen, L.M., Lee, T., Padmanabhan, V., and 
Lehman, M.N. 2011. Effects of prenatal testosterone on KNDy-GnRH circuitry 
in the sheep hypothalamus. Anita Payne Lectureship and Poster Day, 
University of Michigan, 2010, Abstract and Poster.  
 
203 
 
RELEVANT WORK EXPERIENCE 
 
2009-2010  Teaching Assistant  
Anatcell 9531a: Neuroscience for Rehabilitation Sciences: two 2hr 
lectures per week, five 3hr labs in place of lecture, five 3 hr prep for lab 
including pre lab meetings, preparation of lab case studies and case study 
presentation). 
 
   
 
 
 
PROFESSIONAL AFFILIATIONS 
Society for Neuroscience Member (2010-Present) 
The Endocrine Society Member (2010-Present) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
204 
 
REFERENCES 
Dr. Michael N. Lehman 
Chairman and Professor 
Department of Neurobiology and Anatomical Sciences 
The University of Mississippi Medical Center 
2500 North State Street 
Jackson, Mississippi 39216-4505 
 
 
Dr. Lique M. Coolen 
Department of Physiology 
The University of Mississippi Medical Center 
2500 North State Street 
Jackson, Mississippi 39216-4505 
 
 
Dr. Ian C. Webb 
Assistant Professor 
Department of Neurobiology and Anatomical Sciences 
University of Mississippi Medical Center 
2500 North State Street 
Jackson, Mississippi 39216-4505 
 
